Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Pathways

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:inorganic hydroxy compound
go back to main search page
Accession:CHEBI:52625 term browser browse the term
Synonyms:related_synonym: inorganic hydroxides



show annotations for term's descendants           Sort by:
ammonium hydroxide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression EXP Ammonium Hydroxide results in increased expression of FOS protein CTD PMID:14750966 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
increases expression
ISO Ammonium Hydroxide results in increased expression of and results in increased activity of HMOX1 protein
Ammonium Hydroxide results in increased expression of HMOX1 mRNA
CTD PMID:27867098 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
JBrowse link
Augmentin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP binding cassette subfamily B member 11 decreases expression ISO Amoxicillin-Potassium Clavulanate Combination results in decreased expression of ABCB11 mRNA CTD PMID:34767876 NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:74,424,979...74,520,581
JBrowse link
G Akr1b10 aldo-keto reductase family 1 member B10 increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of AKR1B10 mRNA CTD PMID:34767876 NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:64,007,420...64,020,847
JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions EXP Augmentin inhibits the reaction [Ethanol decreases phosphorylation of Akt1 protein in the prefrontal cortex RGD PMID:26168897 RGD:598147077 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
JBrowse link
G Casp3 caspase 3 increases activity EXP Amoxicillin-Potassium Clavulanate Combination results in increased activity of CASP3 protein CTD PMID:30273099 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Casp9 caspase 9 increases activity EXP Amoxicillin-Potassium Clavulanate Combination results in increased activity of CASP9 protein CTD PMID:30273099 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Cycs cytochrome c, somatic increases secretion EXP Amoxicillin-Potassium Clavulanate Combination results in increased secretion of CYCS protein CTD PMID:30273099 NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:80,982,668...80,984,816
Ensembl chr18:80,982,668...80,984,816
JBrowse link
G Cyp27a1 cytochrome P450, family 27, subfamily a, polypeptide 1 decreases expression ISO Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP27A1 mRNA CTD PMID:34767876 NCBI chr 9:83,712,402...83,743,222
Ensembl chr 9:83,713,293...83,743,215
JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 decreases expression ISO Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP7A1 mRNA CTD PMID:34767876 NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:24,174,505...24,184,202
JBrowse link
G Cyp8b1 cytochrome P450 family 8 subfamily B member 1 decreases expression ISO Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP8B1 mRNA CTD PMID:34767876 NCBI chr 8:130,455,622...130,457,592
Ensembl chr 8:130,442,503...130,457,689
JBrowse link
G Fgf19 fibroblast growth factor 19 increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of FGF19 mRNA CTD PMID:34767876 NCBI chr 1:200,056,526...200,060,980
Ensembl chr 1:209,485,813...209,490,267
JBrowse link
G G6pd glucose-6-phosphate dehydrogenase increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of G6PD mRNA CTD PMID:34767876 NCBI chr  X:157,352,364...157,372,144
Ensembl chr  X:157,352,373...157,372,144
JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of GCLC mRNA CTD PMID:34767876 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of GCLM mRNA CTD PMID:34767876 NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003
JBrowse link
G Ggt1 gamma-glutamyltransferase 1 increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of GGT1 protein CTD PMID:34767876 NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,141...13,088,050
JBrowse link
G Got1 glutamic-oxaloacetic transaminase 1 increases activity EXP Amoxicillin-Potassium Clavulanate Combination results in increased activity of GOT1 protein CTD PMID:30273099 NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:252,284,434...252,329,871
JBrowse link
G Gpt glutamic--pyruvic transaminase increases activity EXP Amoxicillin-Potassium Clavulanate Combination results in increased activity of GPT protein CTD PMID:30273099 NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:110,296,206...110,300,160
JBrowse link
G Gpx2 glutathione peroxidase 2 increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of GPX2 mRNA CTD PMID:34767876 NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862
JBrowse link
G Gsr glutathione-disulfide reductase increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of GSR mRNA CTD PMID:34767876 NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
JBrowse link
G Me1 malic enzyme 1 increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of ME1 mRNA CTD PMID:34767876 NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:96,429,057...96,540,275
JBrowse link
G Nr0b2 nuclear receptor subfamily 0, group B, member 2 increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of NR0B2 mRNA CTD PMID:34767876 NCBI chr 5:151,063,160...151,066,475
Ensembl chr 5:151,063,160...151,066,475
JBrowse link
G Slc10a1 solute carrier family 10 member 1 decreases expression ISO Amoxicillin-Potassium Clavulanate Combination results in decreased expression of SLC10A1 mRNA CTD PMID:34767876 NCBI chr 6:100,613,045...100,626,670
Ensembl chr 6:106,344,319...106,357,944
JBrowse link
G Slc1a2 solute carrier family 1 member 2 increases expression
multiple interactions
EXP Augmentin cotreated with ethanol increases expression of Slc1a2 in prefrontal cortex and nucleus accumbens
Augmentin inhibits the reaction [ethanol decreases expression of Slc1a2 protein in nucleus accumbens]
Augmentin inhibits the reaction [ethanol decreases expression of Slc1a2 protein in prefrontal cortex]
RGD PMID:27993695 PMID:27199635 PMID:26168897 RGD:598147066, RGD:598154609, RGD:598147077 NCBI chr 3:89,005,129...89,135,469
Ensembl chr 3:109,459,630...109,605,249
JBrowse link
G Slc51a solute carrier family 51 member A decreases expression ISO Amoxicillin-Potassium Clavulanate Combination results in decreased expression of SLC51A mRNA CTD PMID:34767876 NCBI chr11:68,299,086...68,313,485
Ensembl chr11:81,803,972...81,818,539
JBrowse link
G Slc7a11 solute carrier family 7 member 11 increases expression
multiple interactions
increases expression
ISO
EXP
Amoxicillin-Potassium Clavulanate Combination results in increased expression of SLC7A11 mRNA
Augmentin inhibits the reaction [ethanol decreases expression of Slc7a11 protein in nucleus accumbens and prefrontal cortex]
Augmentin cotreated with ethanol increases expression of Slc7a11 in prefrontal cortex and nucleus accumbens
CTD
RGD
PMID:34767876 PMID:27199635 PMID:27993695 RGD:598154609, RGD:598147066 NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:136,532,246...136,695,695
JBrowse link
G Tkt transketolase increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of TKT mRNA CTD PMID:34767876 NCBI chr16:5,723,764...5,748,702
Ensembl chr16:5,729,991...5,756,431
JBrowse link
G Txnrd1 thioredoxin reductase 1 increases expression ISO Amoxicillin-Potassium Clavulanate Combination results in increased expression of TXNRD1 mRNA CTD PMID:34767876 NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817
JBrowse link
calcium dihydroxide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Alpl alkaline phosphatase, biomineralization associated increases expression ISO Calcium Hydroxide results in increased expression of ALPL mRNA CTD PMID:22083529 NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:155,234,775...155,254,167
JBrowse link
G Col1a1 collagen type I alpha 1 chain increases expression ISO Calcium Hydroxide results in increased expression of COL1A1 mRNA CTD PMID:22083529 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
JBrowse link
G Esr1 estrogen receptor 1 increases expression ISO Calcium Hydroxide results in increased expression of ESR1 mRNA CTD PMID:22083529 NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:43,644,392...43,900,354
JBrowse link
G Polg DNA polymerase gamma, catalytic subunit affects expression ISO Calcium Hydroxide affects the expression of POLG mRNA CTD PMID:30615914 NCBI chr 1:133,382,764...133,399,578
Ensembl chr 1:142,792,119...142,808,838
JBrowse link
G Polg2 DNA polymerase gamma 2, accessory subunit affects expression ISO Calcium Hydroxide affects the expression of POLG2 mRNA CTD PMID:30615914 NCBI chr10:91,712,586...91,723,008
Ensembl chr10:92,212,304...92,222,726
JBrowse link
G Tfam transcription factor A, mitochondrial affects expression ISO Calcium Hydroxide affects the expression of TFAM mRNA CTD PMID:30615914 NCBI chr20:17,355,373...17,367,422
Ensembl chr20:17,355,363...17,369,877
JBrowse link
G Trpv1 transient receptor potential cation channel, subfamily V, member 1 increases expression ISO Calcium Hydroxide results in increased expression of TRPV1 mRNA CTD PMID:22083529 NCBI chr10:57,851,428...57,876,513
Ensembl chr10:58,340,223...58,375,021
JBrowse link
carbidopa term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Bax BCL2 associated X, apoptosis regulator multiple interactions ISO [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in increased expression of BAX protein]; Carbidopa inhibits the reaction [Cisplatin results in increased expression of BAX protein]
Carbidopa inhibits the reaction [Carbon Tetrachloride results in increased expression of BAX protein]; Carbidopa promotes the reaction [sarpogrelate inhibits the reaction [Carbon Tetrachloride results in increased expression of BAX protein]]; sarpogrelate promotes the reaction [Carbidopa inhibits the reaction [Carbon Tetrachloride results in increased expression of BAX protein]]
CTD PMID:34560070 PMID:35202708 NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:105,076,473...105,086,429
JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions ISO [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]; Carbidopa inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 protein]; Carbidopa promotes the reaction [sarpogrelate inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 protein]]; sarpogrelate promotes the reaction [Carbidopa inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 protein]]
[sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]; Carbidopa inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]
CTD PMID:34560070 PMID:35202708 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
JBrowse link
G Casp3 caspase 3 multiple interactions ISO [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]; Carbidopa inhibits the reaction [Carbon Tetrachloride results in increased cleavage of CASP3 protein]; Carbidopa promotes the reaction [sarpogrelate inhibits the reaction [Carbon Tetrachloride results in increased cleavage of CASP3 protein]]; sarpogrelate promotes the reaction [Carbidopa inhibits the reaction [Carbon Tetrachloride results in increased cleavage of CASP3 protein]]
[sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]; Carbidopa inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]
CTD PMID:34560070 PMID:35202708 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Casp9 caspase 9 multiple interactions ISO [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein]; Carbidopa inhibits the reaction [Carbon Tetrachloride results in increased cleavage of CASP9 protein]; Carbidopa promotes the reaction [sarpogrelate inhibits the reaction [Carbon Tetrachloride results in increased cleavage of CASP9 protein]]; sarpogrelate promotes the reaction [Carbidopa inhibits the reaction [Carbon Tetrachloride results in increased cleavage of CASP9 protein]]
[sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein]; Carbidopa inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein]
CTD PMID:34560070 PMID:35202708 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Comt catechol-O-methyltransferase increases methylation ISO
EXP
COMT protein results in increased methylation of Carbidopa CTD PMID:11160877 NCBI chr11:96,072,371...96,091,956
Ensembl chr11:96,072,489...96,092,533
JBrowse link
G Ddc dopa decarboxylase multiple interactions ISO [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Carbon Tetrachloride results in increased expression of DDC mRNA]
Carbidopa binds to and results in decreased activity of DDC protein
CTD PMID:35151785 PMID:35202708 NCBI chr14:90,592,304...90,682,830
Ensembl chr14:90,592,304...90,682,806
JBrowse link
G Dnm1l dynamin 1-like multiple interactions ISO Carbidopa inhibits the reaction [Carbon Tetrachloride results in increased expression of DNM1L protein]; Carbidopa promotes the reaction [sarpogrelate inhibits the reaction [Carbon Tetrachloride results in increased expression of DNM1L protein]]; sarpogrelate promotes the reaction [Carbidopa inhibits the reaction [Carbon Tetrachloride results in increased expression of DNM1L protein]] CTD PMID:35202708 NCBI chr11:98,084,049...98,135,663
Ensembl chr11:98,085,397...98,137,420
JBrowse link
G Fis1 fission, mitochondrial 1 multiple interactions ISO Carbidopa inhibits the reaction [Carbon Tetrachloride results in increased expression of FIS1 protein]; Carbidopa promotes the reaction [sarpogrelate inhibits the reaction [Carbon Tetrachloride results in increased expression of FIS1 protein]]; sarpogrelate promotes the reaction [Carbidopa inhibits the reaction [Carbon Tetrachloride results in increased expression of FIS1 protein]] CTD PMID:35202708 NCBI chr12:19,708,560...19,723,392
Ensembl chr12:25,345,239...25,349,335
JBrowse link
G Gpt glutamic--pyruvic transaminase multiple interactions ISO Carbidopa inhibits the reaction [Carbon Tetrachloride results in increased activity of GPT protein]; Carbidopa promotes the reaction [sarpogrelate inhibits the reaction [Carbon Tetrachloride results in increased activity of GPT protein]]; sarpogrelate promotes the reaction [Carbidopa inhibits the reaction [Carbon Tetrachloride results in increased activity of GPT protein]] CTD PMID:35202708 NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:110,296,206...110,300,160
JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in increased expression of IL1B protein]
[sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in increased secretion of IL1B protein]; Carbidopa inhibits the reaction [Cisplatin results in increased secretion of IL1B protein]
CTD PMID:34560070 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
JBrowse link
G Maoa monoamine oxidase A multiple interactions ISO [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Carbon Tetrachloride results in increased expression of MAOA mRNA]; [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in increased expression of MAOA protein]; Carbidopa inhibits the reaction [Carbon Tetrachloride results in increased expression of MAOA mRNA]; Carbidopa inhibits the reaction [Carbon Tetrachloride results in increased expression of MAOA protein]; Carbidopa inhibits the reaction [Cisplatin results in increased expression of MAOA protein]; Carbidopa promotes the reaction [sarpogrelate inhibits the reaction [Carbon Tetrachloride results in increased expression of MAOA protein]]; sarpogrelate promotes the reaction [Carbidopa inhibits the reaction [Carbon Tetrachloride results in increased expression of MAOA protein]] CTD PMID:34560070 PMID:35202708 NCBI chr  X:8,615,239...8,681,372
Ensembl chr  X:8,615,239...8,682,631
JBrowse link
G Mfn1 mitofusin 1 multiple interactions ISO [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Carbon Tetrachloride results in decreased expression of MFN1 protein]; Carbidopa inhibits the reaction [Carbon Tetrachloride results in decreased expression of MFN1 protein]; Carbidopa promotes the reaction [sarpogrelate inhibits the reaction [Carbon Tetrachloride results in decreased expression of MFN1 protein]] CTD PMID:35202708 NCBI chr 2:115,313,380...115,359,651
Ensembl chr 2:117,241,759...117,290,190
JBrowse link
G Mt-atp6 mitochondrially encoded ATP synthase membrane subunit 6 multiple interactions ISO Carbidopa inhibits the reaction [Carbon Tetrachloride results in decreased expression of ATP6 protein]; Carbidopa promotes the reaction [sarpogrelate inhibits the reaction [Carbon Tetrachloride results in decreased expression of ATP6 protein]]; sarpogrelate promotes the reaction [Carbidopa inhibits the reaction [Carbon Tetrachloride results in decreased expression of ATP6 protein]] CTD PMID:35202708 NCBI chr MT:7,919...8,599
Ensembl chr MT:7,904...8,584
JBrowse link
G Mt-cyb mitochondrially encoded cytochrome b multiple interactions ISO Carbidopa inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYTB protein]; Carbidopa promotes the reaction [sarpogrelate inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYTB protein]]; sarpogrelate promotes the reaction [Carbidopa inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYTB protein]] CTD PMID:35202708 NCBI chr MT:14,136...15,278
Ensembl chr MT:14,124...15,266
JBrowse link
G Mt-nd1 mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 multiple interactions ISO [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Carbon Tetrachloride results in decreased expression of ND1 protein]; Carbidopa inhibits the reaction [Carbon Tetrachloride results in decreased expression of ND1 protein]; Carbidopa promotes the reaction [sarpogrelate inhibits the reaction [Carbon Tetrachloride results in decreased expression of ND1 protein]] CTD PMID:35202708 NCBI chr MT:2,740...3,694
Ensembl chr MT:2,729...3,685
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in increased phosphorylation of RELA protein]; Carbidopa inhibits the reaction [Cisplatin results in increased phosphorylation of RELA protein] CTD PMID:34560070 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
JBrowse link
G Snca synuclein alpha multiple interactions EXP [Levodopa co-treated with Carbidopa] inhibits the reaction [Reserpine results in increased expression of SNCA protein] CTD PMID:38229316 NCBI chr 4:91,026,474...91,127,444
Ensembl chr 4:91,026,474...91,126,315
JBrowse link
G Stat3 signal transducer and activator of transcription 3 multiple interactions ISO [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in increased phosphorylation of STAT3 protein]; Carbidopa inhibits the reaction [Cisplatin results in increased phosphorylation of STAT3 protein] CTD PMID:34560070 NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in increased expression of TNF protein]
[sarpogrelate co-treated with Carbidopa] inhibits the reaction [Cisplatin results in increased secretion of TNF protein]; Carbidopa inhibits the reaction [Cisplatin results in increased secretion of TNF protein]
CTD PMID:34560070 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
G Tph1 tryptophan hydroxylase 1 multiple interactions ISO [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Carbon Tetrachloride results in increased expression of TPH1 mRNA]; [sarpogrelate co-treated with Carbidopa] inhibits the reaction [Carbon Tetrachloride results in increased expression of TPH1 protein] CTD PMID:35202708 NCBI chr 1:97,157,375...97,178,415
Ensembl chr 1:106,085,953...106,312,484
JBrowse link
ceftazidime pentahydrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcc4 ATP binding cassette subfamily C member 4 increases transport ISO ABCC4 protein results in increased transport of Ceftazidime CTD PMID:17939016 NCBI chr15:95,541,186...95,774,898
Ensembl chr15:101,949,433...102,181,375
JBrowse link
G Dhfr dihydrofolate reductase decreases activity ISO Ceftazidime results in decreased activity of DHFR protein CTD PMID:25418905 NCBI chr 2:25,320,895...25,346,004 JBrowse link
G Hsf1 heat shock transcription factor 1 decreases activity ISO Ceftazidime results in decreased activity of HSF1 protein CTD PMID:34170685 NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:110,076,710...110,103,665
JBrowse link
G Il10 interleukin 10 multiple interactions ISO Ceftazidime inhibits the reaction [Lipopolysaccharides results in increased secretion of IL10 protein] CTD PMID:16939481 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
JBrowse link
cilazapril monohydrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ace angiotensin I converting enzyme affects response to substance ISO ACE gene polymorphism affects the susceptibility to Cilazapril CTD PMID:15498266 NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing increases expression ISO Cilazapril results in increased expression of ADIPOQ protein CTD PMID:19789415 NCBI chr11:77,721,912...77,735,644
Ensembl chr11:91,226,180...91,240,169
JBrowse link
G Agtr1a angiotensin II receptor, type 1a multiple interactions EXP [Cilazapril co-treated with Losartan] promotes the reaction [Doxorubicin results in increased expression of AGTR1 mRNA]; Cilazapril promotes the reaction [Doxorubicin results in increased expression of AGTR1 mRNA] CTD PMID:15331931 NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,381,467...34,435,660
JBrowse link
G Agtr2 angiotensin II receptor, type 2 multiple interactions EXP [Losartan co-treated with Cilazapril] inhibits the reaction [Doxorubicin results in decreased expression of AGTR2 mRNA]; Cilazapril inhibits the reaction [Doxorubicin results in decreased expression of AGTR2 mRNA] CTD PMID:15331931 NCBI chr  X:112,119,876...112,124,060
Ensembl chr  X:116,913,656...116,918,745
JBrowse link
G Fgf2 fibroblast growth factor 2 decreases expression EXP Cilazapril results in decreased expression of FGF2 mRNA; Cilazapril results in decreased expression of FGF2 protein CTD PMID:9640960 NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:122,164,454...122,224,493
JBrowse link
G Nppa natriuretic peptide A multiple interactions
affects secretion
ISO [Cilazapril co-treated with Verapamil] affects the secretion of NPPA protein
Cilazapril affects the secretion of NPPA protein
CTD PMID:1457087 NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:163,712,184...163,713,493
JBrowse link
G Ren renin increases activity EXP Cilazapril results in increased activity of REN protein CTD PMID:2425185 NCBI chr13:44,796,260...44,807,491
Ensembl chr13:47,348,143...47,359,543
JBrowse link
G Slc15a1 solute carrier family 15 member 1 multiple interactions ISO Cilazapril inhibits the reaction [SLC15A1 protein results in increased uptake of glycylsarcosine] CTD PMID:18713951 NCBI chr15:98,537,641...98,582,544
Ensembl chr15:104,944,463...104,989,369
JBrowse link
G Slc15a2 solute carrier family 15 member 2 multiple interactions EXP Cilazapril inhibits the reaction [SLC15A2 protein results in increased uptake of glycylsarcosine] CTD PMID:18713951 NCBI chr11:64,014,182...64,043,228
Ensembl chr11:77,519,529...77,548,606
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions EXP [Losartan co-treated with Cilazapril] inhibits the reaction [Doxorubicin results in increased expression of TGFB1 protein]; Cilazapril inhibits the reaction [Doxorubicin results in increased expression of TGFB1 protein] CTD PMID:15331931 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
JBrowse link
dideuterium oxide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akt1 AKT serine/threonine kinase 1 decreases phosphorylation
multiple interactions
ISO Deuterium Oxide results in decreased phosphorylation of AKT1 protein
Acetylcysteine inhibits the reaction [Deuterium Oxide results in decreased phosphorylation of AKT1 protein]
CTD PMID:37751786 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
JBrowse link
G Akt2 AKT serine/threonine kinase 2 decreases phosphorylation
multiple interactions
ISO Deuterium Oxide results in decreased phosphorylation of AKT2 protein
Acetylcysteine inhibits the reaction [Deuterium Oxide results in decreased phosphorylation of AKT2 protein]
CTD PMID:37751786 NCBI chr 1:82,877,228...82,933,828
Ensembl chr 1:92,014,859...92,061,420
JBrowse link
G Akt3 AKT serine/threonine kinase 3 decreases phosphorylation
multiple interactions
ISO Deuterium Oxide results in decreased phosphorylation of AKT3 protein
Acetylcysteine inhibits the reaction [Deuterium Oxide results in decreased phosphorylation of AKT3 protein]
CTD PMID:37751786 NCBI chr13:91,475,839...91,758,060
Ensembl chr13:91,475,839...91,748,020
JBrowse link
G Bax BCL2 associated X, apoptosis regulator increases expression ISO Deuterium Oxide results in increased expression of BAX protein CTD PMID:37751786 NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:105,076,473...105,086,429
JBrowse link
G Becn1 beclin 1 increases expression
multiple interactions
ISO Deuterium Oxide results in increased expression of BECN1 protein
Acetylcysteine inhibits the reaction [Deuterium Oxide results in increased expression of BECN1 protein]
CTD PMID:37751786 NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,731,650...86,747,002
JBrowse link
G Casp3 caspase 3 increases cleavage ISO Deuterium Oxide results in increased cleavage of CASP3 protein CTD PMID:37751786 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta multiple interactions ISO Acetylcysteine inhibits the reaction [Deuterium Oxide results in increased expression of and results in increased lipidation of MAP1LC3B protein]; Deuterium Oxide results in increased expression of and results in increased lipidation of MAP1LC3B protein CTD PMID:37751786 NCBI chr19:49,665,795...49,673,655
Ensembl chr19:66,574,407...66,584,358
Ensembl chr16:66,574,407...66,584,358
JBrowse link
G Mtor mechanistic target of rapamycin kinase decreases phosphorylation
multiple interactions
ISO Deuterium Oxide results in decreased phosphorylation of MTOR protein
Acetylcysteine inhibits the reaction [Deuterium Oxide results in decreased phosphorylation of MTOR protein]
CTD PMID:37751786 NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:164,167,928...164,277,435
JBrowse link
G Pik3r1 phosphoinositide-3-kinase regulatory subunit 1 multiple interactions
decreases phosphorylation
ISO Acetylcysteine inhibits the reaction [Deuterium Oxide results in decreased phosphorylation of PIK3R1 protein] CTD PMID:37751786 NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:34,612,946...34,626,347
JBrowse link
dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin decreases expression ISO Antimony Potassium Tartrate results in decreased expression of A2M mRNA CTD PMID:17547211 NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:156,569,860...156,619,868
JBrowse link
G Abcc1 ATP binding cassette subfamily C member 1 affects response to substance
decreases response to substance
increases secretion
multiple interactions
ISO ABCC1 protein affects the susceptibility to Antimony Potassium Tartrate
ABCC1 protein results in decreased susceptibility to Antimony Potassium Tartrate
ABCC1 protein results in increased secretion of Antimony Potassium Tartrate
[MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Antimony Potassium Tartrate; Glutathione affects the reaction [ABCC1 protein results in increased secretion of Antimony Potassium Tartrate]; verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Antimony Potassium Tartrate]; verlukast inhibits the reaction [ABCC1 protein results in increased secretion of Antimony Potassium Tartrate]
CTD PMID:10025956 PMID:10348353 PMID:11278867 PMID:12018890 PMID:12731862 NCBI chr10:528,961...655,179
Ensembl chr10:1,038,947...1,162,404
JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 increases expression
multiple interactions
EXP
ISO
Antimony Potassium Tartrate results in increased expression of ABCC2 mRNA; Antimony Potassium Tartrate results in increased expression of ABCC2 protein
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of ABCC2 mRNA
CTD PMID:11408547 PMID:32076005 NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:252,614,017...252,673,471
JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of ABCC3 mRNA CTD PMID:32076005 NCBI chr10:79,793,571...79,839,528
Ensembl chr10:79,793,583...79,839,494
JBrowse link
G Acp2 acid phosphatase 2, lysosomal decreases expression ISO Antimony Potassium Tartrate results in decreased expression of ACP2 mRNA CTD PMID:17547211 NCBI chr 3:77,175,022...77,185,180
Ensembl chr 3:97,631,326...97,642,565
JBrowse link
G Acsl1 acyl-CoA synthetase long-chain family member 1 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of ACSL1 mRNA CTD PMID:17547211 NCBI chr16:45,755,246...45,821,541
Ensembl chr16:52,487,870...52,554,023
JBrowse link
G Adm adrenomedullin increases expression ISO Antimony Potassium Tartrate results in increased expression of ADM mRNA CTD PMID:17547211 NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:174,178,773...174,182,371
JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B1 decreases expression
increases expression
ISO Antimony Potassium Tartrate results in decreased expression of AKR1B1 mRNA
Antimony Potassium Tartrate results in increased expression of AKR1B1 mRNA
CTD PMID:17547211 PMID:28713220 NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:63,899,222...63,913,315
JBrowse link
G Akr1b10 aldo-keto reductase family 1 member B10 increases expression
multiple interactions
ISO Antimony Potassium Tartrate results in increased expression of AKR1B10 mRNA
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of AKR1B10 mRNA
CTD PMID:28713220 PMID:32076005 NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:64,007,420...64,020,847
JBrowse link
G Akr1c2 aldo-keto reductase family 1, member C2 increases expression ISO Antimony Potassium Tartrate results in increased expression of AKR1C2 protein CTD PMID:28713220 NCBI chr17:70,669,684...70,717,935
Ensembl chr17:70,669,710...70,685,686
JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 increases expression
multiple interactions
ISO Antimony Potassium Tartrate results in increased expression of AKR1C3 mRNA; Antimony Potassium Tartrate results in increased expression of AKR1C3 protein
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of AKR1C3 mRNA
CTD PMID:28713220 PMID:32076005 NCBI chr17:66,110,970...66,127,867
Ensembl chr17:70,970,900...71,048,438
JBrowse link
G Aldh3a2 aldehyde dehydrogenase 3 family, member A2 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of ALDH3A2 mRNA CTD PMID:32076005 NCBI chr10:45,928,313...45,949,366
Ensembl chr10:46,407,993...46,448,648
JBrowse link
G Aldh3b2 aldehyde dehydrogenase 3 family, member B2 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ALDH3B2 mRNA CTD PMID:32076005 NCBI chr 1:201,250,260...201,264,699
Ensembl chr 1:210,675,302...210,694,155
JBrowse link
G Aldh3b3 aldehyde dehydrogenase 3 family, member B3 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ALDH3B2 mRNA CTD PMID:32076005 NCBI chr 1:201,193,832...201,201,666
Ensembl chr 1:210,622,639...210,629,879
JBrowse link
G Aldh6a1 aldehyde dehydrogenase 6 family, member A1 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of ALDH6A1 mRNA CTD PMID:17547211 NCBI chr 6:104,077,975...104,098,636
Ensembl chr 6:109,809,122...109,829,743
JBrowse link
G Aldoa aldolase, fructose-bisphosphate A increases expression ISO Antimony Potassium Tartrate results in increased expression of ALDOA mRNA CTD PMID:28713220 NCBI chr 1:190,832,820...190,838,021
Ensembl chr 1:190,832,820...190,838,211
JBrowse link
G Aldoc aldolase, fructose-bisphosphate C increases expression ISO Antimony Potassium Tartrate results in increased expression of ALDOC mRNA CTD PMID:28713220 NCBI chr10:63,217,477...63,221,066
Ensembl chr10:63,715,489...63,719,133
JBrowse link
G Ar androgen receptor increases phosphorylation ISO Antimony Potassium Tartrate results in increased phosphorylation of AR protein CTD PMID:29462692 NCBI chr  X:63,104,771...63,273,934
Ensembl chr  X:67,135,317...67,304,467
JBrowse link
G Atp2b1 ATPase plasma membrane Ca2+ transporting 1 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of ATP2B1 mRNA CTD PMID:17547211 NCBI chr 7:33,735,595...33,845,226
Ensembl chr 7:35,622,461...35,731,904
JBrowse link
G Azgp1 alpha-2-glycoprotein 1, zinc-binding decreases expression ISO Antimony Potassium Tartrate results in decreased expression of AZGP1 mRNA CTD PMID:17547211 NCBI chr12:16,930,990...16,939,333
Ensembl chr12:22,044,751...22,053,020
JBrowse link
G Barx2 BARX homeobox 2 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BARX2 mRNA CTD PMID:32076005 NCBI chr 8:30,251,132...30,319,105
Ensembl chr 8:38,509,277...38,576,978
JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of BAX protein CTD PMID:32920012 NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:105,076,473...105,086,429
JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions EXP
ISO
666-15 compound promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of BCL2 protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of BCL2 protein CTD PMID:32920012 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
JBrowse link
G Becn1 beclin 1 multiple interactions ISO BECN1 protein affects the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of FTH1 protein]; BECN1 protein affects the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of FTL protein] CTD PMID:39954839 NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,731,650...86,747,002
JBrowse link
G Bmp6 bone morphogenetic protein 6 multiple interactions ISO Antimony Potassium Tartrate inhibits the reaction [BMP6 protein results in increased expression of DUSP12 mRNA]; Antimony Potassium Tartrate inhibits the reaction [BMP6 protein results in increased expression of DUSP2 mRNA] CTD PMID:28713220 NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,523,704...26,675,261
JBrowse link
G Btf3 basic transcription factor 3 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BTF3 mRNA CTD PMID:32076005 NCBI chr 2:29,659,764...29,666,898
Ensembl chr 2:31,394,011...31,401,125
Ensembl chr13:31,394,011...31,401,125
JBrowse link
G Btg2 BTG anti-proliferation factor 2 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of BTG2 mRNA CTD PMID:32076005 NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690
JBrowse link
G Calml5 calmodulin-like 5 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of CALML5 mRNA CTD PMID:28713220 NCBI chr17:66,394,433...66,395,352
Ensembl chr17:71,304,326...71,305,245
JBrowse link
G Calr calreticulin multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CALR mRNA CTD PMID:32076005 NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236
JBrowse link
G Casp3 caspase 3 multiple interactions EXP
ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased cleavage of CASP3 protein CTD PMID:32920012 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Cbr1 carbonyl reductase 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CBR1 mRNA CTD PMID:32076005 NCBI chr11:46,346,405...46,348,815
Ensembl chr11:46,378,411...46,381,104
Ensembl chr11:46,378,411...46,381,104
JBrowse link
G Ccnb2 cyclin B2 increases expression ISO Antimony Potassium Tartrate results in increased expression of CCNB2 mRNA CTD PMID:17547211 NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:79,968,465...79,981,682
JBrowse link
G Ccnd1 cyclin D1 multiple interactions EXP 666-15 compound inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of CCND1 protein] CTD PMID:34571074 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A increases expression ISO Antimony Potassium Tartrate results in increased expression of CDKN1A mRNA CTD PMID:17547211 NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
JBrowse link
G Cdkn2b cyclin-dependent kinase inhibitor 2B multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CDKN2B mRNA CTD PMID:32076005 NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:109,114,322...109,134,855
JBrowse link
G Cdkn3 cyclin-dependent kinase inhibitor 3 increases expression ISO Antimony Potassium Tartrate results in increased expression of CDKN3 mRNA CTD PMID:17547211 NCBI chr15:20,022,522...20,033,948
Ensembl chr15:22,502,382...22,513,722
JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CEBPA mRNA CTD PMID:32076005 NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309
JBrowse link
G Cfb complement factor B decreases expression ISO Antimony Potassium Tartrate results in decreased expression of CFB mRNA CTD PMID:17547211 NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,955,776...3,981,740
JBrowse link
G Cks2 CDC28 protein kinase regulatory subunit 2 increases expression ISO Antimony Potassium Tartrate results in increased expression of CKS2 mRNA CTD PMID:17547211 NCBI chr17:13,722,360...13,727,519
Ensembl chr17:13,722,361...13,727,519
JBrowse link
G Clgn calmegin decreases expression ISO Antimony Potassium Tartrate results in decreased expression of CLGN mRNA CTD PMID:17547211 NCBI chr19:24,695,140...24,728,542
Ensembl chr19:41,601,568...41,633,325
JBrowse link
G Clptm1 CLPTM1 regulator of GABA type A receptor forward trafficking decreases expression ISO Antimony Potassium Tartrate results in decreased expression of CLPTM1 mRNA CTD PMID:17547211 NCBI chr 1:79,289,478...79,321,079
Ensembl chr 1:88,417,447...88,449,446
JBrowse link
G Cnbp CCHC-type zinc finger, nucleic acid binding protein multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of CNBP mRNA CTD PMID:32076005 NCBI chr 4:120,302,768...120,311,694
Ensembl chr 4:121,860,105...121,869,010
JBrowse link
G Creb1 cAMP responsive element binding protein 1 multiple interactions ISO
EXP
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein; pyrazolanthrone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein]; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of CREB1 protein]
CTD PMID:32920012 PMID:34571074 NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:73,397,306...73,466,339
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CYP1B1 mRNA CTD PMID:32076005 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
JBrowse link
G Dazap1 DAZ associated protein 1 increases expression ISO Antimony Potassium Tartrate results in increased expression of DAZAP1 mRNA CTD PMID:17547211 NCBI chr 7:9,423,673...9,448,116
Ensembl chr 7:10,074,849...10,095,599
JBrowse link
G Dcp1a decapping mRNA 1A increases expression ISO Antimony Potassium Tartrate results in increased expression of DCP1A mRNA CTD PMID:17547211 NCBI chr16:5,656,960...5,702,151
Ensembl chr16:5,663,203...5,708,618
JBrowse link
G Dhrs9 dehydrogenase/reductase 9 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DHRS9 mRNA CTD PMID:32076005 NCBI chr 3:54,147,834...54,170,052
Ensembl chr 3:74,555,606...74,581,376
JBrowse link
G Dnajb1 DnaJ heat shock protein family (Hsp40) member B1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DNAJB1 mRNA CTD PMID:32076005 NCBI chr19:41,427,453...41,431,141
Ensembl chr19:41,427,453...41,431,416
JBrowse link
G Dnajb4 DnaJ heat shock protein family (Hsp40) member B4 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of DNAJB4 mRNA CTD PMID:32076005 NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:243,790,297...243,819,042
JBrowse link
G Dsc1 desmocollin 1 decreases expression
multiple interactions
ISO Antimony Potassium Tartrate results in decreased expression of DSC1 mRNA
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSC1 mRNA; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSC1 mRNA]
CTD PMID:28713220 PMID:32076005 NCBI chr18:11,499,936...11,556,801
Ensembl chr18:11,775,010...11,803,522
JBrowse link
G Dsg1 desmoglein 1 multiple interactions ISO 2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of DSG1 mRNA] CTD PMID:32076005 NCBI chr18:11,674,687...11,705,383
Ensembl chr18:11,949,488...11,980,451
JBrowse link
G Dst dystonin decreases expression ISO Antimony Potassium Tartrate results in decreased expression of DST protein CTD PMID:28713220 NCBI chr 9:36,135,657...36,529,617
Ensembl chr 9:43,631,517...44,025,533
JBrowse link
G Duox1 dual oxidase 1 multiple interactions
decreases expression
ISO Antimony Potassium Tartrate inhibits the reaction [IL4 protein results in increased expression of DUOX1 mRNA]
Antimony Potassium Tartrate results in decreased expression of DUOX1 mRNA
CTD PMID:29031483 NCBI chr 3:109,260,526...109,295,588
Ensembl chr 3:129,714,149...129,749,187
JBrowse link
G Duoxa1 dual oxidase maturation factor 1 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of DUOXA1 mRNA CTD PMID:29031483 NCBI chr 3:109,249,815...109,260,511
Ensembl chr 3:129,703,416...129,706,829
JBrowse link
G Dusp1 dual specificity phosphatase 1 increases expression ISO Antimony Potassium Tartrate results in increased expression of DUSP1 mRNA CTD PMID:17547211 NCBI chr10:16,680,478...16,683,275
Ensembl chr10:17,184,823...17,187,644
JBrowse link
G Dusp12 dual specificity phosphatase 12 multiple interactions ISO Antimony Potassium Tartrate inhibits the reaction [BMP6 protein results in increased expression of DUSP12 mRNA] CTD PMID:28713220 NCBI chr13:83,122,192...83,131,800
Ensembl chr13:85,654,914...85,664,007
JBrowse link
G Dusp2 dual specificity phosphatase 2 multiple interactions ISO Antimony Potassium Tartrate inhibits the reaction [BMP6 protein results in increased expression of DUSP2 mRNA] CTD PMID:28713220 NCBI chr 3:114,556,325...114,558,510
Ensembl chr 3:135,009,590...135,011,809
JBrowse link
G Egr3 early growth response 3 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EGR3 mRNA CTD PMID:32076005 NCBI chr15:45,150,335...45,156,052
Ensembl chr15:51,560,344...51,565,712
JBrowse link
G Ehf ets homologous factor multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EHF mRNA CTD PMID:32076005 NCBI chr 3:89,639,845...89,680,061
Ensembl chr 3:110,096,756...110,134,928
JBrowse link
G Elf3 E74 like ETS transcription factor 3 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ELF3 mRNA CTD PMID:32076005 NCBI chr13:46,690,460...46,695,394
Ensembl chr13:49,242,267...49,247,380
JBrowse link
G Epha1 Eph receptor A1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EPHA1 protein CTD PMID:32076005 NCBI chr 4:71,246,409...71,260,920
Ensembl chr 4:72,213,037...72,227,474
JBrowse link
G Epha2 Eph receptor A2 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of EPHA2 protein CTD PMID:32076005 NCBI chr 5:158,888,629...158,917,100
Ensembl chr 5:158,888,629...158,917,234
JBrowse link
G Ephx1 epoxide hydrolase 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of EPHX1 mRNA CTD PMID:32076005 NCBI chr13:95,246,079...95,275,852
Ensembl chr13:95,246,080...95,321,981
JBrowse link
G F5 coagulation factor V decreases expression ISO Antimony Potassium Tartrate results in decreased expression of F5 mRNA CTD PMID:17547211 NCBI chr13:76,513,509...76,583,106
Ensembl chr13:79,046,448...79,116,247
JBrowse link
G Fabp5 fatty acid binding protein 5 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of FABP5 mRNA CTD PMID:28713220 NCBI chr 2:91,765,056...91,768,716
Ensembl chr 2:93,672,458...93,676,127
JBrowse link
G Fdft1 farnesyl diphosphate farnesyl transferase 1 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of FDFT1 mRNA CTD PMID:17547211 NCBI chr15:37,412,143...37,440,198
Ensembl chr15:41,588,117...41,616,168
JBrowse link
G Fdps farnesyl diphosphate synthase decreases expression ISO Antimony Potassium Tartrate results in decreased expression of FDPS mRNA CTD PMID:17547211 NCBI chr 2:174,497,402...174,507,031
Ensembl chr 2:176,795,192...176,807,136
JBrowse link
G Fgfr3 fibroblast growth factor receptor 3 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FGFR3 mRNA CTD PMID:32076005 NCBI chr14:81,211,800...81,227,215
Ensembl chr14:81,211,800...81,227,209
JBrowse link
G Flg filaggrin decreases expression
multiple interactions
ISO Antimony Potassium Tartrate results in decreased expression of FLG mRNA
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FLG mRNA]
CTD PMID:28713220 PMID:32076005 NCBI chr 2:178,884,793...178,912,986
Ensembl chr 2:181,583,808...181,595,968
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FOS mRNA CTD PMID:32076005 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit increases expression ISO Antimony Potassium Tartrate results in increased expression of FOSL1 mRNA CTD PMID:17547211 NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:212,183,833...212,192,391
JBrowse link
G Foxq1 forkhead box Q1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of FOXQ1 mRNA CTD PMID:32076005 NCBI chr17:32,912,744...32,915,377
Ensembl chr17:33,121,545...33,123,720
JBrowse link
G Fth1 ferritin heavy chain 1 increases expression
multiple interactions
ISO Antimony Potassium Tartrate results in increased expression of FTH1 mRNA; Antimony Potassium Tartrate results in increased expression of FTH1 protein
3-methyladenine inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of FTH1 protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of FTH1 protein; FTH1 protein inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of GPX4 protein]
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of FTH1 mRNA; [Antimony Potassium Tartrate results in increased abundance of Antimony] promotes the reaction [Cycloheximide results in decreased expression of FTH1 protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of FTH1 mRNA; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of FTH1 protein; BECN1 protein affects the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of FTH1 protein]; Chloroquine inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of FTH1 protein]; FTH1 protein inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of GPX4 protein]; NCOA4 protein affects the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of FTH1 protein]
CTD PMID:28713220 PMID:32076005 PMID:39954839 NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:216,051,998...216,055,214
JBrowse link
G Ftl1 ferritin light chain 1 increases expression
multiple interactions
ISO Antimony Potassium Tartrate results in increased expression of FTL mRNA
3-methyladenine inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of FTL protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of FTL protein
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of FTL mRNA; [Antimony Potassium Tartrate results in increased abundance of Antimony] promotes the reaction [Cycloheximide results in decreased expression of FTL protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of FTL mRNA; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of FTL protein; BECN1 protein affects the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of FTL protein]; Chloroquine inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of FTL protein]; NCOA4 protein affects the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of FTL protein]
CTD PMID:28713220 PMID:32076005 PMID:39954839 NCBI chr 1:95,936,387...95,938,234
Ensembl chr  X:45,399,355...45,399,915
Ensembl chr 2:45,399,355...45,399,915
Ensembl chr 1:45,399,355...45,399,915
JBrowse link
G G6pd glucose-6-phosphate dehydrogenase increases expression ISO Antimony Potassium Tartrate results in increased expression of G6PD mRNA; Antimony Potassium Tartrate results in increased expression of G6PD protein CTD PMID:28713220 NCBI chr  X:157,352,364...157,372,144
Ensembl chr  X:157,352,373...157,372,144
JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase increases expression ISO Antimony Potassium Tartrate results in increased expression of GAPDH mRNA CTD PMID:28713220 NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:159,648,592...159,653,377
JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit increases expression
multiple interactions
ISO Antimony Potassium Tartrate results in increased expression of GCLC mRNA; Antimony Potassium Tartrate results in increased expression of GCLC protein
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GCLC mRNA
CTD PMID:28713220 PMID:32076005 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit increases expression
multiple interactions
ISO Antimony Potassium Tartrate results in increased expression of GCLM mRNA
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GCLM mRNA
CTD PMID:28713220 PMID:32076005 NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:213,031,838...213,055,003
JBrowse link
G Gcnt3 glucosaminyl (N-acetyl) transferase 3, mucin type increases expression ISO Antimony Potassium Tartrate results in increased expression of GCNT3 mRNA CTD PMID:17547211 NCBI chr 8:79,570,081...79,577,389
Ensembl chr 8:79,566,753...79,581,595
JBrowse link
G Gfap glial fibrillary acidic protein multiple interactions EXP
ISO
666-15 compound inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP mRNA; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP mRNA]; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP protein]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of GFAP mRNA] CTD PMID:34571074 NCBI chr10:87,852,891...87,861,631
Ensembl chr10:88,352,986...88,361,685
JBrowse link
G Ggt1 gamma-glutamyltransferase 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GGT1 mRNA CTD PMID:32076005 NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,141...13,088,050
JBrowse link
G Ghitm growth hormone inducible transmembrane protein decreases expression ISO Antimony Potassium Tartrate results in decreased expression of GHITM mRNA CTD PMID:17547211 NCBI chr16:12,885,551...12,897,887
Ensembl chr16:12,905,806...12,918,123
JBrowse link
G Gla galactosidase, alpha increases expression ISO Antimony Potassium Tartrate results in increased expression of GLA mRNA CTD PMID:17547211 NCBI chr  X:97,769,227...97,780,646
Ensembl chr  X:102,056,718...102,073,915
JBrowse link
G Glrx glutaredoxin multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GLRX mRNA CTD PMID:32076005 NCBI chr 2:5,341,873...5,351,686
Ensembl chr 2:7,073,759...7,083,543
JBrowse link
G Gpx2 glutathione peroxidase 2 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GPX2 mRNA CTD PMID:32076005 NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:101,226,745...101,230,862
JBrowse link
G Gpx4 glutathione peroxidase 4 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of GPX4 protein; ferrostatin-1 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of GPX4 protein]; FTH1 protein inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of GPX4 protein]
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of GPX4 protein; Deferoxamine inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of GPX4 protein]; ferrostatin-1 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of GPX4 protein]; FTH1 protein inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of GPX4 protein]
CTD PMID:39954839 NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:10,300,832...10,303,629
JBrowse link
G Grhl1 grainyhead-like transcription factor 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of GRHL1 mRNA CTD PMID:32076005 NCBI chr 6:41,207,325...41,257,516
Ensembl chr 6:46,935,967...46,980,264
JBrowse link
G Gsto1 glutathione S-transferase omega 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of GSTO1 mRNA CTD PMID:32076005 NCBI chr 1:256,662,377...256,672,515
Ensembl chr 1:256,662,531...256,676,167
JBrowse link
G Gtpbp6 GTP binding protein 6 (putative) increases expression ISO Antimony Potassium Tartrate results in increased expression of GTPBP6 mRNA CTD PMID:17547211 NCBI chr12:46,574,913...46,578,873
Ensembl chr12:52,234,572...52,238,578
JBrowse link
G Hltf helicase-like transcription factor multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HLTF mRNA CTD PMID:32076005 NCBI chr 2:102,549,724...102,609,492
Ensembl chr 2:104,478,772...104,538,818
JBrowse link
G Hmga1 high mobility group AT-hook 1 increases expression ISO Antimony Potassium Tartrate results in increased expression of HMGA1 mRNA CTD PMID:17547211 NCBI chr20:5,611,088...5,618,755
Ensembl chr20:5,613,471...5,620,593
JBrowse link
G Hmox1 heme oxygenase 1 increases expression
multiple interactions
ISO Antimony Potassium Tartrate results in increased expression of HMOX1 mRNA; Antimony Potassium Tartrate results in increased expression of HMOX1 protein
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HMOX1 mRNA
CTD PMID:17547211 PMID:28713220 PMID:32076005 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
JBrowse link
G Hopx HOP homeobox multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of HOPX mRNA CTD PMID:32076005 NCBI chr14:31,055,912...31,082,909
Ensembl chr14:31,410,221...31,437,188
JBrowse link
G Hsd17b2 hydroxysteroid (17-beta) dehydrogenase 2 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of HSD17B2 mRNA CTD PMID:17547211 NCBI chr19:62,662,320...62,733,944
Ensembl chr19:62,662,098...62,733,943
JBrowse link
G Hsd17b7 hydroxysteroid (17-beta) dehydrogenase 7 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of HSD17B7 mRNA CTD PMID:17547211 NCBI chr13:82,170,079...82,190,018
Ensembl chr13:84,705,631...84,722,754
JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPA1A mRNA CTD PMID:32076005 NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,855,780...3,877,979
JBrowse link
G Hspa8 heat shock protein family A (Hsp70) member 8 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPA8 mRNA CTD PMID:32076005 NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372
JBrowse link
G Hspb8 heat shock protein family B (small) member 8 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HSPB8 mRNA CTD PMID:32076005 NCBI chr12:40,176,405...40,205,002
Ensembl chr12:45,837,066...45,851,937
JBrowse link
G Htatip2 HIV-1 Tat interactive protein 2 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of HTATIP2 mRNA CTD PMID:32076005 NCBI chr 1:108,609,424...108,624,810
Ensembl chr 1:108,605,811...108,624,815
JBrowse link
G Id1 inhibitor of DNA binding 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of ID1 mRNA CTD PMID:32076005 NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:161,671,538...161,672,685
JBrowse link
G Ier2 immediate early response 2 increases expression ISO Antimony Potassium Tartrate results in increased expression of IER2 mRNA CTD PMID:17547211 NCBI chr19:40,399,373...40,400,897
Ensembl chr19:40,398,160...40,402,708
JBrowse link
G Ifrd1 interferon-related developmental regulator 1 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of IFRD1 mRNA CTD PMID:17547211 NCBI chr 6:62,996,560...63,044,996
Ensembl chr 6:62,996,562...63,016,131
JBrowse link
G Ikzf2 IKAROS family zinc finger 2 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IKZF2 mRNA CTD PMID:32076005 NCBI chr 9:71,046,038...71,191,296
Ensembl chr 9:78,492,275...78,640,463
JBrowse link
G Il1rn interleukin 1 receptor antagonist multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IL1RN mRNA CTD PMID:32076005 NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732
JBrowse link
G Il4 interleukin 4 multiple interactions ISO Antimony Potassium Tartrate inhibits the reaction [IL4 protein results in increased expression of DUOX1 mRNA] CTD PMID:29031483 NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
JBrowse link
G Ing3 inhibitor of growth family, member 3 increases expression ISO Antimony Potassium Tartrate results in increased expression of ING3 mRNA CTD PMID:17547211 NCBI chr 4:50,477,954...50,505,168
Ensembl chr 4:51,443,763...51,470,951
JBrowse link
G Itgb3bp integrin subunit beta 3 binding protein increases expression ISO Antimony Potassium Tartrate results in increased expression of ITGB3BP mRNA CTD PMID:17547211 NCBI chr 5:114,460,217...114,525,538
Ensembl chr 5:119,575,248...119,640,997
JBrowse link
G Itih3 inter-alpha trypsin inhibitor, heavy chain 3 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of ITIH3 mRNA CTD PMID:17547211 NCBI chr16:6,108,378...6,123,609
Ensembl chr16:6,108,382...6,123,374
JBrowse link
G Ivl involucrin decreases expression
multiple interactions
ISO Antimony Potassium Tartrate results in decreased expression of IVL mRNA; Antimony Potassium Tartrate results in decreased expression of IVL protein
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of IVL mRNA
CTD PMID:28713220 PMID:32076005 NCBI chr 2:178,146,694...178,160,807
Ensembl chr 2:180,842,307...180,846,578
JBrowse link
G Klf5 KLF transcription factor 5 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KLF5 mRNA CTD PMID:32076005 NCBI chr15:76,060,320...76,079,445
Ensembl chr15:82,472,065...82,487,262
JBrowse link
G Klf6 KLF transcription factor 6 increases expression ISO Antimony Potassium Tartrate results in increased expression of KLF6 mRNA CTD PMID:17547211 NCBI chr17:64,539,456...64,548,451
Ensembl chr17:69,441,493...69,498,601
JBrowse link
G Klk1c10 kallikrein 1-related peptidase C10 increases expression
multiple interactions
ISO Antimony Potassium Tartrate results in increased expression of KLK3 mRNA; Antimony Potassium Tartrate results in increased expression of KLK3 protein
bicalutamide inhibits the reaction [Antimony Potassium Tartrate results in increased expression of KLK3 mRNA]
CTD PMID:29462692 NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:103,539,527...103,543,586
JBrowse link
G Krt1 keratin 1 multiple interactions ISO 2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT1 mRNA] CTD PMID:32076005 NCBI chr 7:132,976,618...132,981,844
Ensembl chr 7:134,855,313...134,860,537
JBrowse link
G Krt10 keratin 10 decreases expression
multiple interactions
ISO Antimony Potassium Tartrate results in decreased expression of KRT10 mRNA; Antimony Potassium Tartrate results in decreased expression of KRT10 protein
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA; Hydrocortisone inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA]; U 0126 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of KRT10 mRNA]
CTD PMID:28713220 PMID:32076005 NCBI chr10:84,338,695...84,343,279
Ensembl chr10:84,834,840...84,839,160
JBrowse link
G Krtdap keratinocyte differentiation associated protein decreases expression ISO Antimony Potassium Tartrate results in decreased expression of KRTDAP mRNA CTD PMID:28713220 NCBI chr 1:86,038,296...86,041,594
Ensembl chr 1:95,165,862...95,169,012
JBrowse link
G Lipa lipase A, lysosomal acid type decreases expression ISO Antimony Potassium Tartrate results in decreased expression of LIPA mRNA CTD PMID:17547211 NCBI chr 1:232,024,351...232,057,735
Ensembl chr 1:241,437,524...241,470,740
JBrowse link
G Loricrin loricrin cornified envelope precursor protein multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of LORICRIN mRNA CTD PMID:32076005 NCBI chr 2:177,558,062...177,560,960
Ensembl chr 2:180,253,674...180,256,572
JBrowse link
G Lrig1 leucine-rich repeats and immunoglobulin-like domains 1 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of LRIG1 mRNA CTD PMID:28713220 NCBI chr 4:127,130,899...127,230,956
Ensembl chr 4:128,687,723...128,788,219
JBrowse link
G Lss lanosterol synthase decreases expression ISO Antimony Potassium Tartrate results in decreased expression of LSS mRNA CTD PMID:17547211 NCBI chr20:12,091,138...12,118,858
Ensembl chr20:12,073,543...12,118,253
JBrowse link
G Maff MAF bZIP transcription factor F increases expression ISO Antimony Potassium Tartrate results in increased expression of MAFF mRNA CTD PMID:17547211 NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:112,791,416...112,804,147
JBrowse link
G Man1a2 mannosidase, alpha, class 1A, member 2 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of MAN1A2 mRNA CTD PMID:17547211 NCBI chr 2:187,947,484...188,096,332
Ensembl chr 2:190,615,094...190,784,975
JBrowse link
G Maoa monoamine oxidase A multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of MAOA mRNA CTD PMID:32076005 NCBI chr  X:8,615,239...8,681,372
Ensembl chr  X:8,615,239...8,682,631
JBrowse link
G Map1lc3b microtubule-associated protein 1 light chain 3 beta multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased lipidation of MAP1LC3B protein; Chloroquine promotes the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased lipidation of MAP1LC3B protein] CTD PMID:39954839 NCBI chr19:49,665,795...49,673,655
Ensembl chr19:66,574,407...66,584,358
Ensembl chr16:66,574,407...66,584,358
JBrowse link
G Map2k1 mitogen activated protein kinase kinase 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of MAP2K1 mRNA CTD PMID:32076005 NCBI chr 8:64,683,449...64,754,900
Ensembl chr 8:73,578,752...73,650,184
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions EXP
ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of MAPK1 protein
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased phosphorylation of MAPK1 protein
CTD PMID:32076005 PMID:32920012 PMID:34571074 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:97,462,025...97,527,825
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions EXP
ISO
[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased phosphorylation of MAPK3 protein
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased phosphorylation of MAPK3 protein
CTD PMID:32076005 PMID:32920012 PMID:34571074 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:190,797,185...190,803,411
JBrowse link
G Mcm2 minichromosome maintenance complex component 2 increases expression ISO Antimony Potassium Tartrate results in increased expression of MCM2 mRNA CTD PMID:17547211 NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:122,903,682...122,918,094
JBrowse link
G Me1 malic enzyme 1 increases expression ISO Antimony Potassium Tartrate results in increased expression of ME1 mRNA CTD PMID:28713220 NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:96,429,057...96,540,275
JBrowse link
G Mgat2 alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase decreases expression ISO Antimony Potassium Tartrate results in decreased expression of MGAT2 mRNA CTD PMID:17547211 NCBI chr 6:87,656,360...87,658,849
Ensembl chr 6:93,390,555...93,395,176
JBrowse link
G Mgst1 microsomal glutathione S-transferase 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of MGST1 mRNA CTD PMID:32076005 NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:172,760,886...172,776,875
JBrowse link
G Mt1-ps3 metallothionein 1, pseudogene 3 increases expression ISO Antimony Potassium Tartrate results in increased expression of MT1E mRNA CTD PMID:28713220 NCBI chr17:74,786,652...74,787,040
Ensembl chr17:79,695,809...79,696,200
JBrowse link
G Mt2 metallothionein 2 increases expression ISO Antimony Potassium Tartrate results in increased expression of MT2A mRNA CTD PMID:28713220 NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709
JBrowse link
G Mycn MYCN proto-oncogene, bHLH transcription factor multiple interactions
decreases response to substance
ISO [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Antimony Potassium Tartrate
MYCN protein results in decreased susceptibility to Antimony Potassium Tartrate
CTD PMID:10348353 NCBI chr 6:41,446,683...41,452,584
Ensembl chr 6:41,446,684...41,452,508
JBrowse link
G Ncoa4 nuclear receptor coactivator 4 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NCOA4 protein; NCOA4 protein affects the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of FTH1 protein]; NCOA4 protein affects the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of FTL protein] CTD PMID:39954839 NCBI chr16:7,389,222...7,409,564
Ensembl chr16:7,401,802...7,415,840
JBrowse link
G Ndrg2 NDRG family member 2 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of NDRG2 mRNA CTD PMID:17547211 NCBI chr15:24,600,981...24,609,621
Ensembl chr15:27,074,481...27,083,125
JBrowse link
G Nfkb2 nuclear factor kappa B subunit 2 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of NFKB2 mRNA CTD PMID:32076005 NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:255,107,374...255,114,637
JBrowse link
G Nfkbia NFKB inhibitor alpha decreases expression ISO Antimony Potassium Tartrate results in decreased expression of NFKBIA mRNA CTD PMID:17547211 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
JBrowse link
G Nkx3-1 NK3 homeobox 1 increases expression
multiple interactions
ISO Antimony Potassium Tartrate results in increased expression of NKX3-1 mRNA; Antimony Potassium Tartrate results in increased expression of NKX3-1 protein
bicalutamide inhibits the reaction [Antimony Potassium Tartrate results in increased expression of NKX3-1 mRNA]
CTD PMID:29462692 NCBI chr15:44,473,851...44,476,443
Ensembl chr15:50,883,597...50,886,251
JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions EXP
ISO
666-15 compound inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 mRNA; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 protein; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 mRNA]; SB 203580 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of NOS2 protein] CTD PMID:34571074 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 increases expression
multiple interactions
ISO Antimony Potassium Tartrate results in increased expression of NQO1 mRNA; Antimony Potassium Tartrate results in increased expression of NQO1 protein
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of NQO1 mRNA
CTD PMID:28713220 PMID:32076005 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
JBrowse link
G Nqo2 N-ribosyldihydronicotinamide:quinone dehydrogenase 2 increases expression ISO Antimony Potassium Tartrate results in increased expression of NQO2 mRNA CTD PMID:28713220 NCBI chr17:30,909,482...30,938,725
Ensembl chr17:31,114,529...31,143,662
JBrowse link
G Nr0b2 nuclear receptor subfamily 0, group B, member 2 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of NR0B2 mRNA CTD PMID:17547211 NCBI chr 5:151,063,160...151,066,475
Ensembl chr 5:151,063,160...151,066,475
JBrowse link
G Os9 OS9, endoplasmic reticulum lectin decreases expression ISO Antimony Potassium Tartrate results in decreased expression of OS9 mRNA CTD PMID:17547211 NCBI chr 7:62,915,498...62,957,591
Ensembl chr 7:64,802,103...64,829,070
JBrowse link
G Osm oncostatin M multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] inhibits the reaction [OSM protein results in increased phosphorylation of STAT1 protein] CTD PMID:32076005 NCBI chr14:79,103,638...79,108,500
Ensembl chr14:83,327,554...83,331,827
JBrowse link
G Pbx1 PBX homeobox 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PBX1 mRNA CTD PMID:32076005 NCBI chr13:80,278,766...80,588,563
Ensembl chr13:82,812,131...83,121,066
JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions EXP [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of PCNA protein CTD PMID:34571074 NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
JBrowse link
G Pdia4 protein disulfide isomerase family A, member 4 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of PDIA4 mRNA CTD PMID:17547211 NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:78,134,144...78,153,191
JBrowse link
G Pgc progastricsin decreases expression ISO Antimony Potassium Tartrate results in decreased expression of PGC mRNA CTD PMID:17547211 NCBI chr 9:13,257,462...13,265,682
Ensembl chr 9:20,755,002...20,763,220
JBrowse link
G Pgd phosphogluconate dehydrogenase increases expression ISO Antimony Potassium Tartrate results in increased expression of PGD protein CTD PMID:28713220 NCBI chr 5:164,865,830...164,882,029
Ensembl chr 5:164,865,830...164,882,029
JBrowse link
G Pgm1 phosphoglucomutase 1 increases expression ISO Antimony Potassium Tartrate results in increased expression of PGM1 mRNA CTD PMID:28713220 NCBI chr 5:114,595,298...114,654,728
Ensembl chr 5:119,710,737...119,770,159
JBrowse link
G Pgm3 phosphoglucomutase 3 increases expression ISO Antimony Potassium Tartrate results in increased expression of PGM3 mRNA CTD PMID:28713220 NCBI chr 8:87,518,317...87,536,021
Ensembl chr 8:96,398,269...96,416,021
JBrowse link
G Pik3r1 phosphoinositide-3-kinase regulatory subunit 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PIK3R1 mRNA CTD PMID:32076005 NCBI chr 2:32,878,942...32,963,668
Ensembl chr 2:34,612,946...34,626,347
JBrowse link
G Pik3r2 phosphoinositide-3-kinase regulatory subunit 2 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PIK3R2 mRNA CTD PMID:32076005 NCBI chr16:18,665,517...18,674,067
Ensembl chr16:18,699,448...18,709,665
JBrowse link
G Pir pirin multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of PIR mRNA CTD PMID:32076005 NCBI chr  X:33,740,428...33,851,049
Ensembl chr  X:33,740,429...33,851,049
JBrowse link
G Pitx1 paired-like homeodomain 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of PITX1 mRNA CTD PMID:32076005 NCBI chr17:8,794,134...8,800,292
Ensembl chr17:8,799,319...8,805,476
JBrowse link
G Pml PML nuclear body scaffold affects localization
multiple interactions
increases degradation
ISO Antimony Potassium Tartrate affects the localization of PML protein
Antimony Potassium Tartrate promotes the reaction [SUMO1 protein binds to PML protein]
Antimony Potassium Tartrate results in increased degradation of PML protein mutant form
CTD PMID:9834237 NCBI chr 8:67,523,164...67,557,801
Ensembl chr 8:67,523,164...67,576,083
JBrowse link
G Ppih peptidylprolyl isomerase H increases expression ISO Antimony Potassium Tartrate results in increased expression of PPIH mRNA CTD PMID:17547211 NCBI chr 5:132,906,324...132,924,341
Ensembl chr 5:138,191,624...138,209,580
JBrowse link
G Prdx1 peroxiredoxin 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of PRDX1 mRNA CTD PMID:32076005 NCBI chr 5:135,383,906...135,399,504
Ensembl chr 5:135,383,906...135,399,504
JBrowse link
G Psph phosphoserine phosphatase decreases expression ISO Antimony Potassium Tartrate results in decreased expression of PSPH mRNA CTD PMID:17547211 NCBI chr12:26,882,524...26,905,084
Ensembl chr12:32,519,269...32,541,180
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of PTGS2 protein; Deferoxamine inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of PTGS2 protein]; ferrostatin-1 inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in increased expression of PTGS2 protein] CTD PMID:39954839 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
JBrowse link
G Pttg1 PTTG1 regulator of sister chromatid separation, securin increases expression ISO Antimony Potassium Tartrate results in increased expression of PTTG1 mRNA CTD PMID:17547211 NCBI chr10:27,893,466...27,904,965
Ensembl chr10:28,394,814...28,406,309
JBrowse link
G Rara retinoic acid receptor, alpha increases degradation ISO Antimony Potassium Tartrate results in increased degradation of RARA protein mutant form CTD PMID:9834237 NCBI chr10:84,379,780...84,424,371
Ensembl chr10:84,389,622...84,425,160
JBrowse link
G Rbfox3 RNA binding fox-1 homolog 3 multiple interactions ISO 3-methyladenine inhibits the reaction [[Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of RBFOX3 protein]; [Antimony Potassium Tartrate results in increased abundance of Antimony] which results in decreased expression of RBFOX3 protein CTD PMID:39954839 NCBI chr10:103,720,355...104,157,277
Ensembl chr10:104,218,940...104,551,945
JBrowse link
G Rbpms RNA binding protein, mRNA processing factor increases expression ISO Antimony Potassium Tartrate results in increased expression of RBPMS mRNA CTD PMID:17547211 NCBI chr16:58,239,370...58,395,424
Ensembl chr16:64,942,530...65,098,503
JBrowse link
G Rfc2 replication factor C subunit 2 increases expression ISO Antimony Potassium Tartrate results in increased expression of RFC2 mRNA CTD PMID:17547211 NCBI chr12:22,120,449...22,133,576
Ensembl chr12:27,756,922...27,770,025
JBrowse link
G Rnaseh2a ribonuclease H2, subunit A increases expression ISO Antimony Potassium Tartrate results in increased expression of RNASEH2A mRNA CTD PMID:17547211 NCBI chr19:23,186,325...23,196,045
Ensembl chr19:40,091,210...40,100,899
JBrowse link
G Rnh1 ribonuclease/angiogenin inhibitor 1 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of RNH1 protein CTD PMID:28713220 NCBI chr 1:196,269,293...196,281,763
Ensembl chr 1:205,698,882...205,711,582
JBrowse link
G Rptn repetin decreases expression ISO Antimony Potassium Tartrate results in decreased expression of RPTN mRNA CTD PMID:28713220 NCBI chr 2:179,061,768...179,066,056
Ensembl chr 2:181,745,307...181,749,364
JBrowse link
G Ryr1 ryanodine receptor 1 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of RYR1 mRNA CTD PMID:28713220 NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:93,420,078...93,551,305
JBrowse link
G S100a2 S100 calcium binding protein A2 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of S100A2 mRNA CTD PMID:28713220 NCBI chr 2:176,077,081...176,078,325 JBrowse link
G S100a8 S100 calcium binding protein A8 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of S100A8 mRNA; Antimony Potassium Tartrate results in decreased expression of S100A8 protein CTD PMID:28713220 NCBI chr 2:178,464,095...178,465,223
Ensembl chr 2:178,464,702...178,465,221
JBrowse link
G S100a9 S100 calcium binding protein A9 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of S100A9 mRNA; Antimony Potassium Tartrate results in decreased expression of S100A9 protein CTD PMID:28713220 NCBI chr 2:178,487,941...178,490,622
Ensembl chr 2:178,487,941...178,490,870
JBrowse link
G Scd stearoyl-CoA desaturase decreases expression ISO Antimony Potassium Tartrate results in decreased expression of SCD mRNA CTD PMID:17547211 NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:253,218,970...253,231,785
JBrowse link
G Sephs2 selenophosphate synthetase 2 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of SEPHS2 mRNA CTD PMID:17547211 NCBI chr 1:181,893,146...181,895,464
Ensembl chr 1:191,323,641...191,325,955
JBrowse link
G Serpinb1a serpin family B member 1A decreases expression ISO Antimony Potassium Tartrate results in decreased expression of SERPINB1 mRNA CTD PMID:17547211 NCBI chr17:31,590,695...31,599,102
Ensembl chr17:31,799,415...31,808,166
JBrowse link
G Serpinc1 serpin family C member 1 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of SERPINC1 mRNA CTD PMID:17547211 NCBI chr13:73,257,208...73,271,476
Ensembl chr13:75,790,546...75,817,643
JBrowse link
G Serpine1 serpin family E member 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SERPINE1 mRNA CTD PMID:32076005 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
JBrowse link
G Sik1 salt-inducible kinase 1 increases expression ISO Antimony Potassium Tartrate results in increased expression of SIK1 mRNA CTD PMID:17547211 NCBI chr20:9,949,407...9,959,036
Ensembl chr20:9,947,105...9,958,698
JBrowse link
G Slc2a3 solute carrier family 2 member 3 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SLC2A3 mRNA CTD PMID:32076005 NCBI chr 4:155,960,944...156,026,000
Ensembl chr 4:157,632,887...157,646,186
JBrowse link
G Snrpa small nuclear ribonucleoprotein polypeptide A increases expression ISO Antimony Potassium Tartrate results in increased expression of SNRPA mRNA CTD PMID:17547211 NCBI chr 1:82,481,770...82,490,540
Ensembl chr 1:91,609,420...91,618,042
JBrowse link
G Sod1 superoxide dismutase 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SOD1 mRNA CTD PMID:32076005 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
JBrowse link
G Sprr1a small proline-rich protein 1A decreases expression ISO Antimony Potassium Tartrate results in decreased expression of SPRR1A mRNA; Antimony Potassium Tartrate results in decreased expression of SPRR1A protein CTD PMID:28713220 NCBI chr 2:178,055,096...178,057,012
Ensembl chr 2:180,750,709...180,752,991
JBrowse link
G Sprr1b small proline-rich protein 1B decreases expression ISO Antimony Potassium Tartrate results in decreased expression of SPRR1B mRNA; Antimony Potassium Tartrate results in decreased expression of SPRR1B protein CTD PMID:28713220 NCBI chr 2:178,008,844...178,010,742
Ensembl chr 2:180,704,457...180,706,355
JBrowse link
G Sprr3 small proline-rich protein 3 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of SPRR3 mRNA; Antimony Potassium Tartrate results in decreased expression of SPRR3 protein CTD PMID:28713220 NCBI chr 2:178,027,743...178,028,501
Ensembl chr 2:180,723,061...180,725,505
JBrowse link
G Sqle squalene epoxidase decreases expression ISO Antimony Potassium Tartrate results in decreased expression of SQLE mRNA CTD PMID:17547211 NCBI chr 7:90,867,973...90,883,623
Ensembl chr 7:92,757,409...92,773,050
JBrowse link
G Sqstm1 sequestosome 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of SQSTM1 mRNA CTD PMID:32076005 NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
JBrowse link
G Srsf1 serine and arginine rich splicing factor 1 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of SRSF1 mRNA CTD PMID:17547211 NCBI chr10:73,335,519...73,342,549
Ensembl chr10:73,336,422...73,342,548
JBrowse link
G Srsf5 serine and arginine rich splicing factor 5 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of SRSF5 mRNA CTD PMID:17547211 NCBI chr 6:100,605,165...100,610,192
Ensembl chr 6:106,336,756...106,341,931
JBrowse link
G Srxn1 sulfiredoxin 1 increases expression ISO Antimony Potassium Tartrate results in increased expression of SRXN1 mRNA CTD PMID:28713220 NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:161,059,931...161,088,765
JBrowse link
G St6galnac4 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of ST6GALNAC4 mRNA CTD PMID:17547211 NCBI chr 3:15,872,230...15,885,250
Ensembl chr 3:36,269,878...36,282,971
JBrowse link
G Stat1 signal transducer and activator of transcription 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] inhibits the reaction [OSM protein results in increased phosphorylation of STAT1 protein]; [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of STAT1 mRNA CTD PMID:32076005 NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:56,911,523...57,077,346
JBrowse link
G Sult1c3 sulfotransferase family 1C member 3 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of SULT1C3 mRNA CTD PMID:32076005 NCBI chr 9:7,221,580...7,266,991
Ensembl chr 9:7,548,622...7,594,295
JBrowse link
G Sult1e1 sulfotransferase family 1E member 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of SULT1E1 mRNA CTD PMID:32076005 NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,700,292...20,718,716
JBrowse link
G Sult2b1 sulfotransferase family 2B member 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of SULT2B1 mRNA CTD PMID:32076005 NCBI chr 1:96,200,155...96,261,295
Ensembl chr 1:105,336,614...105,397,744
JBrowse link
G Sumo1 small ubiquitin-like modifier 1 affects localization
multiple interactions
ISO Antimony Potassium Tartrate affects the localization of SUMO1 protein
Antimony Potassium Tartrate promotes the reaction [SUMO1 protein binds to PML protein]
CTD PMID:9834237 NCBI chr 9:61,078,790...61,108,697
Ensembl chr 9:68,572,911...68,602,890
JBrowse link
G Tardbp TAR DNA binding protein decreases expression ISO Antimony Potassium Tartrate results in decreased expression of TARDBP mRNA CTD PMID:17547211 NCBI chr 5:159,050,518...159,062,218
Ensembl chr 5:164,334,924...164,345,204
JBrowse link
G Tgm1 transglutaminase 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of TGM1 mRNA CTD PMID:32076005 NCBI chr15:29,191,039...29,206,000
Ensembl chr15:33,160,987...33,174,463
JBrowse link
G Tnfaip3 TNF alpha induced protein 3 increases expression ISO Antimony Potassium Tartrate results in increased expression of TNFAIP3 mRNA CTD PMID:17547211 NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:15,528,921...15,543,979
JBrowse link
G Tnfsf10 TNF superfamily member 10 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of TNFSF10 mRNA CTD PMID:17547211 NCBI chr 2:112,136,550...112,155,903 JBrowse link
G Tob1 transducer of ErbB-2.1 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of TOB1 mRNA CTD PMID:17547211 NCBI chr10:79,163,093...79,165,131
Ensembl chr10:79,656,433...79,666,601
JBrowse link
G Tp63 tumor protein p63 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of TP63 mRNA CTD PMID:32076005 NCBI chr11:74,838,858...75,049,764
Ensembl chr11:88,343,651...88,554,177
JBrowse link
G Tpi1 triosephosphate isomerase 1 increases expression ISO Antimony Potassium Tartrate results in increased expression of TPI1 mRNA CTD PMID:28713220 NCBI chr 4:157,615,283...157,618,813
Ensembl chr 4:159,301,562...159,305,413
JBrowse link
G Tsc22d3 TSC22 domain family, member 3 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of TSC22D3 mRNA CTD PMID:32076005 NCBI chr  X:104,217,898...104,277,886
Ensembl chr  X:109,006,420...109,015,519
JBrowse link
G Tspan7 tetraspanin 7 decreases expression ISO Antimony Potassium Tartrate results in decreased expression of TSPAN7 mRNA CTD PMID:17547211 NCBI chr  X:14,881,327...14,978,627
Ensembl chr  X:14,881,334...14,978,655
JBrowse link
G Tuft1 tuftelin 1 increases expression ISO Antimony Potassium Tartrate results in increased expression of TUFT1 mRNA CTD PMID:17547211 NCBI chr 2:182,259,457...182,306,296
Ensembl chr 2:184,949,437...184,995,383
JBrowse link
G Txn1 thioredoxin 1 multiple interactions ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of TXN mRNA CTD PMID:32076005 NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307
JBrowse link
G Txnrd1 thioredoxin reductase 1 increases expression
multiple interactions
ISO Antimony Potassium Tartrate results in increased expression of TXNRD1 mRNA
[Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of TXNRD1 mRNA
CTD PMID:17547211 PMID:28713220 PMID:32076005 NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:22,719,317...22,739,817
JBrowse link
G Tyms thymidylate synthetase increases expression ISO Antimony Potassium Tartrate results in increased expression of TYMS mRNA CTD PMID:17547211 NCBI chr 9:120,760,057...120,776,149
Ensembl chr 9:120,763,386...120,776,097
JBrowse link
G Ube2c ubiquitin-conjugating enzyme E2C increases expression ISO Antimony Potassium Tartrate results in increased expression of UBE2C mRNA CTD PMID:17547211 NCBI chr 3:153,506,636...153,509,036
Ensembl chr 3:173,925,934...173,932,678
JBrowse link
G Ugt1a6 UDP glucuronosyltransferase family 1 member A6 multiple interactions
increases expression
ISO [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in increased expression of UGT1A6 mRNA
Antimony Potassium Tartrate results in increased expression of UGT1A6 mRNA
CTD PMID:28713220 PMID:32076005 NCBI chr 9:96,195,018...96,256,264
Ensembl chr 9:96,144,786...96,256,264
JBrowse link
G Zwint ZW10 interacting kinetochore protein increases expression ISO Antimony Potassium Tartrate results in increased expression of ZWINT mRNA CTD PMID:17547211 NCBI chr20:15,938,157...15,953,997
Ensembl chr20:15,937,396...15,953,203
JBrowse link
diprotium oxide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Agrp agouti related neuropeptide multiple interactions EXP [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of AGRP mRNA; AM 251 promotes the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of AGRP mRNA] CTD PMID:26468265 NCBI chr19:33,447,992...33,481,602
Ensembl chr19:50,357,905...50,358,698
JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of AKT1 mRNA CTD PMID:29335169 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
JBrowse link
G Aqp1 aquaporin 1 increases transport
multiple interactions
ISO
EXP
AQP1 protein results in increased transport of Water
Mercuric Chloride inhibits the reaction [AQP1 protein results in increased transport of Water]; Mercury inhibits the reaction [AQP1 protein results in increased transport of Water]
CTD PMID:7528928 PMID:8457558 PMID:10559675 PMID:11035042 PMID:11078688 More... NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504
JBrowse link
G Aqp11 aquaporin 11 multiple interactions
increases transport
ISO Mercaptoethanol inhibits the reaction [Mercuric Chloride inhibits the reaction [AQP11 protein results in increased transport of Water]]; Mercuric Chloride inhibits the reaction [AQP11 protein results in increased transport of Water] CTD PMID:21251984 NCBI chr 1:152,046,515...152,056,675
Ensembl chr 1:161,457,754...161,467,945
JBrowse link
G Aqp2 aquaporin 2 increases expression EXP Water deficiency results in increased expression of AQP2 mRNA CTD PMID:15462210 NCBI chr 7:130,711,433...130,716,468
Ensembl chr 7:132,590,225...132,595,319
JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) multiple interactions
increases expression
increases transport
ISO
EXP
Dexamethasone promotes the reaction [AQP3 protein results in increased transport of Water]; Mercaptoethanol inhibits the reaction [Mercuric Chloride inhibits the reaction [AQP3 protein results in increased transport of Water]]; Mercuric Chloride inhibits the reaction [AQP3 protein results in increased transport of Water]; Mercuric Chloride inhibits the reaction [Dexamethasone promotes the reaction [AQP3 protein results in increased transport of Water]]
Water deficiency results in increased expression of AQP3 mRNA; Water deficiency results in increased expression of AQP3 protein
Copper Sulfate inhibits the reaction [AQP3 protein results in increased transport of Water]; Mercuric Chloride inhibits the reaction [AQP3 protein results in increased transport of Water]
CTD PMID:9124401 PMID:9374739 PMID:15462210 PMID:22687538 NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:61,035,166...61,040,685
JBrowse link
G Aqp4 aquaporin 4 increases transport
increases response to substance
increases expression
affects transport
EXP
ISO
AQP4 protein results in increased transport of Water
AQP4 protein results in increased susceptibility to Water
Water deficiency results in increased expression of AQP4 mRNA
AQP4 protein affects the transport of Water
CTD PMID:7528931 PMID:15462210 PMID:20815926 PMID:21251984 NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,782,389...6,799,098
JBrowse link
G Aqp7 aquaporin 7 affects transport
increases transport
EXP AQP7 protein affects the transport of Water
AQP7 protein results in increased transport of Water
CTD PMID:9252401 PMID:18059526 NCBI chr 5:56,171,649...56,186,642
Ensembl chr 5:60,967,558...60,982,618
JBrowse link
G Aqp8 aquaporin 8 multiple interactions
increases transport
affects transport
EXP
ISO
Copper affects the reaction [AQP8 protein affects the transport of Water]; Mercury affects the reaction [AQP8 protein affects the transport of Water]
AQP8 protein results in increased transport of Water
Mercuric Chloride inhibits the reaction [AQP8 protein results in increased transport of Water]
CTD PMID:18059526 PMID:19840149 NCBI chr 1:177,993,313...177,999,158
Ensembl chr 1:187,424,417...187,430,242
JBrowse link
G Aqp9 aquaporin 9 multiple interactions
increases transport
affects transport
EXP
ISO
CFTR protein promotes the reaction [AQP9 protein affects the transport of Water]; lonidamine inhibits the reaction [CFTR protein promotes the reaction [AQP9 protein affects the transport of Water]]; Mercuric Chloride inhibits the reaction [AQP9 protein results in increased transport of Water]; Mercury inhibits the reaction [AQP9 protein results in increased transport of Water]; Phloretin inhibits the reaction [AQP9 protein results in increased transport of Water]; Phloretin inhibits the reaction [CFTR protein promotes the reaction [AQP9 protein affects the transport of Water]] CTD PMID:9514918 PMID:9733774 PMID:10205677 PMID:12606488 PMID:21259319 More... NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:80,678,030...80,717,240
JBrowse link
G Avp arginine vasopressin multiple interactions EXP [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of AVP mRNA; [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased secretion of AVP protein; AM 251 promotes the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of AVP mRNA]; arachidonyl-2-chloroethylamide inhibits the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of AVP mRNA] CTD PMID:26468265 NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:138,246,554...138,248,522
JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of BCL2 mRNA CTD PMID:29335169 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
JBrowse link
G Becn1 beclin 1 multiple interactions ISO [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of BECN1 protein; Berberine promotes the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of BECN1 protein] CTD PMID:38705399 NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,731,650...86,747,002
JBrowse link
G Bnip3 BCL2 interacting protein 3 multiple interactions ISO [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of BNIP3 protein; Berberine promotes the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of BNIP3 protein] CTD PMID:38705399 NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:203,137,778...203,154,962
JBrowse link
G Cartpt CART prepropeptide multiple interactions EXP [AM 251 co-treated with Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of CARTPT mRNA; [arachidonyl-2-chloroethylamide co-treated with Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of CARTPT mRNA CTD PMID:26468265 NCBI chr 2:31,255,098...31,257,452
Ensembl chr 2:32,989,215...32,999,712
JBrowse link
G Casp1 caspase 1 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which affects the expression of CASP1 mRNA; [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of and results in increased cleavage of CASP1 protein; [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CASP1 mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of and results in increased cleavage of CASP1 protein]; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CASP1 mRNA] CTD PMID:29335169 PMID:38705399 NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:10,746,333...10,882,275
JBrowse link
G Casp3 caspase 3 multiple interactions EXP [Water deficiency co-treated with Diclofenac] results in increased expression of CASP3 protein; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in increased expression of CASP3 protein] CTD PMID:31042592 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Cat catalase multiple interactions EXP
ISO
[Water deficiency co-treated with Diclofenac] results in decreased activity of CAT protein; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in decreased activity of CAT protein]
[[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of CAT mRNA
CTD PMID:29335169 PMID:31042592 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions EXP
ISO
[Water deficiency co-treated with Diclofenac] results in increased expression of CCL2 protein; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in increased expression of CCL2 protein]
[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CCL2 mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CCL2 mRNA]
CTD PMID:31042592 PMID:38705399 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
JBrowse link
G Cftr CF transmembrane conductance regulator multiple interactions EXP 1-Methyl-3-isobutylxanthine promotes the reaction [CFTR protein affects the transport of Water]; CFTR protein promotes the reaction [AQP9 protein affects the transport of Water]; lonidamine inhibits the reaction [CFTR protein promotes the reaction [AQP9 protein affects the transport of Water]]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [CFTR protein affects the transport of Water]; Phloretin inhibits the reaction [CFTR protein promotes the reaction [AQP9 protein affects the transport of Water]] CTD PMID:12606488 NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:47,526,735...47,694,643
JBrowse link
G Cnr1 cannabinoid receptor 1 multiple interactions EXP [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of CNR1 mRNA; [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of CNR1 protein CTD PMID:26468265 NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:53,204,260...53,239,252
JBrowse link
G Col3a1 collagen type III alpha 1 chain multiple interactions EXP [Water deficiency co-treated with Diclofenac] results in increased expression of COL3A1 protein; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in increased expression of COL3A1 protein] CTD PMID:31042592 NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232
JBrowse link
G Cr1l complement C3b/C4b receptor 1 like multiple interactions EXP [Water deficiency co-treated with Diclofenac] results in decreased expression of CR1L protein; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in decreased expression of CR1L protein] CTD PMID:31042592 NCBI chr13:106,606,952...106,660,442
Ensembl chr13:109,103,235...109,188,869
JBrowse link
G Crh corticotropin releasing hormone multiple interactions EXP [AM 251 co-treated with Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of CRH mRNA CTD PMID:26468265 NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:104,058,770...104,061,386
JBrowse link
G Cst3 cystatin C multiple interactions ISO [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CST3 protein; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CST3 protein] CTD PMID:38705399 NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:156,790,079...156,793,937
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in decreased expression of CYP1A1 mRNA CTD PMID:29335169 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in decreased expression of CYP2E1 mRNA CTD PMID:29335169 NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:205,267,505...205,293,495
JBrowse link
G Edn1 endothelin 1 affects export ISO EDN1 protein affects the export of Water CTD PMID:16340664 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
JBrowse link
G Fgf2 fibroblast growth factor 2 increases expression ISO Water results in increased expression of FGF2 mRNA CTD PMID:26800359 NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:122,164,454...122,224,493
JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of GCLC mRNA CTD PMID:29335169 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of GPX1 mRNA CTD PMID:29335169 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
JBrowse link
G Gsr glutathione-disulfide reductase multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of GSR mRNA CTD PMID:29335169 NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
JBrowse link
G Hbegf heparin-binding EGF-like growth factor decreases expression ISO Water results in decreased expression of HBEGF mRNA CTD PMID:26800359 NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,380,337...28,390,220
JBrowse link
G Hcrt hypocretin neuropeptide precursor multiple interactions EXP [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of HCRT mRNA; AM 251 inhibits the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of HCRT mRNA] CTD PMID:26468265 NCBI chr10:85,689,979...85,691,214
Ensembl chr10:86,189,775...86,191,524
JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions ISO [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of HMGB1 protein; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of HMGB1 protein] CTD PMID:38705399 NCBI chr12:5,972,950...5,979,658
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327
JBrowse link
G Hmox1 heme oxygenase 1 increases expression
multiple interactions
EXP
ISO
Water deficiency results in increased expression of HMOX1 protein
[[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of HMOX1 mRNA
CTD PMID:22060896 PMID:29335169 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
JBrowse link
G Hpgds hematopoietic prostaglandin D synthase multiple interactions ISO Water affects the reaction [Isoquinolines analog binds to and results in decreased activity of HPGDS protein] CTD PMID:22546671 NCBI chr 4:94,368,426...94,397,931
Ensembl chr 4:95,702,392...95,938,501
JBrowse link
G Il10 interleukin 10 multiple interactions EXP [Gum Arabic co-treated with Water deficiency co-treated with Diclofenac] results in increased expression of IL10 protein CTD PMID:31042592 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP
ISO
[Water deficiency co-treated with Diclofenac] results in increased expression of IL1B protein; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in increased expression of IL1B protein]
[[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of IL1B mRNA; [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL1B mRNA; [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL1B protein; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL1B mRNA]; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL1B protein]
CTD PMID:29335169 PMID:31042592 PMID:38705399 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
JBrowse link
G Il6 interleukin 6 multiple interactions ISO [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL6 mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL6 mRNA] CTD PMID:38705399 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
JBrowse link
G Mt2 metallothionein 2 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which affects the expression of MT2 mRNA CTD PMID:29335169 NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709
JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of NFE2L2 mRNA CTD PMID:29335169 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
JBrowse link
G Nlrp3 NLR family, pyrin domain containing 3 multiple interactions ISO [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of NLRP3 mRNA; [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of NLRP3 protein; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of NLRP3 mRNA]; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of NLRP3 protein] CTD PMID:38705399 NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394
JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of NOS2 mRNA CTD PMID:29335169 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
JBrowse link
G Npy neuropeptide Y multiple interactions EXP [AM 251 co-treated with Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of NPY mRNA CTD PMID:26468265 NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:80,212,111...80,219,310
JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of NQO1 mRNA CTD PMID:29335169 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
JBrowse link
G Oxt oxytocin/neurophysin I prepropeptide multiple interactions EXP [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of OXT mRNA; [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased secretion of OXT protein; AM 251 promotes the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of OXT mRNA]; arachidonyl-2-chloroethylamide inhibits the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of OXT mRNA]; arachidonyl-2-chloroethylamide inhibits the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased secretion of OXT protein] CTD PMID:26468265 NCBI chr 3:117,782,650...117,783,490
Ensembl chr 3:138,235,754...138,236,594
JBrowse link
G Pmch pro-melanin-concentrating hormone multiple interactions EXP [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of PMCH mRNA; arachidonyl-2-chloroethylamide promotes the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of PMCH mRNA] CTD PMID:26468265 NCBI chr 7:22,511,934...22,513,250
Ensembl chr 7:24,399,404...24,400,720
JBrowse link
G Pomc proopiomelanocortin multiple interactions EXP [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of POMC mRNA; AM 251 promotes the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of POMC mRNA]; arachidonyl-2-chloroethylamide inhibits the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of POMC mRNA] CTD PMID:26468265 NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:32,659,346...32,665,173
JBrowse link
G Pycard PYD and CARD domain containing multiple interactions ISO [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of PYCARD mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of PYCARD mRNA] CTD PMID:38705399 NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:192,032,124...192,033,419
JBrowse link
G Slc12a1 solute carrier family 12 member 1 multiple interactions
increases import
EXP [Glucose results in increased activity of SLC12A1 protein] which results in increased import of Water; [Mannitol results in increased activity of SLC12A1 protein] which results in increased import of Water
SLC12A1 protein results in increased import of Water
CTD PMID:12433675 NCBI chr 3:112,406,140...112,482,913
Ensembl chr 3:132,859,590...132,936,340
JBrowse link
G Slc5a3 solute carrier family 5 member 3 increases expression ISO Water deficiency results in increased expression of SLC5A3 mRNA CTD PMID:21219332 NCBI chr11:44,799,787...44,802,233
Ensembl chr11:44,790,297...44,818,157
JBrowse link
G Sod1 superoxide dismutase 1 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of SOD1 mRNA CTD PMID:29335169 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
JBrowse link
G Sod2 superoxide dismutase 2 increases expression
multiple interactions
ISO Water deficiency results in increased expression of SOD2 protein
[[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of SOD2 mRNA
CTD PMID:22718889 PMID:29335169 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
JBrowse link
G Sqstm1 sequestosome 1 multiple interactions ISO [Berberine co-treated with Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of SQSTM1 protein CTD PMID:38705399 NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
JBrowse link
G Tac1 tachykinin, precursor 1 multiple interactions EXP TAC1 protein alternative form inhibits the reaction [Cholera Toxin results in increased secretion of Water]; TAC1 protein inhibits the reaction [Cholera Toxin results in increased secretion of Water] CTD PMID:11040190 NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:36,645,571...36,653,546
JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP
ISO
[Water deficiency co-treated with Diclofenac] results in increased expression of TNF protein; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in increased expression of TNF protein]
[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of TNF mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of TNF mRNA]
CTD PMID:31042592 PMID:38705399 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
enalaprilat dihydrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ace angiotensin I converting enzyme multiple interactions ISO Enalaprilat inhibits the reaction [Glucose results in increased expression of ACE protein] CTD PMID:16452552 NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
JBrowse link
G Adrb1 adrenoceptor beta 1 affects expression EXP Enalaprilat affects the expression of ADRB1 protein CTD PMID:9260993 NCBI chr 1:255,771,962...255,774,973
Ensembl chr 1:265,766,079...265,849,237
JBrowse link
G Adrb2 adrenoceptor beta 2 affects expression EXP Enalaprilat affects the expression of ADRB2 protein CTD PMID:9260993 NCBI chr18:55,642,459...55,644,501
Ensembl chr18:57,911,348...57,914,803
JBrowse link
G Agt angiotensinogen decreases expression
multiple interactions
EXP
ISO
Enalaprilat results in decreased expression of AGT protein modified form
Enalaprilat inhibits the reaction [Glucose results in increased expression of AGT protein]
CTD PMID:16452552 PMID:21795644 NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
JBrowse link
G Agtr1a angiotensin II receptor, type 1a multiple interactions ISO Enalaprilat inhibits the reaction [Glucose results in increased expression of AGTR1 protein] CTD PMID:16452552 NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,381,467...34,435,660
JBrowse link
G Bcl2 BCL2, apoptosis regulator increases expression ISO Enalaprilat results in increased expression of BCL2 mRNA CTD PMID:17342403 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
JBrowse link
G Bdkrb1 bradykinin receptor B1 multiple interactions
increases activity
ISO bradykinin, Lys-Leu(8)-desArg(9)- inhibits the reaction [Enalaprilat results in increased activity of BDKRB1 protein]; Zinc affects the reaction [Enalaprilat results in increased activity of BDKRB1 protein] CTD PMID:11880373 NCBI chr 6:130,275,631...130,284,968
Ensembl chr 6:130,275,478...130,280,973
JBrowse link
G Edn1 endothelin 1 decreases secretion ISO Enalaprilat results in decreased secretion of EDN1 protein CTD PMID:19079593 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
JBrowse link
G Fn1 fibronectin 1 decreases expression
multiple interactions
EXP
ISO
Enalaprilat results in decreased expression of FN1 mRNA; Enalaprilat results in decreased expression of FN1 protein
Enalaprilat inhibits the reaction [Glucose results in increased expression of FN1 mRNA]
CTD PMID:14520012 PMID:21795644 NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:80,645,507...80,714,137
JBrowse link
G Glud1 glutamate dehydrogenase 1 multiple interactions EXP Enalaprilat inhibits the reaction [Dexamethasone results in decreased expression of GLUD1 mRNA]; Enalaprilat inhibits the reaction [Dexamethasone results in decreased expression of GLUD2 mRNA] CTD PMID:32494933 NCBI chr16:9,640,312...9,673,961
Ensembl chr16:9,646,509...9,680,210
JBrowse link
G Grm1 glutamate metabotropic receptor 1 multiple interactions EXP Enalaprilat inhibits the reaction [Dexamethasone results in increased expression of GRM1 mRNA] CTD PMID:32494933 NCBI chr 1:5,058,285...5,453,170
Ensembl chr 1:6,878,545...7,273,443
JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions EXP Enalaprilat inhibits the reaction [Dexamethasone results in increased expression of HMGB1 mRNA]; Enalaprilat inhibits the reaction [Dexamethasone results in increased expression of HMGB1 protein] CTD PMID:32494933 NCBI chr12:5,972,950...5,979,658
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327
JBrowse link
G Ins2 insulin 2 multiple interactions ISO Enalaprilat inhibits the reaction [Glucose results in decreased secretion of INS protein] CTD PMID:16452552 NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805
JBrowse link
G Ppard peroxisome proliferator-activated receptor delta multiple interactions EXP [Enalaprilat co-treated with Daunorubicin] results in increased expression of PPARD mRNA CTD PMID:23834779 NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,352,183...6,365,707
JBrowse link
G Ren renin increases expression EXP Enalaprilat results in increased expression of REN mRNA CTD PMID:21795644 NCBI chr13:44,796,260...44,807,491
Ensembl chr13:47,348,143...47,359,543
JBrowse link
G Serpine1 serpin family E member 1 decreases expression EXP Enalaprilat results in decreased expression of SERPINE1 mRNA CTD PMID:21795644 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
JBrowse link
G Slc22a8 solute carrier family 22 member 8 multiple interactions
increases uptake
ISO verlukast inhibits the reaction [SLC22A8 protein results in increased uptake of Enalaprilat] CTD PMID:33007874 NCBI chr 1:205,496,331...205,516,378
Ensembl chr 1:214,925,508...214,946,588
JBrowse link
G Tgfb1 transforming growth factor, beta 1 decreases expression EXP Enalaprilat results in decreased expression of TGFB1 mRNA; Enalaprilat results in decreased expression of TGFB1 protein CTD PMID:21795644 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions EXP Enalaprilat inhibits the reaction [Dexamethasone results in increased expression of TLR4 mRNA] CTD PMID:32494933 NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:85,161,192...85,175,007
JBrowse link
G Tnf tumor necrosis factor decreases expression ISO Enalaprilat results in decreased expression of TNF mRNA CTD PMID:17342403 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
gadodiamide hydrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adipoq adiponectin, C1Q and collagen domain containing decreases expression ISO gadodiamide results in decreased expression of ADIPOQ mRNA; gadodiamide results in decreased expression of ADIPOQ protein CTD PMID:37437671 NCBI chr11:77,721,912...77,735,644
Ensembl chr11:91,226,180...91,240,169
JBrowse link
G Akt1 AKT serine/threonine kinase 1 increases phosphorylation
multiple interactions
ISO gadodiamide results in increased phosphorylation of AKT1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [gadodiamide results in increased phosphorylation of AKT1 protein]
CTD PMID:19561517 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 increases expression ISO gadodiamide results in increased expression of ALDH1A1 mRNA CTD PMID:20959327 NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500
JBrowse link
G Ankrd22 ankyrin repeat domain 22 increases expression ISO gadodiamide results in increased expression of ANKRD22 mRNA CTD PMID:20959327 NCBI chr 1:231,639,035...231,670,537
Ensembl chr 1:241,052,237...241,105,559
JBrowse link
G Atm ATM serine/threonine kinase increases expression ISO gadodiamide results in increased expression of ATM mRNA CTD PMID:20959327 NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:62,727,291...62,828,629
JBrowse link
G Atp8b1 ATPase phospholipid transporting 8B1 increases expression ISO gadodiamide results in increased expression of ATP8B1 mRNA CTD PMID:20959327 NCBI chr18:58,016,382...58,157,213
Ensembl chr18:60,288,464...60,427,027
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 increases expression
increases secretion
ISO
EXP
gadodiamide results in increased expression of CCL2 mRNA
gadodiamide results in increased expression of CCL2 mRNA; gadodiamide results in increased expression of CCL2 protein
gadodiamide results in increased secretion of CCL2 protein
CTD PMID:20938346 PMID:20959327 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
JBrowse link
G Ccl4 C-C motif chemokine ligand 4 increases expression EXP gadodiamide results in increased expression of CCL4 protein CTD PMID:20938346 NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,950,289...68,965,722
JBrowse link
G Ccl7 C-C motif chemokine ligand 7 increases expression EXP gadodiamide results in increased expression of CCL7 protein CTD PMID:20938346 NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,514,091...67,515,947
JBrowse link
G Cep15 centrosomal protein 15 increases expression ISO gadodiamide results in increased expression of CEP15 mRNA CTD PMID:20959327 NCBI chr15:12,815,159...12,835,115
Ensembl chr15:15,247,932...15,265,475
JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 increases expression
increases secretion
ISO
EXP
gadodiamide results in increased expression of CXCL10 mRNA
gadodiamide results in increased expression of CXCL10 protein
gadodiamide results in increased secretion of CXCL10 protein
CTD PMID:20938346 PMID:20959327 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
JBrowse link
G Cxcl11 C-X-C motif chemokine ligand 11 increases secretion
increases expression
ISO gadodiamide results in increased secretion of CXCL11 protein
gadodiamide results in increased expression of CXCL11 mRNA
CTD PMID:20959327 NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,973,720...15,976,567
JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 increases expression ISO gadodiamide results in increased expression of CXCL12 mRNA CTD PMID:20959327 NCBI chr 4:152,060,781...152,073,628
Ensembl chr 4:152,060,780...152,073,627
JBrowse link
G Cxcl9 C-X-C motif chemokine ligand 9 increases expression ISO gadodiamide results in increased expression of CXCL9 mRNA CTD PMID:20959327 NCBI chr14:16,007,166...16,012,077
Ensembl chr14:16,007,204...16,014,299
JBrowse link
G Fabp4 fatty acid binding protein 4 decreases expression ISO gadodiamide results in decreased expression of FABP4 mRNA; gadodiamide results in decreased expression of FABP4 protein CTD PMID:37437671 NCBI chr 2:91,580,879...91,585,567
Ensembl chr 2:93,488,271...93,492,972
JBrowse link
G Ido1 indoleamine 2,3-dioxygenase 1 increases expression ISO gadodiamide results in increased expression of IDO1 mRNA CTD PMID:20959327 NCBI chr16:67,430,654...67,442,726
Ensembl chr16:74,133,259...74,145,328
JBrowse link
G Ifi44l interferon-induced protein 44-like increases expression ISO gadodiamide results in increased expression of IFI44L mRNA CTD PMID:20959327 NCBI chr 2:240,668,742...240,706,425
Ensembl chr 2:243,328,723...243,366,404
JBrowse link
G Ifit3 interferon-induced protein with tetratricopeptide repeats 3 increases expression ISO gadodiamide results in increased expression of IFIT3 mRNA CTD PMID:20959327 NCBI chr 1:241,527,326...241,532,469
Ensembl chr 1:241,526,880...241,532,521
JBrowse link
G Ifng interferon gamma increases expression ISO gadodiamide results in increased expression of IFNG mRNA; gadodiamide results in increased expression of IFNG protein CTD PMID:19404939 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
JBrowse link
G Il13 interleukin 13 increases expression ISO gadodiamide results in increased expression of IL13 mRNA; gadodiamide results in increased expression of IL13 protein CTD PMID:19404939 NCBI chr10:37,790,130...37,792,687
Ensembl chr10:38,290,926...38,293,483
JBrowse link
G Il1a interleukin 1 alpha increases expression EXP gadodiamide results in increased expression of IL1A protein CTD PMID:20938346 NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
JBrowse link
G Il4 interleukin 4 increases expression
affects expression
ISO gadodiamide results in increased expression of IL4 protein
gadodiamide affects the expression of IL4 mRNA
CTD PMID:19404939 NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
JBrowse link
G Il4i1 interleukin 4 induced 1 increases expression ISO gadodiamide results in increased expression of IL4I1 mRNA CTD PMID:20959327 NCBI chr 1:95,299,457...95,324,564
Ensembl chr 1:104,435,981...104,461,053
JBrowse link
G Il6 interleukin 6 affects expression
increases expression
ISO gadodiamide affects the expression of IL6 protein
gadodiamide results in increased expression of IL6 mRNA
CTD PMID:19404939 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
JBrowse link
G Kitlg KIT ligand increases expression EXP gadodiamide results in increased expression of KITLG protein CTD PMID:20938346 NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:36,782,638...36,863,793
JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions
increases phosphorylation
ISO 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [gadodiamide results in increased phosphorylation of MAPK1 protein]; U 0126 inhibits the reaction [gadodiamide results in increased phosphorylation of MAPK1 protein] CTD PMID:19561517 NCBI chr11:83,957,813...84,023,629
Ensembl chr11:97,462,025...97,527,825
JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
increases phosphorylation
ISO 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [gadodiamide results in increased phosphorylation of MAPK3 protein]; U 0126 inhibits the reaction [gadodiamide results in increased phosphorylation of MAPK3 protein] CTD PMID:19561517 NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:190,797,185...190,803,411
JBrowse link
G Mmp1 matrix metallopeptidase 1 multiple interactions
increases expression
ISO 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [gadodiamide results in increased expression of MMP1 protein]; U 0126 inhibits the reaction [gadodiamide results in increased expression of MMP1 protein]
gadodiamide results in increased expression of MMP1 mRNA; gadodiamide results in increased expression of MMP1 protein
CTD PMID:19561517 NCBI chr 8:12,943,453...12,963,966
Ensembl chr 8:12,943,453...12,963,964
JBrowse link
G Nos2 nitric oxide synthase 2 increases expression ISO gadodiamide results in increased expression of NOS2 protein CTD PMID:20959327 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
JBrowse link
G Nxpe3 neurexophilin and PC-esterase domain family, member 3 increases expression ISO gadodiamide results in increased expression of NXPE3 mRNA CTD PMID:20959327 NCBI chr11:44,726,905...44,777,694
Ensembl chr11:58,195,976...58,248,644
JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma decreases expression ISO gadodiamide results in decreased expression of PPARG mRNA; gadodiamide results in decreased expression of PPARG protein CTD PMID:37437671 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit increases localization ISO gadodiamide results in increased localization of RELA protein CTD PMID:20959327 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
JBrowse link
G Rhoq ras homolog family member Q increases expression ISO gadodiamide results in increased expression of RHOQ mRNA CTD PMID:20959327 NCBI chr 6:7,613,632...7,652,047
Ensembl chr 1:115,757,909...115,759,467
JBrowse link
G Rit1 Ras-like without CAAX 1 increases expression ISO gadodiamide results in increased expression of RIT1 mRNA CTD PMID:20959327 NCBI chr 2:174,180,742...174,195,455
Ensembl chr 2:176,478,596...176,494,684
JBrowse link
G Rnf125 ring finger protein 125 increases expression ISO gadodiamide results in increased expression of RNF125 mRNA CTD PMID:20959327 NCBI chr18:12,254,066...12,275,719
Ensembl chr18:12,528,838...12,554,430
JBrowse link
G Rsad2 radical S-adenosyl methionine domain containing 2 increases expression ISO gadodiamide results in increased expression of RSAD2 mRNA CTD PMID:20959327 NCBI chr 6:48,774,985...48,788,245
Ensembl chr 6:48,774,985...48,788,320
JBrowse link
G Slc39a10 solute carrier family 39 member 10 increases expression ISO gadodiamide results in increased expression of SLC39A10 mRNA CTD PMID:20959327 NCBI chr 9:54,836,841...54,960,325
Ensembl chr 9:62,370,598...62,454,747
JBrowse link
G Spn sialophorin increases expression ISO gadodiamide results in increased expression of SPN mRNA CTD PMID:20959327 NCBI chr 1:181,746,937...181,759,564
Ensembl chr 1:191,178,096...191,187,852
JBrowse link
G Spp1 secreted phosphoprotein 1 increases expression EXP gadodiamide results in increased expression of SPP1 protein CTD PMID:20938346 NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,613,576...5,619,820
JBrowse link
G Tgfb1 transforming growth factor, beta 1 increases expression ISO
EXP
gadodiamide results in increased expression of TGFB1 mRNA; gadodiamide results in increased expression of TGFB1 protein CTD PMID:19404939 PMID:20938346 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 increases expression
multiple interactions
ISO
EXP
gadodiamide results in increased expression of TIMP1 mRNA; gadodiamide results in increased expression of TIMP1 protein
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [gadodiamide results in increased expression of TIMP1 protein]; U 0126 inhibits the reaction [gadodiamide results in increased expression of TIMP1 protein]
CTD PMID:19561517 PMID:20938346 NCBI chr  X:1,212,969...1,217,714
Ensembl chr  X:3,766,510...3,771,135
JBrowse link
G Ubd ubiquitin D increases expression ISO gadodiamide results in increased expression of UBD mRNA CTD PMID:20959327 NCBI chr20:1,390,734...1,392,685
Ensembl chr20:1,390,600...1,413,965
JBrowse link
G Vegfa vascular endothelial growth factor A increases expression ISO
EXP
gadodiamide results in increased expression of VEGFA mRNA; gadodiamide results in increased expression of VEGFA protein CTD PMID:19404939 PMID:20938346 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
JBrowse link
G Wdr5 WD repeat domain 5 increases expression ISO gadodiamide results in increased expression of WDR5 mRNA CTD PMID:20959327 NCBI chr 3:10,836,964...10,856,682
Ensembl chr 3:31,235,222...31,254,727
JBrowse link
G Xiap X-linked inhibitor of apoptosis increases expression ISO gadodiamide results in increased expression of XIAP mRNA CTD PMID:20959327 NCBI chr  X:125,756,107...125,803,979
Ensembl chr  X:125,737,971...125,803,978
JBrowse link
G Zfp652 zinc finger protein 652 increases expression ISO gadodiamide results in increased expression of ZNF652 mRNA CTD PMID:20959327 NCBI chr10:80,626,555...80,706,397
Ensembl chr10:81,146,507...81,198,827
JBrowse link
lisinopril dihydrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ace angiotensin I converting enzyme decreases activity ISO Lisinopril analog results in decreased activity of ACE protein CTD PMID:22200082 NCBI chr10:91,410,129...91,430,246
Ensembl chr10:91,409,819...91,430,942
JBrowse link
G Ace2 angiotensin converting enzyme 2 increases expression
multiple interactions
increases activity
EXP
ISO
Lisinopril results in increased expression of ACE2 mRNA
ACE2 protein affects the reaction [[[Lisinopril co-treated with Thiorphan co-treated with N-benzyloxycarbonylprolylprolinal] affects the metabolism of AGT protein] which results in decreased abundance of angiotensin I (1-7)]
Lisinopril results in increased activity of ACE2 protein
CTD PMID:15897343 PMID:16221218 PMID:27649628 NCBI chr  X:30,293,597...30,340,961
Ensembl chr  X:33,925,458...33,971,596
JBrowse link
G Ache acetylcholinesterase multiple interactions ISO
EXP
bisphenol A diglycidyl ether inhibits the reaction [Lisinopril inhibits the reaction [Streptozocin results in increased activity of ACHE protein]]; Lisinopril inhibits the reaction [Streptozocin results in increased activity of ACHE protein]
Lisinopril inhibits the reaction [Sodium Fluoride results in decreased activity of ACHE protein]
CTD PMID:23060470 PMID:31710167 NCBI chr12:19,406,133...19,413,713
Ensembl chr12:25,043,461...25,050,410
JBrowse link
G Agt angiotensinogen decreases expression
increases expression
affects response to substance
increases secretion
decreases secretion
multiple interactions
affects metabolic processing
ISO
EXP
Lisinopril results in decreased expression of AGT protein
Lisinopril results in increased expression of AGT mRNA
AGT gene alternative form affects the susceptibility to Lisinopril
Lisinopril results in increased secretion of AGT protein alternative form
Lisinopril results in decreased secretion of AGT protein
[Lisinopril co-treated with Losartan] results in increased expression of AGT mRNA
Lisinopril affects the metabolism of AGT protein
[[Lisinopril co-treated with chymostatin] affects the metabolism of AGT protein] which results in decreased abundance of Angiotensin II; [[Lisinopril co-treated with Thiorphan co-treated with N-benzyloxycarbonylprolylprolinal] affects the metabolism of AGT protein] which results in decreased abundance of angiotensin I (1-7); [[Lisinopril co-treated with Thiorphan] affects the metabolism of AGT protein] which results in decreased abundance of angiotensin I (1-7); [Lisinopril affects the metabolism of AGT protein] which results in decreased abundance of Angiotensin II; [Lisinopril co-treated with chymostatin] affects the metabolism of AGT protein; [Lisinopril co-treated with Thiorphan co-treated with N-benzyloxycarbonylprolylprolinal] affects the metabolism of AGT protein; [Lisinopril co-treated with Thiorphan] affects the metabolism of AGT protein
[[Lisinopril co-treated with Thiorphan co-treated with N-benzyloxycarbonylprolylprolinal] affects the metabolism of AGT protein] which results in decreased abundance of angiotensin I (1-7); [[Lisinopril co-treated with Thiorphan] affects the metabolism of AGT protein] which results in decreased abundance of angiotensin I (1-7); [Lisinopril affects the metabolism of AGT protein] which results in decreased abundance of Angiotensin II; [Lisinopril affects the metabolism of AGT protein] which results in increased abundance of angiotensin I (1-7); [Lisinopril co-treated with Thiorphan co-treated with N-benzyloxycarbonylprolylprolinal] affects the metabolism of AGT protein; [Lisinopril co-treated with Thiorphan] affects the metabolism of AGT protein; ACE2 protein affects the reaction [[[Lisinopril co-treated with Thiorphan co-treated with N-benzyloxycarbonylprolylprolinal] affects the metabolism of AGT protein] which results in decreased abundance of angiotensin I (1-7)]; Thiorphan inhibits the reaction [[Lisinopril affects the metabolism of AGT protein] which results in increased abundance of angiotensin I (1-7)]
CTD PMID:8393685 PMID:8915971 PMID:15897343 PMID:16221218 PMID:16685205 More... NCBI chr19:69,426,540...69,447,017
Ensembl chr19:69,421,638...69,446,944
JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression ISO Lisinopril results in decreased expression of BCL2 CTD PMID:10075388 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
JBrowse link
G Cd2ap CD2-associated protein multiple interactions EXP Lisinopril inhibits the reaction [Doxorubicin results in increased expression of CD2AP protein] CTD PMID:16636307 NCBI chr 9:18,086,744...18,182,744
Ensembl chr 9:25,583,975...25,679,968
JBrowse link
G Edn1 endothelin 1 decreases secretion ISO Lisinopril results in decreased secretion of EDN1 protein CTD PMID:19079593 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
JBrowse link
G Gh1 growth hormone 1 multiple interactions EXP [Lisinopril co-treated with GH1 protein] inhibits the reaction [Doxorubicin results in decreased expression of TIMP1 protein]; [Lisinopril co-treated with GH1 protein] inhibits the reaction [Doxorubicin results in increased expression of MMP2 protein]; [Lisinopril co-treated with GH1 protein] inhibits the reaction [Doxorubicin results in increased expression of NOS2 mRNA] CTD PMID:20051877 NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,727,884...91,729,859
JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 multiple interactions EXP Lisinopril inhibits the reaction [Doxorubicin results in increased expression of HAVCR1 mRNA]; Lisinopril inhibits the reaction [Doxorubicin results in increased expression of HAVCR1 protein] CTD PMID:19225054 NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,619,897...31,653,268
JBrowse link
G Hpse heparanase multiple interactions EXP [Spironolactone co-treated with Lisinopril] inhibits the reaction [Doxorubicin results in increased expression of HPSE protein]; Lisinopril inhibits the reaction [Doxorubicin results in increased expression of HPSE protein] CTD PMID:19429930 NCBI chr14:8,896,593...8,937,011
Ensembl chr14:9,188,275...9,241,754
JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 increases expression ISO Lisinopril results in increased expression of IGFBP1 protein CTD PMID:9663927 NCBI chr14:82,047,415...82,052,482
Ensembl chr14:86,261,277...86,266,344
JBrowse link
G Mmp2 matrix metallopeptidase 2 multiple interactions EXP [Lisinopril co-treated with GH1 protein] inhibits the reaction [Doxorubicin results in increased expression of MMP2 protein]; Lisinopril inhibits the reaction [Doxorubicin results in increased expression of MMP2 protein] CTD PMID:20051877 NCBI chr19:30,327,643...30,355,856
Ensembl chr19:30,327,643...30,355,856
JBrowse link
G Mpo myeloperoxidase multiple interactions ISO bisphenol A diglycidyl ether inhibits the reaction [Lisinopril inhibits the reaction [Streptozocin results in increased activity of MPO protein]]; Lisinopril inhibits the reaction [Streptozocin results in increased activity of MPO protein] CTD PMID:23060470 NCBI chr10:72,594,883...72,608,862
Ensembl chr10:73,092,400...73,102,056
JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions EXP [Lisinopril co-treated with GH1 protein] inhibits the reaction [Doxorubicin results in increased expression of NOS2 mRNA]; Lisinopril inhibits the reaction [Doxorubicin results in increased expression of NOS2 mRNA] CTD PMID:20051877 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
JBrowse link
G Nphs2 NPHS2 stomatin family member, podocin multiple interactions EXP Lisinopril affects the reaction [Doxorubicin results in increased expression of NPHS2 mRNA]; Lisinopril affects the reaction [Doxorubicin results in increased expression of NPHS2 protein] CTD PMID:16636307 NCBI chr13:68,448,720...68,461,312
Ensembl chr13:70,999,186...71,011,572
JBrowse link
G Nppa natriuretic peptide A decreases expression ISO Lisinopril results in decreased expression of NPPA protein CTD PMID:8393685 NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:163,712,184...163,713,493
JBrowse link
G Ren renin increases expression
multiple interactions
ISO
EXP
Lisinopril results in increased expression of REN protein
[Lisinopril co-treated with Losartan] results in increased expression of REN mRNA
Lisinopril results in increased expression of REN mRNA
CTD PMID:2550029 PMID:8915971 PMID:16221218 NCBI chr13:44,796,260...44,807,491
Ensembl chr13:47,348,143...47,359,543
JBrowse link
G RT1-M3-1 RT1 class Ib, locus M3, gene 1 affects expression ISO Lisinopril affects the expression of HLA-G mRNA CTD PMID:25811541 NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,329,225...1,333,366
JBrowse link
G Spmip11 sperm microtubule inner protein 11 multiple interactions EXP Lisinopril inhibits the reaction [Doxorubicin results in decreased phosphorylation of NPHS1 protein]; Lisinopril inhibits the reaction [Doxorubicin results in increased expression of NPHS1 protein] CTD PMID:16636307 PMID:19293598 NCBI chr 7:129,720,950...129,742,485
Ensembl chr 7:131,599,973...131,621,506
JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 multiple interactions EXP [Lisinopril co-treated with GH1 protein] inhibits the reaction [Doxorubicin results in decreased expression of TIMP1 protein]; Lisinopril inhibits the reaction [Doxorubicin results in decreased expression of TIMP1 protein] CTD PMID:20051877 NCBI chr  X:1,212,969...1,217,714
Ensembl chr  X:3,766,510...3,771,135
JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions EXP Lisinopril inhibits the reaction [Doxorubicin results in decreased expression of VEGFA protein] CTD PMID:19293598 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
JBrowse link
magnesium dihydroxide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Casp1 caspase 1 multiple interactions ISO [Aluminum Hydroxide co-treated with Magnesium Hydroxide] promotes the reaction [N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine results in increased activity of CASP1 protein]; [Aluminum Hydroxide co-treated with Magnesium Hydroxide] promotes the reaction [N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine results in increased expression of and results in increased secretion of CASP1 protein modified form]; CASP1 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein] CTD PMID:18604214 PMID:22075093 NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:10,746,333...10,882,275
JBrowse link
G Chrna4 cholinergic receptor nicotinic alpha 4 subunit multiple interactions ISO Magnesium Hydroxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]] CTD PMID:22750351 NCBI chr 3:188,506,802...188,535,558
Ensembl chr 3:188,501,209...188,535,105
JBrowse link
G Chrnb2 cholinergic receptor nicotinic beta 2 subunit multiple interactions ISO Magnesium Hydroxide inhibits the reaction [Acetylcholine results in increased activity of [CHRNA4 protein co-treated with CHRNB2 protein]] CTD PMID:22750351 NCBI chr 2:175,181,402...175,189,619
Ensembl chr 2:177,479,091...177,491,326
JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 multiple interactions ISO [Aluminum Hydroxide co-treated with Magnesium Hydroxide] inhibits the reaction [K-12 lipopolysaccharide results in increased secretion of CXCL10 protein] CTD PMID:17404311 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO [[Aluminum Hydroxide co-treated with Magnesium Hydroxide] co-treated with K-12 lipopolysaccharide] results in increased secretion of IL1B protein modified form; [Aluminum Hydroxide co-treated with Magnesium Hydroxide] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein; CASP1 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein]; N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine promotes the reaction [[Aluminum Hydroxide co-treated with Magnesium Hydroxide] results in increased secretion of IL1B protein]
[[Aluminum Hydroxide co-treated with Magnesium Hydroxide] co-treated with N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine] results in increased secretion of IL1B protein; [Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein; IL1R1 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein]; NLRP3 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein]; PYCARD protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein]
CTD PMID:17404311 PMID:18604214 PMID:22075093 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
JBrowse link
G Il1r1 interleukin 1 receptor type 1 multiple interactions ISO IL1R1 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein] CTD PMID:18604214 NCBI chr 9:50,000,558...50,076,579
Ensembl chr 9:50,000,566...50,076,579
JBrowse link
G Il2 interleukin 2 multiple interactions ISO [Aluminum Hydroxide co-treated with Magnesium Hydroxide] results in increased secretion of IL2 protein; N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine promotes the reaction [[Aluminum Hydroxide co-treated with Magnesium Hydroxide] results in increased secretion of IL2 protein]; TLR4 protein affects the reaction [N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine promotes the reaction [[Aluminum Hydroxide co-treated with Magnesium Hydroxide] results in increased secretion of IL2 protein]] CTD PMID:22075093 NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
JBrowse link
G Nlrp3 NLR family, pyrin domain containing 3 multiple interactions ISO NLRP3 protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein] CTD PMID:18604214 NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394
JBrowse link
G Pycard PYD and CARD domain containing multiple interactions ISO PYCARD protein affects the reaction [[Lipopolysaccharides co-treated with [Aluminum Hydroxide co-treated with Magnesium Hydroxide]] results in increased cleavage of and results in increased secretion of IL1B protein] CTD PMID:18604214 NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:192,032,124...192,033,419
JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions ISO TLR4 protein affects the reaction [N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine promotes the reaction [[Aluminum Hydroxide co-treated with Magnesium Hydroxide] results in increased secretion of IL2 protein]]; TLR4 protein affects the susceptibility to [[Aluminum Hydroxide co-treated with Magnesium Hydroxide] co-treated with N-t-butyl-n'-tetradecyl-3-tetradecylaminopropionamidine]; TLR4 protein affects the susceptibility to [Aluminum Hydroxide co-treated with Magnesium Hydroxide] CTD PMID:22075093 NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:85,161,192...85,175,007
JBrowse link
mosapride citrate dihydrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ano1 anoctamin 1 multiple interactions ISO mosapride inhibits the reaction [Loperamide results in decreased expression of ANO1 mRNA]; mosapride inhibits the reaction [Loperamide results in decreased expression of ANO1 protein] CTD PMID:37375548 NCBI chr 1:199,751,439...199,900,099
Ensembl chr 1:209,180,755...209,329,550
JBrowse link
G Htr4 5-hydroxytryptamine receptor 4 multiple interactions ISO mosapride inhibits the reaction [Loperamide results in decreased expression of HTR4 mRNA] CTD PMID:37375548 NCBI chr18:55,765,981...55,949,921
Ensembl chr18:58,036,277...58,219,622
JBrowse link
G Mylk myosin light chain kinase multiple interactions ISO mosapride inhibits the reaction [Loperamide results in decreased expression of MYLK mRNA] CTD PMID:37375548 NCBI chr11:65,783,008...66,030,239
Ensembl chr11:79,288,243...79,535,659
JBrowse link
G Nos1 nitric oxide synthase 1 multiple interactions ISO mosapride inhibits the reaction [Loperamide results in decreased expression of NOS1 protein] CTD PMID:37375548 NCBI chr12:38,615,111...38,795,492
Ensembl chr12:44,287,614...44,371,837
JBrowse link
G Ryr3 ryanodine receptor 3 multiple interactions ISO mosapride inhibits the reaction [Loperamide results in decreased expression of RYR3 mRNA] CTD PMID:37375548 NCBI chr 3:99,431,755...99,979,125
Ensembl chr 3:119,885,878...120,433,677
JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO mosapride inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:50,668,817...50,711,019
JBrowse link
potassium citrate monohydrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Nefh neurofilament heavy chain affects expression EXP Potassium Citrate affects the expression of NEFH mRNA CTD PMID:22954530 NCBI chr14:79,830,362...79,840,347
Ensembl chr14:84,044,023...84,054,417
JBrowse link
potassium hydroxide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Cfl1 cofilin 1 increases expression ISO potassium hydroxide results in increased expression of CFL1 mRNA; potassium hydroxide results in increased expression of CFL1 protein CTD PMID:21469165 NCBI chr 1:212,227,124...212,230,656
Ensembl chr 1:212,226,121...212,231,353
JBrowse link
G Hspb1 heat shock protein family B (small) member 1 multiple interactions
increases expression
ISO potassium hydroxide results in decreased expression of and affects the localization of HSPB1 protein
potassium hydroxide results in increased expression of HSPB1 mRNA
CTD PMID:21469165 NCBI chr12:26,430,640...26,432,301
Ensembl chr12:26,430,640...26,432,301
JBrowse link
G Il1a interleukin 1 alpha multiple interactions ISO potassium hydroxide results in increased expression of and results in increased secretion of IL1A protein CTD PMID:21469165 NCBI chr 3:136,979,804...136,990,236
Ensembl chr 3:136,979,805...136,998,013
JBrowse link
G Sod1 superoxide dismutase 1 increases expression
decreases expression
ISO potassium hydroxide results in increased expression of SOD1 mRNA
potassium hydroxide results in decreased expression of SOD1 protein
CTD PMID:21469165 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
JBrowse link
royal jelly term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Bax BCL2 associated X, apoptosis regulator multiple interactions EXP royal jelly inhibits the reaction [Fluorides results in decreased expression of BAX protein] CTD PMID:34227456 NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:105,076,473...105,086,429
JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions ISO
EXP
royal jelly inhibits the reaction [Nicotine results in decreased expression of BCL2 mRNA]
royal jelly inhibits the reaction [Fluorides results in increased expression of BCL2 protein]
CTD PMID:30896085 PMID:34227456 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
JBrowse link
G Bdnf brain-derived neurotrophic factor multiple interactions EXP royal jelly inhibits the reaction [Fluorides results in decreased expression of BDNF protein] CTD PMID:34227456 NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:116,619,633...116,670,657
JBrowse link
G Casp3 caspase 3 multiple interactions ISO
EXP
royal jelly inhibits the reaction [Nicotine results in increased expression of CASP3 mRNA]
royal jelly inhibits the reaction [Fluorides results in decreased expression of CASP3 protein]
CTD PMID:30896085 PMID:34227456 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Casp6 caspase 6 multiple interactions EXP royal jelly inhibits the reaction [Fluorides results in decreased expression of CASP6 protein] CTD PMID:34227456 NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:221,140,256...221,152,726
JBrowse link
G Casp9 caspase 9 multiple interactions EXP royal jelly inhibits the reaction [Fluorides results in decreased expression of CASP9 protein] CTD PMID:34227456 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Cat catalase multiple interactions EXP
ISO
royal jelly inhibits the reaction [Cisplatin results in decreased activity of CAT protein]; royal jelly inhibits the reaction [Fluorides results in decreased activity of CAT protein]; royal jelly inhibits the reaction [Tartrazine results in decreased activity of CAT protein]
royal jelly inhibits the reaction [Nicotine results in decreased activity of CAT protein]
CTD PMID:20369241 PMID:26190785 PMID:30896085 PMID:34227456 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
JBrowse link
G Ccnd1 cyclin D1 multiple interactions ISO royal jelly inhibits the reaction [phenylhydrazine affects the expression of CCND1 mRNA] CTD PMID:35099105 NCBI chr 1:209,518,288...209,527,986
Ensembl chr 1:209,518,288...209,527,810
JBrowse link
G E2f1 E2F transcription factor 1 multiple interactions EXP royal jelly inhibits the reaction [Paclitaxel results in increased expression of E2F1 mRNA] CTD PMID:27496854 NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:163,524,739...163,535,563
JBrowse link
G Esr1 estrogen receptor 1 multiple interactions
affects binding
increases activity
ISO Estradiol inhibits the reaction [royal jelly binds to ESR1 protein]; royal jelly binds to and results in increased activity of ESR1 protein; royal jelly inhibits the reaction [Estradiol binds to ESR1 protein]
royal jelly results in increased activity of ESR1 protein
CTD PMID:15946813 PMID:17287592 NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:43,644,392...43,900,354
JBrowse link
G Esr2 estrogen receptor 2 multiple interactions
affects binding
ISO Estradiol inhibits the reaction [royal jelly binds to ESR2 protein]; royal jelly binds to and results in increased activity of ESR2 protein; royal jelly inhibits the reaction [Estradiol binds to ESR2 protein] CTD PMID:15946813 PMID:17287592 NCBI chr 6:100,589,553...100,645,240
Ensembl chr 6:100,545,206...100,644,709
JBrowse link
G Gsk3b glycogen synthase kinase 3 beta multiple interactions EXP royal jelly inhibits the reaction [Fluorides results in increased expression of GSK3B protein] CTD PMID:34227456 NCBI chr11:62,498,997...62,648,665
Ensembl chr11:76,009,507...76,153,249
JBrowse link
G Ins1 insulin 1 multiple interactions EXP royal jelly inhibits the reaction [Fructose results in increased expression of INS1 protein] CTD PMID:18981581 NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:261,186,119...261,186,682
JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions
decreases expression
ISO
EXP
royal jelly inhibits the reaction [phenylhydrazine results in decreased expression of MYC mRNA]
royal jelly results in decreased expression of MYC mRNA
royal jelly inhibits the reaction [Paclitaxel results in decreased expression of MYC mRNA]
CTD PMID:27496854 PMID:35099105 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions EXP royal jelly inhibits the reaction [Fluorides results in decreased expression of NFE2L2 protein] CTD PMID:34227456 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions ISO royal jelly inhibits the reaction [Nicotine results in decreased expression of PCNA protein] CTD PMID:30896085 NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions EXP royal jelly inhibits the reaction [Fluorides results in increased expression of RELA protein] CTD PMID:34227456 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
JBrowse link
G Tff1 trefoil factor 1 increases expression ISO royal jelly results in increased expression of TFF1 mRNA CTD PMID:15946813 NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,237,095...9,240,956
JBrowse link
G Tp53 tumor protein p53 multiple interactions ISO royal jelly inhibits the reaction [Nicotine results in increased expression of TRP53 mRNA] CTD PMID:30896085 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
JBrowse link
G Vegfa vascular endothelial growth factor A increases expression ISO
EXP
royal jelly results in increased expression of VEGFA mRNA CTD PMID:15946813 PMID:17287592 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
JBrowse link
sodium acetate trihydrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Acox1 acyl-CoA oxidase 1 increases expression ISO Sodium Acetate results in increased expression of ACOX1 mRNA CTD PMID:36156098 NCBI chr10:101,905,083...101,930,136
Ensembl chr10:101,905,083...101,930,136
JBrowse link
G Acss1 acyl-CoA synthetase short-chain family member 1 increases expression ISO Sodium Acetate results in increased expression of ACSS1 mRNA CTD PMID:36156098 NCBI chr 3:139,450,383...139,500,325
Ensembl chr 3:159,910,809...159,960,748
JBrowse link
G Acss2 acyl-CoA synthetase short-chain family member 2 increases expression ISO Sodium Acetate results in increased expression of ACSS2 mRNA CTD PMID:36156098 NCBI chr 3:144,003,808...144,047,452
Ensembl chr 3:164,464,055...164,519,830
JBrowse link
G Ada adenosine deaminase multiple interactions EXP Sodium Acetate inhibits the reaction [Nicotine results in increased activity of ADA protein] CTD PMID:31857090 NCBI chr 3:172,818,174...172,842,283
Ensembl chr 3:172,818,176...172,842,293
JBrowse link
G Apob apolipoprotein B multiple interactions ISO [Sodium Acetate co-treated with acetic anhydride] results in increased acetylation of APOB protein CTD PMID:11304478 NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:36,563,704...36,611,814
JBrowse link
G Casp3 caspase 3 multiple interactions ISO
EXP
Sodium Acetate inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein] CTD PMID:36372261 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Casp7 caspase 7 multiple interactions ISO Sodium Acetate inhibits the reaction [Cisplatin results in increased cleavage of CASP7 protein] CTD PMID:36372261 NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
JBrowse link
G Cat catalase multiple interactions ISO
EXP
Sodium Acetate inhibits the reaction [Cisplatin results in decreased expression of CAT protein] CTD PMID:36372261 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions ISO Sodium Acetate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]
Sodium Acetate promotes the reaction [biochanin A results in increased expression of CYP1A1 mRNA]; Sodium Acetate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]
CTD PMID:31621310 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 multiple interactions ISO Sodium Acetate promotes the reaction [biochanin A results in increased expression of CYP1B1 mRNA]; Sodium Acetate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1B1 mRNA] CTD PMID:31621310 NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:21,078,146...21,103,142
JBrowse link
G Ggt1 gamma-glutamyltransferase 1 multiple interactions EXP Sodium Acetate inhibits the reaction [Nicotine results in increased activity of GGT1 protein] CTD PMID:31857090 NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,141...13,088,050
JBrowse link
G Ifng interferon gamma multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IFNG mRNA] CTD PMID:37269894 NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
JBrowse link
G Ikbkb inhibitor of nuclear factor kappa B kinase subunit beta multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IKBKB mRNA]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IKBKB protein] CTD PMID:37269894 NCBI chr16:69,319,487...69,373,251
Ensembl chr16:76,022,008...76,081,911
JBrowse link
G Il2 interleukin 2 multiple interactions ISO Sodium Acetate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of IL2 protein] CTD PMID:17615583 NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
JBrowse link
G Il6 interleukin 6 multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of IL6 mRNA] CTD PMID:37269894 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
JBrowse link
G Ins1 insulin 1 multiple interactions EXP Sodium Acetate inhibits the reaction [Nicotine results in increased expression of INS1 protein] CTD PMID:31857090 NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:261,186,119...261,186,682
JBrowse link
G Kpnb1 karyopherin subunit beta 1 multiple interactions ISO Sodium Acetate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [NFATC2 protein binds to KPNB1 protein]] CTD PMID:17615583 NCBI chr10:82,145,662...82,174,437
Ensembl chr10:82,642,082...82,670,856
JBrowse link
G Myd88 MYD88, innate immune signal transduction adaptor multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of MYD88 mRNA] CTD PMID:37269894 NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:127,952,161...127,956,230
JBrowse link
G Nat2 N-acetyltransferase 2 increases expression ISO Sodium Acetate results in increased expression of NAT2 mRNA CTD PMID:36156098 NCBI chr16:26,974,874...27,005,191
Ensembl chr16:26,974,601...26,976,304
JBrowse link
G Nfatc2 nuclear factor of activated T-cells 2 multiple interactions ISO Sodium Acetate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] affects the localization of NFATC2 protein]; Sodium Acetate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] promotes the reaction [NFATC2 protein binds to KPNB1 protein]]; Sodium Acetate inhibits the reaction [[Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of NFATC2 protein] CTD PMID:17615583 NCBI chr 3:157,195,970...157,328,640
Ensembl chr 3:177,618,314...177,747,380
JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in decreased expression of NFKBIA protein] CTD PMID:37269894 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
JBrowse link
G Pck1 phosphoenolpyruvate carboxykinase 1 increases expression ISO Sodium Acetate results in increased expression of PCK1 mRNA CTD PMID:36156098 NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:182,348,572...182,354,561
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of and results in increased phosphorylation of RELA protein]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of RELA mRNA] CTD PMID:37269894 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
JBrowse link
G Sod2 superoxide dismutase 2 multiple interactions ISO
EXP
Sodium Acetate inhibits the reaction [Cisplatin results in decreased expression of SOD2 protein] CTD PMID:36372261 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TGFB1 mRNA] CTD PMID:37269894 NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
JBrowse link
G Tlr2 toll-like receptor 2 multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR2 mRNA]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR2 protein] CTD PMID:37269894 NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:171,497,060...171,520,194
JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR4 mRNA]; [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TLR4 protein] CTD PMID:37269894 NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:85,161,192...85,175,007
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO [Sodium Acetate co-treated with Butyric Acid co-treated with sodium propionate] inhibits the reaction [Fluorides results in increased expression of TNF mRNA] CTD PMID:37269894 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
G Ugt1a1 UDP glucuronosyltransferase family 1 member A1 multiple interactions ISO Sodium Acetate promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of UGT1A1 mRNA] CTD PMID:31621310 NCBI chr 9:96,249,143...96,256,264
Ensembl chr 9:96,144,786...96,256,264
JBrowse link
G Xdh xanthine dehydrogenase multiple interactions EXP Sodium Acetate inhibits the reaction [Nicotine results in increased activity of XDH protein] CTD PMID:31857090 NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:27,282,057...27,344,350
JBrowse link
sodium hydroxide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Acta2 actin alpha 2, smooth muscle multiple interactions
increases expression
EXP lycium barbarum polysaccharide inhibits the reaction [Sodium Hydroxide results in increased expression of ACTA2 protein] CTD PMID:38202631 NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
JBrowse link
G Casp3 caspase 3 increases expression
multiple interactions
EXP Sodium Hydroxide results in increased expression of CASP3 mRNA
lycium barbarum polysaccharide inhibits the reaction [Sodium Hydroxide results in increased expression of CASP3 mRNA]
CTD PMID:38202631 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Col1a2 collagen type I alpha 2 chain increases expression
multiple interactions
EXP Sodium Hydroxide results in increased expression of COL1A2 protein
lycium barbarum polysaccharide inhibits the reaction [Sodium Hydroxide results in increased expression of COL1A2 protein]
CTD PMID:38202631 NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:33,518,420...33,553,995
JBrowse link
G Col3a1 collagen type III alpha 1 chain multiple interactions
increases expression
EXP lycium barbarum polysaccharide inhibits the reaction [Sodium Hydroxide results in increased expression of COL3A1 protein] CTD PMID:38202631 NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232
JBrowse link
G Egfr epidermal growth factor receptor affects response to substance ISO EGFR SNP affects the susceptibility to Sodium Hydroxide CTD PMID:27206134 NCBI chr14:91,176,979...91,349,722
Ensembl chr14:95,378,626...95,551,358
JBrowse link
G Ezr ezrin increases expression ISO Sodium Hydroxide results in increased expression of EZR mRNA CTD PMID:29893927 NCBI chr 1:46,967,961...47,011,505
Ensembl chr 1:49,373,035...49,416,573
JBrowse link
G Fn1 fibronectin 1 increases expression
multiple interactions
EXP Sodium Hydroxide results in increased expression of FN1 protein
lycium barbarum polysaccharide inhibits the reaction [Sodium Hydroxide results in increased expression of FN1 protein]
CTD PMID:38202631 NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:80,645,507...80,714,137
JBrowse link
G Ier3 immediate early response 3 affects response to substance ISO IER3 SNP affects the susceptibility to Sodium Hydroxide CTD PMID:27258892 NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,933,174...2,934,377
JBrowse link
G Il1b interleukin 1 beta increases expression ISO Sodium Hydroxide results in increased expression of IL1B protein CTD PMID:29953848 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
JBrowse link
G Il22 interleukin 22 affects response to substance ISO IL22 SNP affects the susceptibility to Sodium Hydroxide CTD PMID:27206134 NCBI chr 7:53,801,206...53,805,673
Ensembl chr 7:55,686,896...55,692,201
JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit increases expression
multiple interactions
EXP Sodium Hydroxide results in increased expression of JUN mRNA
lycium barbarum polysaccharide inhibits the reaction [Sodium Hydroxide results in increased expression of JUN mRNA]
CTD PMID:38202631 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
JBrowse link
G Kcnk3 potassium two pore domain channel subfamily K member 3 increases activity
decreases response to substance
ISO Sodium Hydroxide results in increased activity of KCNK3 protein
KCNK3 protein mutant form results in decreased susceptibility to Sodium Hydroxide
CTD PMID:30365877 NCBI chr 6:25,761,487...25,799,153
Ensembl chr 6:31,483,140...31,519,061
JBrowse link
G Mmp9 matrix metallopeptidase 9 increases expression
multiple interactions
EXP Sodium Hydroxide results in increased expression of MMP9 mRNA
lycium barbarum polysaccharide inhibits the reaction [Sodium Hydroxide results in increased expression of MMP9 mRNA]
CTD PMID:38202631 NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:174,084,123...174,111,442
JBrowse link
G Plau plasminogen activator, urokinase affects response to substance ISO PLAU SNP affects the susceptibility to Sodium Hydroxide CTD PMID:27206134 NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,505,487...3,512,030
JBrowse link
G RT1-M3-1 RT1 class Ib, locus M3, gene 1 affects response to substance ISO HLA-G SNP affects the susceptibility to Sodium Hydroxide CTD PMID:27258892 NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,329,225...1,333,366
JBrowse link
G Trim10 tripartite motif-containing 10 affects response to substance ISO TRIM10 SNP affects the susceptibility to Sodium Hydroxide CTD PMID:27258892 NCBI chr20:1,689,554...1,698,948
Ensembl chr20:1,694,779...1,703,469
JBrowse link
G Trim31 tripartite motif-containing 31 affects response to substance ISO TRIM31 SNP affects the susceptibility to Sodium Hydroxide CTD PMID:27258892 NCBI chr20:1,653,165...1,666,494
Ensembl chr20:1,658,386...1,671,711
JBrowse link
G Trim40 tripartite motif-containing 40 affects response to substance ISO TRIM40 SNP affects the susceptibility to Sodium Hydroxide CTD PMID:27258892 NCBI chr20:1,676,114...1,685,906
Ensembl chr20:1,681,333...1,691,123
JBrowse link
sodium thiosulfate pentahydrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Casp3 caspase 3 multiple interactions EXP sodium thiosulfate inhibits the reaction [Isoproterenol results in increased activity of CASP3 protein] CTD PMID:32865837 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Casp9 caspase 9 multiple interactions EXP sodium thiosulfate inhibits the reaction [Isoproterenol results in increased activity of CASP9 protein] CTD PMID:32865837 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Mpo myeloperoxidase multiple interactions EXP sodium thiosulfate inhibits the reaction [Isoproterenol results in increased activity of MPO protein] CTD PMID:32865837 NCBI chr10:72,594,883...72,608,862
Ensembl chr10:73,092,400...73,102,056
JBrowse link
tacrolimus hydrate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin increases expression EXP Tacrolimus results in increased expression of A2M mRNA CTD PMID:21865292 NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:156,569,860...156,619,868
JBrowse link
G Abca1 ATP binding cassette subfamily A member 1 multiple interactions
increases expression
ISO
EXP
[Sirolimus co-treated with Tacrolimus] results in increased expression of ABCA1 protein
Tacrolimus results in increased expression of ABCA1 mRNA
CTD PMID:17016853 PMID:21865292 NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:72,473,676...72,596,473
JBrowse link
G Abcb11 ATP binding cassette subfamily B member 11 decreases activity ISO Tacrolimus results in decreased activity of ABCB11 protein CTD PMID:23956101 NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:74,424,979...74,520,581
JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A affects export
decreases activity
multiple interactions
increases response to substance
increases export
affects response to substance
ISO ABCB1 protein affects the export of Tacrolimus
Tacrolimus results in decreased activity of ABCB1 protein
[Tacrolimus binds to ABCB1 protein] inhibits the reaction [azidoprazosin binds to ABCB1 protein]; [Tacrolimus results in decreased activity of ABCB1 protein] which results in decreased export of Dexamethasone; Verapamil affects the reaction [ABCB1 protein results in increased export of Tacrolimus]
ABCB1 gene SNP results in increased susceptibility to Tacrolimus
ABCB1 protein affects the susceptibility to Tacrolimus
CTD PMID:1381629 PMID:11920757 PMID:12352921 PMID:15919446 PMID:15964336 More... NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:26,312,409...26,397,135
JBrowse link
G Acaa1b acetyl-Coenzyme A acyltransferase 1B decreases expression ISO Tacrolimus results in decreased expression of ACAA1B mRNA CTD PMID:25270620 NCBI chr 8:127,750,771...127,759,589
Ensembl chr 8:127,750,743...127,759,569
JBrowse link
G Acadl acyl-CoA dehydrogenase, long chain decreases expression ISO Tacrolimus results in decreased expression of ACADL mRNA CTD PMID:25270620 NCBI chr 9:68,333,981...68,372,149
Ensembl chr 9:75,783,689...75,822,164
JBrowse link
G Ace2 angiotensin converting enzyme 2 decreases expression EXP Tacrolimus results in decreased expression of ACE2 mRNA CTD PMID:21865292 NCBI chr  X:30,293,597...30,340,961
Ensembl chr  X:33,925,458...33,971,596
JBrowse link
G Acp5 acid phosphatase 5, tartrate resistant multiple interactions ISO Tacrolimus inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein] CTD PMID:15207740 NCBI chr 8:20,663,984...20,670,604
Ensembl chr 8:28,939,985...28,943,929
JBrowse link
G Acta2 actin alpha 2, smooth muscle increases expression ISO Tacrolimus results in increased expression of ACTA2 protein CTD PMID:29362864 NCBI chr 1:241,159,723...241,172,503
Ensembl chr 1:241,159,724...241,172,503
JBrowse link
G Acvr1b activin A receptor type 1B multiple interactions ISO [Tacrolimus inhibits the reaction [FKBP1A protein binds to ACVR1B protein]] which results in decreased ubiquitination of ACVR1B protein; Tacrolimus inhibits the reaction [FKBP1A protein binds to and results in decreased activity of ACVR1B protein]; Tacrolimus inhibits the reaction [FKBP1A protein promotes the reaction [SMURF1 protein binds to SMAD7 protein binds to ACVR1B protein]] CTD PMID:16720724 NCBI chr 7:132,286,266...132,329,679
Ensembl chr 7:134,164,991...134,208,388
JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 increases expression EXP Tacrolimus results in increased expression of ADAMTS1 mRNA CTD PMID:21865292 NCBI chr11:24,932,227...24,941,068
Ensembl chr11:38,418,101...38,427,390
JBrowse link
G Adamts2 ADAM metallopeptidase with thrombospondin type 1 motif, 2 increases expression ISO Tacrolimus results in increased expression of ADAMTS2 mRNA CTD PMID:29362864 NCBI chr10:34,920,992...35,126,465
Ensembl chr10:35,422,030...35,627,483
JBrowse link
G Adcy9 adenylate cyclase 9 multiple interactions ISO Tacrolimus inhibits the reaction [Calcium inhibits the reaction [Miconazole results in increased activity of ADCY9 protein]] CTD PMID:30607468 NCBI chr10:11,645,373...11,768,462
Ensembl chr10:11,645,282...11,765,792
JBrowse link
G Adra1d adrenoceptor alpha 1D increases expression EXP Tacrolimus results in increased expression of ADRA1D mRNA CTD PMID:21865292 NCBI chr 3:118,793,356...118,809,354
Ensembl chr 3:139,246,323...139,262,331
JBrowse link
G Aif1 allograft inflammatory factor 1 increases expression ISO Tacrolimus results in increased expression of AIF1 mRNA CTD PMID:29362864 NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,652,243...3,657,339
JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 decreases expression ISO Tacrolimus results in decreased expression of ALDH1A1 mRNA CTD PMID:25270620 NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:227,427,070...227,579,500
JBrowse link
G Aldh2 aldehyde dehydrogenase 2 family member decreases expression ISO Tacrolimus results in decreased expression of ALDH2 mRNA CTD PMID:25270620 NCBI chr12:40,610,244...40,643,220
Ensembl chr12:40,610,224...40,643,219
JBrowse link
G Aldh9a1 aldehyde dehydrogenase 9 family, member A1 decreases expression ISO Tacrolimus results in decreased expression of ALDH9A1 mRNA CTD PMID:25270620 NCBI chr13:79,505,738...79,522,539
Ensembl chr13:82,038,533...82,055,481
JBrowse link
G Alg3 ALG3, alpha-1,3- mannosyltransferase decreases expression ISO Tacrolimus results in decreased expression of ALG3 mRNA CTD PMID:25270620 NCBI chr11:80,300,487...80,306,014
Ensembl chr11:93,804,891...93,812,060
JBrowse link
G Angptl6 angiopoietin-like 6 increases expression EXP Tacrolimus results in increased expression of ANGPTL6 mRNA CTD PMID:21865292 NCBI chr 8:19,413,617...19,419,925
Ensembl chr 8:27,689,806...27,696,111
JBrowse link
G Ankrd1 ankyrin repeat domain 1 increases expression ISO Tacrolimus results in increased expression of ANKRD1 mRNA CTD PMID:29362864 NCBI chr 1:233,815,851...233,834,891
Ensembl chr 1:243,228,448...243,263,751
JBrowse link
G Ankrd34a ankyrin repeat domain 34A decreases expression ISO Tacrolimus results in decreased expression of ANKRD34A mRNA CTD PMID:25270620 NCBI chr 2:184,129,830...184,135,075
Ensembl chr 2:186,817,216...186,824,467
JBrowse link
G Anpep alanyl aminopeptidase, membrane increases secretion EXP Tacrolimus results in increased secretion of ANPEP protein CTD PMID:7514309 NCBI chr 1:133,767,332...133,810,137
Ensembl chr 1:143,176,645...143,195,101
JBrowse link
G Anxa1 annexin A1 increases expression EXP Tacrolimus results in increased expression of ANXA1 CTD PMID:20484890 NCBI chr 1:227,287,713...227,306,739
Ensembl chr 1:227,287,717...227,306,831
JBrowse link
G Aoc1 amine oxidase, copper containing 1 increases expression ISO Tacrolimus results in increased expression of AOC1 mRNA CTD PMID:29362864 NCBI chr 4:77,812,260...77,831,846
Ensembl chr 4:79,143,126...79,162,704
JBrowse link
G Areg amphiregulin increases expression EXP Tacrolimus results in increased expression of AREG mRNA CTD PMID:21865292 NCBI chr14:16,972,185...16,981,443
Ensembl chr14:17,256,384...17,265,641
JBrowse link
G Arfrp1 ARF related protein 1 increases expression ISO Tacrolimus results in increased expression of ARFRP1 mRNA CTD PMID:25270620 NCBI chr 3:168,466,351...168,473,960
Ensembl chr 3:188,845,511...188,851,431
JBrowse link
G Arhgap45 Rho GTPase activating protein 45 increases expression ISO Tacrolimus results in increased expression of ARHGAP45 mRNA CTD PMID:21621594 NCBI chr 7:9,674,873...9,690,286
Ensembl chr 7:10,325,539...10,341,890
JBrowse link
G Arhgef11 Rho guanine nucleotide exchange factor 11 increases expression ISO Tacrolimus results in increased expression of ARHGEF11 mRNA CTD PMID:29380240 NCBI chr 2:173,074,383...173,195,962
Ensembl chr 2:175,372,290...175,493,852
JBrowse link
G Arpc5 actin related protein 2/3 complex, subunit 5 increases expression ISO Tacrolimus results in increased expression of ARPC5 mRNA CTD PMID:29380240 NCBI chr13:64,904,504...64,913,413
Ensembl chr13:67,437,027...67,463,283
JBrowse link
G Arv1 ARV1 homolog, fatty acid homeostasis modulator increases expression ISO Tacrolimus results in increased expression of ARV1 mRNA CTD PMID:25270620 NCBI chr19:52,692,337...52,704,156
Ensembl chr19:69,589,328...69,601,537
JBrowse link
G Asxl3 ASXL transcriptional regulator 3 decreases expression ISO Tacrolimus results in decreased expression of ASXL3 mRNA CTD PMID:29362864 NCBI chr18:13,593,529...13,766,324
Ensembl chr18:13,868,674...14,037,373
JBrowse link
G Atf3 activating transcription factor 3 increases expression ISO Tacrolimus results in increased expression of ATF3 mRNA CTD PMID:23958496 NCBI chr13:102,751,278...102,800,520
Ensembl chr13:105,282,440...105,295,750
JBrowse link
G Atf4 activating transcription factor 4 increases expression ISO Tacrolimus results in increased expression of ATF4 mRNA CTD PMID:23958496 NCBI chr 7:111,804,135...111,806,457
Ensembl chr 7:113,684,681...113,686,739
JBrowse link
G Atf6 activating transcription factor 6 increases expression ISO Tacrolimus results in increased expression of ATF6 mRNA CTD PMID:23958496 NCBI chr13:85,460,312...85,639,959
Ensembl chr13:85,462,840...85,640,033
JBrowse link
G Atp1b1 ATPase Na+/K+ transporting subunit beta 1 decreases expression ISO Tacrolimus results in decreased expression of ATP1B1 mRNA CTD PMID:25270620 NCBI chr13:79,319,708...79,340,226
Ensembl chr13:79,319,706...79,340,549
JBrowse link
G Atp1b3 ATPase Na+/K+ transporting subunit beta 3 decreases expression ISO Tacrolimus results in decreased expression of ATP1B3 mRNA CTD PMID:25270620 NCBI chr 8:96,910,265...96,941,592
Ensembl chr 8:65,253,361...65,254,304
Ensembl chr 8:65,253,361...65,254,304
JBrowse link
G Atp2a2 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 increases expression ISO Tacrolimus results in increased expression of ATP2A2 mRNA CTD PMID:25270620 NCBI chr12:34,072,710...34,122,142
Ensembl chr12:39,733,458...39,782,934
JBrowse link
G B2m beta-2 microglobulin increases expression ISO Tacrolimus results in increased expression of B2M mRNA CTD PMID:29362864 NCBI chr 3:109,095,740...109,101,764
Ensembl chr 3:129,549,318...129,555,356
JBrowse link
G Bad BCL2-associated agonist of cell death multiple interactions EXP
ISO
Tacrolimus inhibits the reaction [Ammonium Chloride results in decreased phosphorylation of BAD protein]
Tacrolimus inhibits the reaction [Rotenone results in decreased phosphorylation of BAD protein]
CTD PMID:15036616 PMID:15280438 NCBI chr 1:204,133,502...204,142,829
Ensembl chr 1:213,562,187...213,572,034
JBrowse link
G Batf3 basic leucine zipper ATF-like transcription factor 3 increases expression ISO Tacrolimus results in increased expression of BATF3 mRNA CTD PMID:29362864 NCBI chr13:102,689,657...102,701,241
Ensembl chr13:105,220,390...105,232,369
JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions
increases expression
ISO
EXP
Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of BAX protein]
Tacrolimus results in increased expression of BAX protein
[Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BAX protein
CTD PMID:10205001 PMID:15571979 PMID:27606422 PMID:35033536 NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:105,076,473...105,086,429
JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions
decreases expression
increases expression
ISO
EXP
Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in decreased expression of BCL2 protein]
Tacrolimus results in decreased expression of BCL2 protein
[Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BCL2 protein
Tacrolimus results in increased expression of BCL2 protein
CTD PMID:10205001 PMID:15571979 PMID:27606422 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
JBrowse link
G Bcl2l1 Bcl2-like 1 multiple interactions ISO Tacrolimus inhibits the reaction [Superantigens results in increased expression of BCL2L1 protein] CTD PMID:10532544 NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907
Ensembl chr 1:161,745,540...161,764,907
JBrowse link
G Bcl3 BCL3, transcription coactivator increases expression ISO Tacrolimus results in increased expression of BCL3 mRNA CTD PMID:23958496 NCBI chr 1:88,599,321...88,613,555
Ensembl chr 1:88,599,321...88,614,368
JBrowse link
G Bdnf brain-derived neurotrophic factor multiple interactions EXP Tacrolimus inhibits the reaction [decamethrin results in increased expression of BDNF exon]; Tacrolimus promotes the reaction [U 0126 inhibits the reaction [decamethrin results in increased expression of BDNF exon]]; U 0126 promotes the reaction [Tacrolimus inhibits the reaction [decamethrin results in increased expression of BDNF exon]] CTD PMID:22079160 NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:116,619,633...116,670,657
JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 increases expression EXP Tacrolimus results in increased expression of BIRC3 mRNA CTD PMID:21865292 NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 decreases expression ISO Tacrolimus results in decreased expression of BIRC5 mRNA CTD PMID:16574167 NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,572,080...103,582,155
JBrowse link
G Bmp7 bone morphogenetic protein 7 multiple interactions
decreases expression
EXP Ramipril inhibits the reaction [Tacrolimus results in decreased expression of BMP7 protein]; valsartan inhibits the reaction [Tacrolimus results in decreased expression of BMP7 protein] CTD PMID:17703430 NCBI chr 3:182,059,318...182,135,273
Ensembl chr 3:182,052,337...182,135,137
JBrowse link
G Btg2 BTG anti-proliferation factor 2 increases expression EXP Tacrolimus results in increased expression of BTG2 mRNA CTD PMID:21865292 NCBI chr13:48,083,931...48,087,690
Ensembl chr13:48,083,931...48,087,690
JBrowse link
G Btnl9 butyrophilin-like 9 decreases expression ISO Tacrolimus results in decreased expression of BTNL9 mRNA CTD PMID:29362864 NCBI chr10:33,466,059...33,489,229
Ensembl chr10:33,970,675...33,990,354
JBrowse link
G C1qa complement C1q A chain increases expression ISO Tacrolimus results in increased expression of C1QA mRNA CTD PMID:29362864 NCBI chr 5:149,133,635...149,136,482
Ensembl chr 5:154,417,087...154,427,732
JBrowse link
G C1qb complement C1q B chain increases expression ISO Tacrolimus results in increased expression of C1QB mRNA CTD PMID:29362864 NCBI chr 5:149,118,843...149,124,394
Ensembl chr 5:154,402,279...154,407,840
JBrowse link
G C1qc complement C1q C chain increases expression ISO Tacrolimus results in increased expression of C1QC mRNA CTD PMID:29362864 NCBI chr 5:149,127,412...149,130,757
Ensembl chr 5:154,410,848...154,414,468
JBrowse link
G C2 complement C2 increases expression EXP Tacrolimus results in increased expression of C2 mRNA CTD PMID:21865292 NCBI chr20:3,951,474...3,970,376
Ensembl chr20:3,955,776...3,981,740
JBrowse link
G C3 complement C3 increases expression EXP
ISO
Tacrolimus results in increased expression of C3 mRNA CTD PMID:21865292 PMID:29362864 NCBI chr 9:2,174,412...2,201,339
Ensembl chr 9:2,174,412...2,201,339
JBrowse link
G C4b complement C4B increases expression EXP Tacrolimus results in increased expression of C4B mRNA CTD PMID:21865292 NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,201,961...4,216,289
JBrowse link
G Calb1 calbindin 1 decreases expression EXP Tacrolimus results in decreased expression of CALB1 mRNA; Tacrolimus results in decreased expression of CALB1 protein CTD PMID:14978156 PMID:21865292 NCBI chr 5:29,375,624...29,402,532
Ensembl chr 5:34,172,664...34,200,160
JBrowse link
G Calcr calcitonin receptor multiple interactions ISO Tacrolimus inhibits the reaction [TNFSF11 protein results in increased expression of CALCR mRNA] CTD PMID:21869564 NCBI chr 4:31,661,270...31,736,392
Ensembl chr 4:32,615,958...32,691,075
JBrowse link
G Calr calreticulin increases expression ISO Tacrolimus results in increased expression of CALR mRNA CTD PMID:25270620 NCBI chr19:40,213,367...40,218,262
Ensembl chr19:40,213,239...40,219,236
JBrowse link
G Camk1d calcium/calmodulin-dependent protein kinase ID increases expression ISO Tacrolimus results in increased expression of CAMK1D mRNA CTD PMID:23958496 NCBI chr17:72,581,899...72,982,704
Ensembl chr17:77,491,220...77,892,012
JBrowse link
G Capg capping actin protein, gelsolin like increases expression EXP Tacrolimus results in increased expression of CAPG mRNA CTD PMID:21865292 NCBI chr 4:106,152,912...106,170,010
Ensembl chr 4:106,152,890...106,170,672
JBrowse link
G Casp3 caspase 3 multiple interactions
increases cleavage
increases activity
ISO
EXP
Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [Thapsigargin results in increased activity of CASP3 protein]
Tacrolimus results in increased cleavage of CASP3 protein
Tacrolimus results in increased activity of CASP3 protein
MK0626 inhibits the reaction [Tacrolimus results in increased activity of CASP3 protein]; NGF protein inhibits the reaction [Tacrolimus results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [3-nitropropionic acid results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [[Lithium co-treated with Pilocarpine] results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [Hydrogen Peroxide results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [Oxygen deficiency results in increased activity of CASP3 protein]
Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [S-Nitrosoglutathione results in increased activity of CASP3 protein]
CTD PMID:10205001 PMID:12642403 PMID:12871656 PMID:12892836 PMID:15207740 More... NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Casp8 caspase 8 multiple interactions
increases expression
ISO Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP8 protein]
Tacrolimus results in increased expression of CASP8 protein
CTD PMID:15548389 PMID:27606422 NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
JBrowse link
G Casp9 caspase 9 multiple interactions
increases expression
ISO Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP9 protein]
Tacrolimus results in increased expression of CASP9 protein
CTD PMID:15548389 PMID:27606422 Ensembl chr 5:159,391,188...159,409,648 JBrowse link
G Cat catalase increases expression
decreases response to substance
EXP
ISO
Tacrolimus results in increased expression of CAT protein
CAT protein results in decreased susceptibility to Tacrolimus
CTD PMID:14675044 PMID:18766458 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
JBrowse link
G Cbll1 Cbl proto-oncogene like 1 increases expression ISO Tacrolimus results in increased expression of CBLL1 mRNA CTD PMID:21621594 NCBI chr 6:48,071,190...48,086,174
Ensembl chr 6:53,798,712...53,813,880
JBrowse link
G Ccdc88b coiled-coil domain containing 88B increases expression ISO Tacrolimus results in increased expression of CCDC88B mRNA CTD PMID:29362864 NCBI chr 1:204,036,913...204,052,878
Ensembl chr 1:213,461,963...213,522,302
JBrowse link
G Ccl11 C-C motif chemokine ligand 11 decreases expression ISO Tacrolimus results in decreased expression of CCL11 mRNA CTD PMID:15948978 NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,525,862...67,530,575
JBrowse link
G Ccl17 C-C motif chemokine ligand 17 increases expression ISO Tacrolimus results in increased expression of CCL17 mRNA CTD PMID:29362864 NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,208,120...10,209,895
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions
increases expression
EXP
ISO
pyrrolidine dithiocarbamic acid inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]
Tacrolimus inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein]
7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; 7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; parthenolide inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL2 protein]; salubrinal inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]; sulforaphane inhibits the reaction [Tacrolimus results in increased expression of CCL2 mRNA]
CTD PMID:12472797 PMID:23958496 PMID:29362864 PMID:36416909 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
JBrowse link
G Ccl20 C-C motif chemokine ligand 20 increases expression ISO Tacrolimus results in increased expression of CCL20 mRNA CTD PMID:23958496 NCBI chr 9:84,389,031...84,391,629
Ensembl chr 9:91,836,946...91,839,736
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions ISO Tacrolimus inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL3 protein] CTD PMID:36416909 NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,948,889...68,950,439
JBrowse link
G Ccl5 C-C motif chemokine ligand 5 decreases expression
increases expression
multiple interactions
ISO Tacrolimus results in decreased expression of CCL5 mRNA
Tacrolimus results in increased expression of CCL5 mRNA
7-oxozeanol inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; parthenolide inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; pyrazolanthrone inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; salubrinal inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]; sulforaphane inhibits the reaction [Tacrolimus results in increased expression of CCL5 mRNA]
CTD PMID:15948978 PMID:23958496 PMID:25270620 NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,738,651...68,824,884
JBrowse link
G Ccl7 C-C motif chemokine ligand 7 increases expression ISO Tacrolimus results in increased expression of CCL7 mRNA CTD PMID:23958496 PMID:29362864 NCBI chr10:67,016,446...67,018,296
Ensembl chr10:67,514,091...67,515,947
JBrowse link
G Ccl9 C-C motif chemokine ligand 9 increases expression EXP
ISO
Tacrolimus results in increased expression of CCL6 mRNA CTD PMID:21865292 PMID:29362864 NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,863,995...68,868,877
JBrowse link
G Ccn2 cellular communication network factor 2 multiple interactions EXP Tacrolimus inhibits the reaction [Paraquat results in increased expression of CCN2 mRNA]; Tacrolimus inhibits the reaction [Paraquat results in increased secretion of CCN2 protein] CTD PMID:33000210 NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:22,621,501...22,624,976
JBrowse link
G Ccna2 cyclin A2 increases expression ISO Tacrolimus results in increased expression of CCNA2 mRNA CTD PMID:29362864 NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:121,355,363...121,361,701
JBrowse link
G Ccnb2 cyclin B2 decreases expression
increases expression
ISO Tacrolimus results in decreased expression of CCNB2 mRNA
Tacrolimus results in increased expression of CCNB2 mRNA
CTD PMID:16574167 PMID:29362864 NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:79,968,465...79,981,682
JBrowse link
G Ccr2 C-C motif chemokine receptor 2 increases expression ISO Tacrolimus results in increased expression of CCR2 mRNA CTD PMID:29362864 NCBI chr 8:132,611,883...132,619,106
Ensembl chr 8:132,611,410...132,620,059
JBrowse link
G Ccr3 C-C motif chemokine receptor 3 decreases expression ISO Tacrolimus results in decreased expression of CCR3 mRNA CTD PMID:15948978 NCBI chr 8:123,586,100...123,634,178
Ensembl chr 8:132,463,788...132,511,593
JBrowse link
G Ccrl2 C-C motif chemokine receptor like 2 increases expression ISO Tacrolimus results in increased expression of CCRL2 mRNA CTD PMID:23958496 NCBI chr 8:111,034,279...111,036,914
Ensembl chr 8:119,911,288...119,922,380
JBrowse link
G Cd2 Cd2 molecule multiple interactions ISO Tacrolimus inhibits the reaction [CD2 protein results in increased expression of IL2 protein] CTD PMID:1705513 NCBI chr 2:188,710,895...188,724,044
Ensembl chr 2:191,399,510...191,413,665
JBrowse link
G Cd44 CD44 molecule increases expression EXP Tacrolimus results in increased expression of CD44 mRNA CTD PMID:21865292 NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424
JBrowse link
G Cd68 Cd68 molecule increases expression EXP Tacrolimus results in increased expression of CD68 mRNA CTD PMID:21865292 NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,880,563...54,882,540
JBrowse link
G Cd74 CD74 molecule increases expression ISO Tacrolimus results in increased expression of CD74 mRNA CTD PMID:23958496 NCBI chr18:54,256,757...54,266,003
Ensembl chr18:56,527,132...56,536,410
JBrowse link
G Cd80 Cd80 molecule decreases expression ISO Tacrolimus results in decreased expression of CD80 protein CTD PMID:15241357 NCBI chr11:75,760,073...75,798,978
Ensembl chr11:75,760,147...75,797,540
JBrowse link
G Cd83 CD83 molecule increases expression ISO Tacrolimus results in increased expression of CD83 mRNA CTD PMID:29362864 NCBI chr17:20,887,309...20,907,009
Ensembl chr17:21,093,281...21,113,047
JBrowse link
G Cd86 CD86 molecule decreases expression ISO Tacrolimus results in decreased expression of CD86 protein CTD PMID:15241357 NCBI chr11:77,647,565...77,706,178
Ensembl chr11:77,647,600...77,725,361
JBrowse link
G Cdca3 cell division cycle associated 3 increases expression ISO Tacrolimus results in increased expression of CDCA3 mRNA CTD PMID:29362864 NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:159,321,014...159,325,068
JBrowse link
G Cdca5 cell division cycle associated 5 increases expression ISO Tacrolimus results in increased expression of CDCA5 mRNA CTD PMID:29362864 NCBI chr 1:203,378,550...203,392,027
Ensembl chr 1:212,804,014...212,821,309
JBrowse link
G Cdca8 cell division cycle associated 8 increases expression ISO Tacrolimus results in increased expression of CDCA8 mRNA CTD PMID:29362864 NCBI chr 5:142,461,082...142,483,336
Ensembl chr 5:142,461,084...142,483,283
JBrowse link
G Cdh1 cadherin 1 decreases expression ISO Tacrolimus results in decreased expression of CDH1 protein CTD PMID:22416070 NCBI chr19:51,402,178...51,471,572
Ensembl chr19:51,402,034...51,471,565
JBrowse link
G Cdh11 cadherin 11 increases expression ISO Tacrolimus results in increased expression of CDH11 mRNA CTD PMID:29362864 NCBI chr19:2,152,961...2,312,140
Ensembl chr19:2,154,840...2,312,140
JBrowse link
G Cdh16 cadherin 16 decreases expression ISO Tacrolimus results in decreased expression of CDH16 mRNA CTD PMID:22416070 NCBI chr19:360,824...371,008
Ensembl chr19:367,274...388,934
JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B increases expression EXP Tacrolimus results in increased expression of CDKN1B mRNA CTD PMID:21865292 NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha increases expression ISO Tacrolimus results in increased expression of CEBPA mRNA CTD PMID:29362864 NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:96,896,171...96,899,309
JBrowse link
G Cenpw centromere protein W increases expression ISO Tacrolimus results in increased expression of CENPW mRNA CTD PMID:29362864 NCBI chr 1:27,525,324...27,530,464
Ensembl chr 1:29,353,970...29,359,109
JBrowse link
G Cfi complement factor I increases expression EXP Tacrolimus results in increased expression of CFI mRNA CTD PMID:21865292 NCBI chr 2:218,389,079...218,430,565
Ensembl chr 2:221,062,212...221,104,786
JBrowse link
G Ckap2 cytoskeleton associated protein 2 increases expression ISO Tacrolimus results in increased expression of CKAP2 mRNA CTD PMID:29362864 NCBI chr16:69,839,668...69,864,852
Ensembl chr16:76,542,104...76,567,352
JBrowse link
G Ckap4 cytoskeleton-associated protein 4 increases expression EXP Tacrolimus results in increased expression of CKAP4 mRNA CTD PMID:21865292 NCBI chr 7:19,230,814...19,238,914
Ensembl chr 7:21,118,085...21,126,624
JBrowse link
G Cldn1 claudin 1 decreases expression ISO Tacrolimus results in decreased expression of CLDN1 mRNA CTD PMID:22416070 NCBI chr11:74,421,569...74,436,728
Ensembl chr11:87,926,337...87,941,529
JBrowse link
G Cldn4 claudin 4 increases expression EXP Tacrolimus results in increased expression of CLDN4 mRNA CTD PMID:21865292 NCBI chr12:21,751,638...21,753,436
Ensembl chr12:27,387,981...27,389,958
JBrowse link
G Cldn7 claudin 7 increases expression EXP Tacrolimus results in increased expression of CLDN7 mRNA CTD PMID:21865292 NCBI chr10:54,689,684...54,692,177
Ensembl chr10:55,188,684...55,190,905
JBrowse link
G Clec7a C-type lectin domain containing 7A increases expression ISO Tacrolimus results in increased expression of CLEC7A mRNA CTD PMID:29362864 NCBI chr 4:162,902,731...162,913,931
Ensembl chr 4:164,588,754...164,599,919
JBrowse link
G Clk3 CDC-like kinase 3 increases expression ISO Tacrolimus results in increased expression of CLK3 mRNA CTD PMID:25270620 NCBI chr 8:58,152,155...58,167,196
Ensembl chr 8:67,048,123...67,062,881
JBrowse link
G Clu clusterin increases expression EXP Tacrolimus results in increased expression of CLU mRNA CTD PMID:21865292 NCBI chr15:44,336,619...44,375,861
Ensembl chr15:44,359,914...44,375,860
JBrowse link
G Coch cochlin increases expression ISO Tacrolimus results in increased expression of COCH mRNA CTD PMID:25270620 NCBI chr 6:74,766,485...74,780,504
Ensembl chr 6:74,766,419...74,780,502
JBrowse link
G Col1a1 collagen type I alpha 1 chain increases expression ISO Tacrolimus results in increased expression of COL1A1 mRNA CTD PMID:29362864 NCBI chr10:80,380,458...80,397,461
Ensembl chr10:80,380,453...80,397,460
JBrowse link
G Col1a2 collagen type I alpha 2 chain increases expression ISO Tacrolimus results in increased expression of COL1A2 mRNA CTD PMID:29362864 NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:33,518,420...33,553,995
JBrowse link
G Col3a1 collagen type III alpha 1 chain increases expression ISO Tacrolimus results in increased expression of COL3A1 mRNA CTD PMID:29362864 NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232
JBrowse link
G Cops8 COP9 signalosome subunit 8 increases expression ISO Tacrolimus results in increased expression of COPS8 mRNA CTD PMID:25270620 NCBI chr 9:91,207,427...91,217,258
Ensembl chr 9:98,654,870...98,665,381
JBrowse link
G Cp ceruloplasmin increases expression EXP Tacrolimus results in increased expression of CP mRNA CTD PMID:21865292 NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:104,368,456...104,427,087
JBrowse link
G Creb3l3 cAMP responsive element binding protein 3-like 3 decreases expression ISO Tacrolimus results in decreased expression of CREB3L3 mRNA CTD PMID:25270620 NCBI chr 7:8,622,614...8,631,053
Ensembl chr 7:9,273,338...9,281,778
JBrowse link
G Creld2 cysteine-rich with EGF-like domains 2 increases expression ISO Tacrolimus results in increased expression of CRELD2 mRNA CTD PMID:25270620 NCBI chr 7:119,909,626...119,916,556
Ensembl chr 7:121,788,745...121,796,228
JBrowse link
G Csf1 colony stimulating factor 1 increases expression ISO Tacrolimus results in increased expression of CSF1 mRNA CTD PMID:23958496 NCBI chr 2:195,377,215...195,396,608
Ensembl chr 2:198,065,405...198,084,468
JBrowse link
G Csf2 colony stimulating factor 2 decreases expression
increases expression
multiple interactions
ISO Tacrolimus results in decreased expression of CSF2 protein
Tacrolimus results in increased expression of CSF2 mRNA
Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of CSF2 protein]]; Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of CSF2 protein]
CTD PMID:1376361 PMID:11407316 PMID:23958496 NCBI chr10:38,887,692...38,889,673
Ensembl chr10:38,887,692...38,890,031
JBrowse link
G Csf2rb colony stimulating factor 2 receptor subunit beta increases expression ISO Tacrolimus results in increased expression of CSF2RB2 mRNA CTD PMID:29362864 NCBI chr 7:109,876,919...109,901,589
Ensembl chr 7:111,757,405...111,784,654
JBrowse link
G Ctsl cathepsin L multiple interactions
increases expression
ISO
EXP
Tacrolimus inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CTSL protein]
Tacrolimus results in increased expression of CTSL mRNA
CTD PMID:18172886 PMID:21865292 PMID:25270620 NCBI chr17:764,370...770,533
Ensembl chr17:770,093...777,113
JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 increases expression EXP
ISO
Tacrolimus results in increased expression of CXCL10 mRNA CTD PMID:21865292 PMID:23958496 PMID:25270620 NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,989,018...15,991,261
JBrowse link
G Cxcl11 C-X-C motif chemokine ligand 11 increases expression ISO Tacrolimus results in increased expression of CXCL11 mRNA CTD PMID:23958496 NCBI chr14:15,689,432...15,692,207
Ensembl chr14:15,973,720...15,976,567
JBrowse link
G Cyba cytochrome b-245 alpha chain multiple interactions
increases expression
ISO Ramipril inhibits the reaction [Tacrolimus results in increased expression of CYBA mRNA] CTD PMID:12352326 NCBI chr19:50,487,598...50,495,669
Ensembl chr19:67,396,143...67,404,214
JBrowse link
G Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 increases expression EXP Tacrolimus results in increased expression of CYP27B1 mRNA CTD PMID:21865292 NCBI chr 7:62,869,340...62,876,242
Ensembl chr 7:64,756,626...64,761,570
JBrowse link
G Cyp2c6 cytochrome P450, family 2, subfamily C, polypeptide 6 multiple interactions ISO CYP2C19 affects the reaction [Lansoprazole affects the susceptibility to Tacrolimus]; CYP2C19 affects the susceptibility to [Tacrolimus co-treated with Lansoprazole]; CYP2C19 affects the susceptibility to [Tacrolimus co-treated with Rabeprazole]; CYP2C19 gene mutant form affects the susceptibility to [Lansoprazole co-treated with Tacrolimus] CTD PMID:15010519 PMID:15285851 PMID:17377957 NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:247,879,078...247,916,798
JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 increases metabolic processing
affects metabolic processing
decreases methylation
multiple interactions
ISO CYP3A4 protein results in increased metabolism of Tacrolimus
CYP3A4 protein affects the metabolism of Tacrolimus
CYP3A4 protein results in decreased methylation of Tacrolimus
Metronidazole inhibits the reaction [CYP3A4 protein results in increased metabolism of Tacrolimus]
CTD PMID:15010519 PMID:15855244 PMID:15919446 PMID:15951320 PMID:15964336 NCBI chr12:9,207,978...9,230,064
Ensembl chr12:14,321,771...14,343,857
JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 multiple interactions
decreases methylation
affects metabolic processing
affects response to substance
ISO CYP3A5 affects the susceptibility to [Tacrolimus co-treated with Lansoprazole]; CYP3A5 affects the susceptibility to [Tacrolimus co-treated with Rabeprazole]; CYP3A5 gene polymorphism affects the reaction [Ketoconazole results in decreased metabolism of Tacrolimus]
CYP3A5 protein results in decreased methylation of Tacrolimus
CYP3A5 gene polymorphism affects the metabolism of Tacrolimus; CYP3A5 gene SNP affects the metabolism of Tacrolimus; CYP3A5 protein affects the metabolism of Tacrolimus; CYP3A5 protein polymorphism affects the metabolism of Tacrolimus
CYP3A5 gene affects the susceptibility to Tacrolimus; CYP3A5 polymorphism affects the susceptibility to Tacrolimus
CTD PMID:15502717 PMID:15723604 PMID:15729180 PMID:15808586 PMID:15919447 More... NCBI chr12:21,919,955...21,960,160
Ensembl chr12:21,919,940...21,960,154
JBrowse link
G Dcn decorin increases expression ISO Tacrolimus results in increased expression of DCN mRNA CTD PMID:29362864 NCBI chr 7:34,167,973...34,208,004
Ensembl chr 7:34,163,011...34,218,926
JBrowse link
G Ddit3 DNA-damage inducible transcript 3 multiple interactions
increases expression
ISO salubrinal promotes the reaction [Tacrolimus results in increased expression of DDIT3 protein]
Tacrolimus results in increased expression of DDIT3 mRNA
CTD PMID:23958496 PMID:25270620 NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:65,005,501...65,006,509
JBrowse link
G Ddit4l DNA-damage-inducible transcript 4-like decreases expression EXP Tacrolimus results in decreased expression of DDIT4L mRNA CTD PMID:21865292 NCBI chr 2:228,800,831...228,804,478
Ensembl chr 2:228,801,705...228,806,225
JBrowse link
G Dhcr24 24-dehydrocholesterol reductase decreases expression ISO Tacrolimus results in decreased expression of DHCR24 mRNA CTD PMID:25270620 NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:126,573,338...126,599,936
JBrowse link
G Dnajc30 DnaJ heat shock protein family (Hsp40) member C30 decreases expression ISO Tacrolimus results in decreased expression of DNAJC30 mRNA CTD PMID:25270620 NCBI chr12:27,264,861...27,265,940
Ensembl chr12:27,262,802...27,266,169
JBrowse link
G Dnm1l dynamin 1-like multiple interactions ISO PINK1 protein affects the reaction [Tacrolimus results in increased phosphorylation of DNM1L protein]
Tacrolimus inhibits the reaction [ferric ammonium citrate results in decreased phosphorylation of DNM1L protein]
CTD PMID:19492085 PMID:26318285 NCBI chr11:98,084,049...98,135,663
Ensembl chr11:98,085,397...98,137,420
JBrowse link
G Doc2a double C2 domain alpha decreases expression ISO Tacrolimus results in decreased expression of DOC2A mRNA CTD PMID:25270620 NCBI chr 1:181,457,415...181,462,528
Ensembl chr 1:190,888,214...190,893,384
JBrowse link
G Dock10 dedicator of cytokinesis 10 increases expression ISO Tacrolimus results in increased expression of DOCK10 mRNA CTD PMID:29362864 NCBI chr 9:81,843,599...82,101,540
Ensembl chr 9:89,291,800...89,549,973
JBrowse link
G Dpp4 dipeptidylpeptidase 4 increases activity
multiple interactions
EXP Tacrolimus results in increased activity of DPP4 protein
MK0626 inhibits the reaction [Tacrolimus results in increased activity of DPP4 protein]
CTD PMID:24959755 NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:67,370,804...67,452,422
JBrowse link
G Drd2 dopamine receptor D2 affects activity
multiple interactions
EXP Tacrolimus affects the activity of DRD2 protein
Sulpiride inhibits the reaction [Tacrolimus affects the activity of DRD2 protein]
CTD PMID:15332494 NCBI chr 8:49,708,927...49,772,876
Ensembl chr 8:58,605,403...58,669,339
JBrowse link
G Ech1 enoyl-CoA hydratase 1 decreases expression ISO Tacrolimus results in decreased expression of ECH1 mRNA CTD PMID:25270620 NCBI chr 1:84,114,494...84,120,788
Ensembl chr 1:93,241,734...93,248,440
JBrowse link
G Edem1 ER degradation enhancing alpha-mannosidase like protein 1 increases expression ISO Tacrolimus results in increased expression of EDEM1 mRNA CTD PMID:25270620 NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:143,353,624...143,388,060
JBrowse link
G Edn1 endothelin 1 increases expression EXP Tacrolimus results in increased expression of EDN1 mRNA; Tacrolimus results in increased expression of EDN1 protein CTD PMID:9517403 PMID:9931093 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
JBrowse link
G Ednra endothelin receptor type A increases activity
increases expression
EXP Tacrolimus results in increased activity of EDNRA protein
Tacrolimus results in increased expression of EDNRA mRNA
CTD PMID:8587392 PMID:15964565 NCBI chr19:30,233,540...30,303,727
Ensembl chr19:47,137,771...47,201,284
JBrowse link
G Efemp2 EGF containing fibulin extracellular matrix protein 2 increases expression ISO Tacrolimus results in increased expression of EFEMP2 mRNA CTD PMID:29362864 NCBI chr 1:202,781,692...202,789,784
Ensembl chr 1:212,210,972...212,218,739
JBrowse link
G Egr1 early growth response 1 increases expression EXP Tacrolimus results in increased expression of EGR1 mRNA CTD PMID:21865292 NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,736,838...26,740,843
JBrowse link
G Egr2 early growth response 2 increases expression EXP Tacrolimus results in increased expression of EGR2 mRNA CTD PMID:21865292 NCBI chr20:21,051,270...21,056,322
Ensembl chr20:21,050,149...21,057,748
JBrowse link
G Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 multiple interactions ISO Tacrolimus inhibits the reaction [Sirolimus results in decreased phosphorylation of and results in increased activity of EIF4EBP1 protein] CTD PMID:8599949 NCBI chr16:71,495,457...71,508,845
Ensembl chr16:71,487,930...71,508,874
JBrowse link
G Elac2 elaC ribonuclease Z 2 decreases expression ISO Tacrolimus results in decreased expression of ELAC2 mRNA CTD PMID:25270620 NCBI chr10:50,131,449...50,154,755
Ensembl chr10:50,131,521...50,155,069
JBrowse link
G Ern1 endoplasmic reticulum to nucleus signaling 1 increases phosphorylation ISO Tacrolimus results in increased phosphorylation of ERN1 protein CTD PMID:23958496 NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,830,428...91,920,791
JBrowse link
G Ero1a endoplasmic reticulum oxidoreductase 1 alpha increases expression ISO Tacrolimus results in increased expression of ERO1A mRNA CTD PMID:23958496 NCBI chr15:18,495,037...18,530,440
Ensembl chr15:20,972,679...21,018,039
JBrowse link
G Exosc4 exosome component 4 decreases expression ISO Tacrolimus results in decreased expression of EXOSC4 mRNA CTD PMID:25270620 NCBI chr 7:108,047,831...108,050,573
Ensembl chr 7:109,928,498...109,931,820
JBrowse link
G F2r coagulation factor II (thrombin) receptor decreases expression ISO Tacrolimus results in decreased expression of F2R mRNA CTD PMID:25270620 NCBI chr 2:26,869,343...26,885,856
Ensembl chr 2:28,604,066...28,620,579
JBrowse link
G Fabp2 fatty acid binding protein 2 decreases expression ISO Tacrolimus results in decreased expression of FABP2 mRNA CTD PMID:25270620 NCBI chr 2:211,040,032...211,044,089
Ensembl chr 2:213,724,629...213,728,686
JBrowse link
G Fas Fas cell surface death receptor multiple interactions ISO Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP8 protein]; Tacrolimus inhibits the reaction [FAS protein results in increased activity of CASP9 protein] CTD PMID:15548389 NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
JBrowse link
G Faslg Fas ligand decreases secretion ISO Tacrolimus results in decreased secretion of FASLG protein CTD PMID:11692113 NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
JBrowse link
G Fbln1 fibulin 1 increases expression EXP Tacrolimus results in increased expression of FBLN1 mRNA CTD PMID:21865292 NCBI chr 7:116,310,582...116,390,075
Ensembl chr 7:118,190,478...118,269,965
JBrowse link
G Fga fibrinogen alpha chain increases expression EXP Tacrolimus results in increased expression of FGA mRNA CTD PMID:21865292 NCBI chr 2:168,374,120...168,381,523
Ensembl chr 2:170,672,012...170,679,577
JBrowse link
G Fgb fibrinogen beta chain increases expression EXP Tacrolimus results in increased expression of FGB mRNA CTD PMID:21865292 NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:170,692,965...170,705,434
JBrowse link
G Fgd2 FYVE, RhoGEF and PH domain containing 2 increases expression ISO Tacrolimus results in increased expression of FGD2 mRNA CTD PMID:29362864 NCBI chr20:7,424,795...7,441,603
Ensembl chr20:7,426,414...7,443,207
JBrowse link
G Fgf21 fibroblast growth factor 21 decreases expression ISO Tacrolimus results in decreased expression of FGF21 mRNA CTD PMID:25270620 NCBI chr 1:96,083,360...96,084,911
Ensembl chr 1:105,219,825...105,232,056
JBrowse link
G Fgl2 fibrinogen-like 2 increases expression EXP
ISO
Tacrolimus results in increased expression of FGL2 mRNA CTD PMID:21865292 PMID:29362864 NCBI chr 4:13,710,566...13,716,207
Ensembl chr 4:14,602,771...14,608,405
JBrowse link
G Fhl2 four and a half LIM domains 2 increases expression ISO Tacrolimus results in increased expression of FHL2 mRNA CTD PMID:29362864 NCBI chr 9:52,881,091...52,954,540
Ensembl chr 9:52,880,998...52,923,326
JBrowse link
G Fkbp1a FKBP prolyl isomerase 1A multiple interactions
increases expression
ISO
EXP
[Tacrolimus binds to FKBP1A protein] inhibits the reaction [Sirolimus binds to FKBP1A protein]; [Tacrolimus inhibits the reaction [FKBP1A protein binds to ACVR1B protein]] which results in decreased ubiquitination of ACVR1B protein; Tacrolimus inhibits the reaction [FKBP1A protein binds to and results in decreased activity of ACVR1B protein]; Tacrolimus inhibits the reaction [FKBP1A protein promotes the reaction [SMURF1 protein binds to SMAD7 protein binds to ACVR1B protein]]
Tacrolimus results in increased expression of FKBP1A protein
CTD PMID:10361256 PMID:11041285 PMID:16720724 NCBI chr 3:140,040,359...140,060,107
Ensembl chr 3:160,500,726...160,524,233
JBrowse link
G Fkbp5 FKBP prolyl isomerase 5 multiple interactions ISO Tacrolimus inhibits the reaction [NR3C1 protein binds to FKBP5 protein] CTD PMID:15697228 NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,458,940...6,543,118
JBrowse link
G Flt3 Fms related receptor tyrosine kinase 3 increases expression ISO Tacrolimus results in increased expression of FLT3 mRNA CTD PMID:29362864 NCBI chr12:12,660,035...12,735,584
Ensembl chr12:12,659,946...12,735,581
JBrowse link
G Fmo2 flavin containing dimethylaniline monoxygenase 2 increases expression ISO Tacrolimus results in increased expression of FMO2 mRNA CTD PMID:21621594 NCBI chr13:75,221,149...75,244,377
Ensembl chr13:77,757,629...77,777,534
JBrowse link
G Fn1 fibronectin 1 multiple interactions
increases expression
ISO Tacrolimus inhibits the reaction [NPR1 protein affects the expression of FN1 mRNA]
Tacrolimus results in increased expression of FN1 mRNA
CTD PMID:15939815 PMID:29362864 NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:80,645,507...80,714,137
JBrowse link
G Fndc3a fibronectin type III domain containing 3a increases expression ISO Tacrolimus results in increased expression of FNDC3A mRNA CTD PMID:25270620 NCBI chr15:47,689,909...47,867,354
Ensembl chr15:54,099,510...54,276,407
JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit increases expression ISO Tacrolimus results in increased expression of FOS mRNA CTD PMID:23958496 NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit increases expression ISO Tacrolimus results in increased expression of FOSL1 mRNA CTD PMID:23958496 NCBI chr 1:202,754,549...202,763,057
Ensembl chr 1:212,183,833...212,192,391
JBrowse link
G Gbp1 guanylate binding protein 1 decreases expression ISO Tacrolimus results in decreased expression of GBP1 mRNA CTD PMID:21621594 NCBI chr 2:231,398,136...231,432,773
Ensembl chr 2:234,190,708...234,206,802
Ensembl chr 2:234,190,708...234,206,802
JBrowse link
G Gc GC, vitamin D binding protein decreases expression
increases expression
EXP
ISO
Tacrolimus results in decreased expression of GC mRNA
Tacrolimus results in increased expression of GC mRNA
CTD PMID:21865292 PMID:29362864 NCBI chr14:18,632,146...18,667,563
Ensembl chr14:18,916,246...18,951,673
JBrowse link
G Gcg glucagon multiple interactions
decreases secretion
EXP MK0626 inhibits the reaction [Tacrolimus results in decreased secretion of GCG protein modified form] CTD PMID:24959755 NCBI chr 3:47,113,914...47,122,958
Ensembl chr 3:67,522,489...67,531,533
JBrowse link
G Gins2 GINS complex subunit 2 increases expression ISO Tacrolimus results in increased expression of GINS2 mRNA CTD PMID:29362864 NCBI chr19:48,626,770...48,639,523
Ensembl chr19:65,535,492...65,548,052
JBrowse link
G Gjb1 gap junction protein, beta 1 increases expression ISO Tacrolimus results in increased expression of GJB1 mRNA CTD PMID:21621594 NCBI chr  X:66,501,848...66,509,783
Ensembl chr  X:70,541,862...70,549,843
JBrowse link
G Gldc glycine decarboxylase decreases expression ISO Tacrolimus results in decreased expression of GLDC mRNA CTD PMID:25270620 NCBI chr 1:237,296,753...237,375,620
Ensembl chr 1:237,296,753...237,375,604
JBrowse link
G Glp1r glucagon-like peptide 1 receptor decreases expression
multiple interactions
EXP Tacrolimus results in decreased expression of GLP1R protein
MK0626 inhibits the reaction [Tacrolimus results in decreased expression of GLP1R protein]
CTD PMID:24959755 NCBI chr20:8,972,004...9,010,241
Ensembl chr20:8,973,352...9,011,654
JBrowse link
G Gpihbp1 glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 decreases expression ISO Tacrolimus results in decreased expression of GPIHBP1 mRNA CTD PMID:29362864 NCBI chr 7:109,166,334...109,169,448
Ensembl chr 7:109,163,160...109,169,448
JBrowse link
G Gpn2 GPN-loop GTPase 2 increases expression ISO Tacrolimus results in increased expression of GPN2 mRNA CTD PMID:25270620 NCBI chr 5:151,093,279...151,101,114
Ensembl chr 5:151,093,418...151,101,111
JBrowse link
G Gpnmb glycoprotein nmb increases expression EXP Tacrolimus results in increased expression of GPNMB mRNA CTD PMID:21865292 NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:79,341,021...79,380,240
JBrowse link
G Grn granulin precursor increases expression ISO Tacrolimus results in increased expression of GRN mRNA CTD PMID:25270620 NCBI chr10:87,387,672...87,393,777
Ensembl chr10:87,886,122...87,893,936
JBrowse link
G Gsk3a glycogen synthase kinase 3 alpha multiple interactions
increases phosphorylation
ISO [GSK3A protein co-treated with GSK3B protein] affects the reaction [Tacrolimus results in increased expression of SNAI1 protein]
Tacrolimus results in increased phosphorylation of GSK3A protein
CTD PMID:22416070 NCBI chr 1:80,815,843...80,825,732
Ensembl chr 1:89,943,669...89,953,593
JBrowse link
G Gsk3b glycogen synthase kinase 3 beta multiple interactions
increases phosphorylation
ISO [GSK3A protein co-treated with GSK3B protein] affects the reaction [Tacrolimus results in increased expression of SNAI1 protein]
Tacrolimus results in increased phosphorylation of GSK3B protein
CTD PMID:22416070 NCBI chr11:62,498,997...62,648,665
Ensembl chr11:76,009,507...76,153,249
JBrowse link
G Gtpbp4 GTP binding protein 4 decreases expression EXP Tacrolimus results in decreased expression of GTPBP4 mRNA CTD PMID:21865292 NCBI chr17:61,308,033...61,328,184
Ensembl chr17:66,276,566...66,289,637
JBrowse link
G Guca2a guanylate cyclase activator 2A increases expression EXP Tacrolimus results in increased expression of GUCA2A mRNA CTD PMID:21865292 NCBI chr 5:133,237,177...133,239,019
Ensembl chr 5:138,522,446...138,524,287
JBrowse link
G Hadhb hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta decreases expression ISO Tacrolimus results in decreased expression of HADHB mRNA CTD PMID:25270620 NCBI chr 6:26,153,572...26,187,668
Ensembl chr 6:31,873,404...31,907,835
JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 increases expression EXP Tacrolimus results in increased expression of HAVCR1 mRNA CTD PMID:21865292 NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,619,897...31,653,268
JBrowse link
G Herpud1 homocysteine inducible ER protein with ubiquitin like domain 1 increases expression ISO Tacrolimus results in increased expression of HERPUD1 mRNA CTD PMID:23958496 PMID:25270620 NCBI chr19:10,598,411...10,609,002
Ensembl chr19:10,604,362...10,624,081
JBrowse link
G Hexa hexosaminidase subunit alpha increases expression ISO Tacrolimus results in increased expression of HEXA mRNA CTD PMID:25270620 NCBI chr 8:59,936,526...59,961,654
Ensembl chr 8:68,809,615...68,859,560
JBrowse link
G Hgs hepatocyte growth factor-regulated tyrosine kinase substrate increases expression ISO Tacrolimus results in increased expression of HGS mRNA CTD PMID:29380240 NCBI chr10:105,739,617...105,757,838
Ensembl chr10:106,237,824...106,256,174
JBrowse link
G Hk2 hexokinase 2 increases expression ISO Tacrolimus results in increased expression of HK2 mRNA CTD PMID:29362864 NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:116,792,258...116,841,275
JBrowse link
G Hk3 hexokinase 3 increases expression ISO Tacrolimus results in increased expression of HK3 mRNA CTD PMID:29362864 NCBI chr17:9,596,950...9,614,847
Ensembl chr17:9,605,016...9,620,037
JBrowse link
G Hmgcs2 3-hydroxy-3-methylglutaryl-CoA synthase 2 decreases expression ISO Tacrolimus results in decreased expression of HMGCS2 mRNA CTD PMID:25270620 NCBI chr 2:185,875,609...185,903,505
Ensembl chr 2:188,547,767...188,592,242
JBrowse link
G Hmox1 heme oxygenase 1 increases expression
decreases expression
multiple interactions
ISO
EXP
Tacrolimus results in increased expression of HMOX1 mRNA; Tacrolimus results in increased expression of HMOX1 protein
Tacrolimus results in decreased expression of HMOX1 protein
MK0626 inhibits the reaction [Tacrolimus results in decreased expression of HMOX1 protein]
CTD PMID:23958496 PMID:24959755 PMID:26260164 PMID:29362864 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
JBrowse link
G Hnf1b HNF1 homeobox B decreases expression ISO Tacrolimus results in decreased expression of HNF1B mRNA CTD PMID:22416070 NCBI chr10:68,735,894...68,789,888
Ensembl chr10:69,233,131...69,287,361
JBrowse link
G Hsdl2 hydroxysteroid dehydrogenase like 2 decreases expression ISO Tacrolimus results in decreased expression of HSDL2 mRNA CTD PMID:25270620 NCBI chr 5:74,443,933...74,479,104
Ensembl chr 5:79,212,525...79,274,798
JBrowse link
G Hspa5 heat shock protein family A (Hsp70) member 5 increases expression ISO Tacrolimus results in increased expression of HSPA5 mRNA CTD PMID:25270620 NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:38,453,041...38,458,790
JBrowse link
G Hspa8 heat shock protein family A (Hsp70) member 8 multiple interactions
increases expression
EXP Tacrolimus inhibits the reaction [Acrylamide results in decreased expression of HSPA8 protein]
Tacrolimus results in increased expression of HSPA8 protein
CTD PMID:15081597 NCBI chr 8:50,080,514...50,084,376
Ensembl chr 8:50,080,199...50,084,372
JBrowse link
G Htr1a 5-hydroxytryptamine receptor 1A decreases expression ISO Tacrolimus results in decreased expression of HTR1A protein CTD PMID:27606422 NCBI chr 2:36,693,462...36,698,026
Ensembl chr 2:38,427,083...38,540,760
JBrowse link
G Htr1b 5-hydroxytryptamine receptor 1B decreases expression ISO Tacrolimus results in decreased expression of HTR1B protein CTD PMID:27606422 NCBI chr 8:82,513,572...82,534,670
Ensembl chr 8:91,052,432...91,418,583
JBrowse link
G Icam1 intercellular adhesion molecule 1 decreases expression
increases expression
EXP
ISO
Tacrolimus results in decreased expression of ICAM1; Tacrolimus results in decreased expression of ICAM1 protein
Tacrolimus results in increased expression of ICAM1 mRNA
CTD PMID:9794552 PMID:10385251 PMID:23958496 NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:27,829,161...27,841,617
JBrowse link
G Id1 inhibitor of DNA binding 1 increases expression ISO Tacrolimus results in increased expression of ID1 mRNA CTD PMID:25270620 PMID:29362864 NCBI chr 3:141,210,666...141,212,420
Ensembl chr 3:161,671,538...161,672,685
JBrowse link
G Id2 inhibitor of DNA binding 2 increases expression ISO Tacrolimus results in increased expression of ID2 mRNA CTD PMID:25270620 NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:47,457,554...47,472,961
JBrowse link
G Id3 inhibitor of DNA binding 3 increases expression ISO Tacrolimus results in increased expression of ID3 mRNA CTD PMID:29362864 NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:153,630,498...153,657,856
JBrowse link
G Id4 inhibitor of DNA binding 4 increases expression ISO Tacrolimus results in increased expression of ID4 mRNA CTD PMID:25270620 NCBI chr17:16,595,724...16,598,293
Ensembl chr17:16,595,724...16,598,492
JBrowse link
G Idi1 isopentenyl-diphosphate delta isomerase 1 decreases expression ISO Tacrolimus results in decreased expression of IDI1 mRNA CTD PMID:25270620 NCBI chr17:61,629,592...61,637,357
Ensembl chr17:66,539,763...66,547,524
JBrowse link
G Ifi27l2a interferon, alpha-inducible protein 27 like 2A increases expression ISO Tacrolimus results in increased expression of IFI27L2A mRNA CTD PMID:29362864 NCBI chr 6:122,598,872...122,600,358
Ensembl chr 6:128,363,658...128,365,146
JBrowse link
G Ifng interferon gamma multiple interactions
decreases expression
decreases secretion
ISO
EXP
[Tacrolimus co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IFNG mRNA; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IFNG protein]; Tacrolimus inhibits the reaction [enterotoxin A, Staphylococcal results in increased expression of IFNG protein]; Tacrolimus inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IFNG mRNA]
Tacrolimus results in decreased expression of IFNG protein
Tacrolimus results in decreased expression of IFNG mRNA; Tacrolimus results in decreased expression of IFNG protein
[Tacrolimus co-treated with TAK 779] results in decreased expression of IFNG protein
Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in decreased expression of BCL2 protein]; Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of BAX protein]; Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TRP53 protein]
Tacrolimus results in decreased secretion of IFNG protein
CTD PMID:1371491 PMID:8986461 PMID:10205001 PMID:11407316 PMID:11692113 More... NCBI chr 7:55,789,180...55,793,216
Ensembl chr 7:55,761,736...55,793,216
JBrowse link
G Igf1 insulin-like growth factor 1 increases response to substance EXP IGF1 protein results in increased susceptibility to Tacrolimus CTD PMID:12826230 NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 decreases expression
increases expression
EXP Tacrolimus results in decreased expression of IGFBP1 mRNA
Tacrolimus results in increased expression of IGFBP1 mRNA
CTD PMID:21865292 NCBI chr14:82,047,415...82,052,482
Ensembl chr14:86,261,277...86,266,344
JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 increases expression EXP Tacrolimus results in increased expression of IGFBP5 mRNA CTD PMID:21865292 NCBI chr 9:74,452,371...74,464,953
Ensembl chr 9:81,897,616...81,914,390
JBrowse link
G Il12b interleukin 12B multiple interactions ISO Tacrolimus inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein] CTD PMID:36416909 NCBI chr10:28,888,832...28,903,802
Ensembl chr10:29,389,905...29,405,194
JBrowse link
G Il15ra interleukin 15 receptor subunit alpha increases expression ISO Tacrolimus results in increased expression of IL15RA mRNA CTD PMID:23958496 NCBI chr17:66,802,300...66,831,973
Ensembl chr17:71,712,141...71,742,149
JBrowse link
G Il17ra interleukin 17 receptor A increases expression ISO Tacrolimus results in increased expression of IL17RA mRNA CTD PMID:23958496 NCBI chr 4:153,667,534...153,690,174
Ensembl chr 4:155,339,400...155,362,382
JBrowse link
G Il1b interleukin 1 beta increases expression ISO Tacrolimus results in increased expression of IL1B mRNA CTD PMID:29594315 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
JBrowse link
G Il1rn interleukin 1 receptor antagonist increases expression ISO Tacrolimus results in increased expression of IL1RN mRNA CTD PMID:23958496 NCBI chr 3:27,509,836...27,525,738
Ensembl chr 3:27,509,798...27,525,732
JBrowse link
G Il2 interleukin 2 multiple interactions
decreases expression
ISO
EXP
[Tacrolimus co-treated with Ionomycin co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of IL2 mRNA; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL2 protein]; Tacrolimus inhibits the reaction [CD2 protein results in increased expression of IL2 protein]; Tacrolimus inhibits the reaction [enterotoxin A, Staphylococcal results in increased expression of IL2 protein]; Tacrolimus inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of IL2 mRNA]; Tacrolimus inhibits the reaction [Zinc Sulfate inhibits the reaction [Mitogens results in increased expression of IL2 mRNA]]
Tacrolimus results in decreased expression of IL2 mRNA; Tacrolimus results in decreased expression of IL2 protein
Tacrolimus affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of IL2 protein]; Tacrolimus inhibits the reaction [Sirolimus inhibits the reaction [IL2 protein results in increased phosphorylation of RPS6 protein]]
CTD PMID:1371491 PMID:1614535 PMID:1701765 PMID:1705513 PMID:8986461 More... NCBI chr 2:121,932,968...121,937,672
Ensembl chr 2:121,932,968...121,937,672
JBrowse link
G Il23a interleukin 23 subunit alpha increases expression ISO Tacrolimus results in increased expression of IL23A mRNA CTD PMID:25270620 NCBI chr 7:721,809...723,923
Ensembl chr 7:1,306,320...1,308,434
JBrowse link
G Il2ra interleukin 2 receptor subunit alpha decreases expression ISO Tacrolimus results in decreased expression of IL2RA protein CTD PMID:1701765 NCBI chr17:66,849,974...66,898,665
Ensembl chr17:71,759,802...71,808,507
JBrowse link
G Il3 interleukin 3 decreases expression
multiple interactions
ISO Tacrolimus results in decreased expression of IL3 protein
Sirolimus inhibits the reaction [Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL3 protein]]; Tacrolimus inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL3 protein]
CTD PMID:1376361 PMID:11407316 NCBI chr10:38,906,460...38,908,810
Ensembl chr10:38,906,460...38,908,810
JBrowse link
G Il4 interleukin 4 multiple interactions
decreases expression
ISO
EXP
Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL4 protein]
Tacrolimus results in decreased expression of IL4 mRNA; Tacrolimus results in decreased expression of IL4 protein
Tacrolimus inhibits the reaction [bisphenol A promotes the reaction [NFATC3 protein binds to IL4 promoter]]; Tacrolimus inhibits the reaction [bisphenol A results in increased expression of IL4 protein]; Tacrolimus inhibits the reaction [nonylphenol promotes the reaction [NFATC3 protein binds to IL4 promoter]]; Tacrolimus inhibits the reaction [nonylphenol results in increased expression of IL4 protein]
CTD PMID:1371491 PMID:10685002 PMID:11407316 PMID:12709020 PMID:16368244 NCBI chr10:38,272,003...38,277,549
Ensembl chr10:38,272,003...38,277,549
JBrowse link
G Il5 interleukin 5 multiple interactions
decreases expression
ISO Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of IL5 protein]
Tacrolimus results in decreased expression of IL5 mRNA; Tacrolimus results in decreased expression of IL5 protein
CTD PMID:1371491 PMID:7540862 PMID:11407316 PMID:15948978 NCBI chr10:37,874,342...37,877,213
Ensembl chr10:38,375,132...38,378,003
JBrowse link
G Il6 interleukin 6 multiple interactions
increases expression
decreases expression
EXP
ISO
[Tacrolimus co-treated with quinapril] results in decreased expression of IL6 protein; [Tacrolimus co-treated with quinapril] results in increased expression of IL6 protein; [Tacrolimus co-treated with Valsartan] results in decreased expression of IL6 protein; [Tacrolimus co-treated with Valsartan] results in increased expression of IL6 protein
Tacrolimus results in increased expression of IL6 mRNA
parthenolide inhibits the reaction [Tacrolimus results in increased expression of IL6 mRNA]; sulforaphane inhibits the reaction [Tacrolimus results in increased expression of IL6 mRNA]
Tacrolimus results in increased expression of IL6 protein
Tacrolimus results in decreased expression of IL6 protein
CTD PMID:16549154 PMID:23958496 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
JBrowse link
G Imp4 IMP U3 small nucleolar ribonucleoprotein 4 decreases expression ISO Tacrolimus results in decreased expression of IMP4 mRNA CTD PMID:25270620 NCBI chr 9:36,654,127...36,659,265
Ensembl chr 9:44,150,337...44,157,751
JBrowse link
G Ino80e INO80 complex subunit E decreases expression ISO Tacrolimus results in decreased expression of INO80E mRNA CTD PMID:25270620 NCBI chr 1:181,461,406...181,472,059
Ensembl chr 1:190,891,936...190,902,541
JBrowse link
G Ins1 insulin 1 decreases expression
multiple interactions
EXP Tacrolimus results in decreased expression of INS1 protein
MK0626 inhibits the reaction [Tacrolimus results in decreased expression of INS1 protein]
CTD PMID:24959755 NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:261,186,119...261,186,682
JBrowse link
G Ins2 insulin 2 decreases expression ISO Tacrolimus results in decreased expression of INS protein CTD PMID:17391142 NCBI chr 1:207,272,738...207,421,998
Ensembl chr 1:207,272,742...207,273,805
JBrowse link
G Irak1 interleukin-1 receptor-associated kinase 1 increases phosphorylation ISO Tacrolimus results in increased phosphorylation of IRAK1 protein CTD PMID:23958496 NCBI chr  X:151,768,621...151,778,521
Ensembl chr  X:156,920,081...156,929,825
JBrowse link
G Itgal integrin subunit alpha L decreases expression EXP Tacrolimus results in decreased expression of ITGAL CTD PMID:9794552 NCBI chr 1:191,348,424...191,386,228
Ensembl chr 1:191,348,542...191,386,225
JBrowse link
G Jak2 Janus kinase 2 increases phosphorylation ISO Tacrolimus results in increased phosphorylation of JAK2 protein CTD PMID:23958496 NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:236,408,662...236,468,762
JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit decreases expression EXP Tacrolimus results in decreased expression of JUN protein CTD PMID:9674596 NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
JBrowse link
G Junb JunB proto-oncogene, AP-1 transcription factor subunit increases expression ISO Tacrolimus results in increased expression of JUNB mRNA CTD PMID:23958496 NCBI chr19:23,176,265...23,178,049
Ensembl chr19:40,073,541...40,085,218
JBrowse link
G Kifap3 kinesin-associated protein 3 decreases expression EXP Tacrolimus results in decreased expression of KIFAP3 mRNA CTD PMID:21865292 NCBI chr13:76,127,702...76,264,654
Ensembl chr13:78,660,871...78,797,820
JBrowse link
G Kifc1 kinesin family member C1 decreases expression EXP Tacrolimus results in decreased expression of KIFC1 mRNA CTD PMID:21865292 NCBI chr20:5,000,929...5,018,967
Ensembl chr20:5,000,648...5,018,988
JBrowse link
G Klf5 KLF transcription factor 5 increases expression EXP Tacrolimus results in increased expression of KLF5 mRNA CTD PMID:21865292 NCBI chr15:76,060,320...76,079,445
Ensembl chr15:82,472,065...82,487,262
JBrowse link
G Klf6 KLF transcription factor 6 increases expression EXP Tacrolimus results in increased expression of KLF6 mRNA CTD PMID:21865292 NCBI chr17:64,539,456...64,548,451
Ensembl chr17:69,441,493...69,498,601
JBrowse link
G Klk1c10 kallikrein 1-related peptidase C10 increases expression EXP Tacrolimus results in increased expression of KLK1C10 mRNA CTD PMID:21865292 NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:103,539,527...103,543,586
JBrowse link
G Klk1c9 kallikrein 1-related peptidase C9 increases expression EXP Tacrolimus results in increased expression of KLK1C9 mRNA CTD PMID:21865292 NCBI chr 1:94,597,359...94,601,245
Ensembl chr 1:103,727,746...103,737,756
JBrowse link
G Kras KRAS proto-oncogene, GTPase increases expression ISO Tacrolimus results in increased expression of KRAS mRNA CTD PMID:25270620 NCBI chr 4:179,916,255...179,949,613
Ensembl chr 4:179,919,802...179,949,320
JBrowse link
G Krt20 keratin 20 increases expression ISO Tacrolimus results in increased expression of KRT20 mRNA CTD PMID:29362864 NCBI chr10:84,384,790...84,394,125
Ensembl chr10:84,880,952...84,890,285
JBrowse link
G Lamc2 laminin subunit gamma 2 increases expression EXP Tacrolimus results in increased expression of LAMC2 mRNA CTD PMID:21865292 NCBI chr13:65,284,664...65,344,164
Ensembl chr13:67,835,199...67,895,102
JBrowse link
G Lbp lipopolysaccharide binding protein increases expression EXP Tacrolimus results in increased expression of LBP mRNA CTD PMID:21865292 NCBI chr 3:146,953,889...146,981,032
Ensembl chr 3:167,373,924...167,401,518
JBrowse link
G Lcn2 lipocalin 2 increases expression EXP
ISO
Tacrolimus results in increased expression of LCN2 mRNA CTD PMID:21865292 PMID:29362864 NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:36,078,436...36,081,842
JBrowse link
G Lias lipoic acid synthetase decreases expression ISO Tacrolimus results in decreased expression of LIAS mRNA CTD PMID:21621594 NCBI chr14:43,230,369...43,247,469
Ensembl chr14:43,230,375...43,247,423
JBrowse link
G Lif LIF, interleukin 6 family cytokine increases expression ISO Tacrolimus results in increased expression of LIF mRNA CTD PMID:23958496 NCBI chr14:83,354,602...83,364,053
Ensembl chr14:83,358,164...83,364,053
JBrowse link
G Limk1 LIM domain kinase 1 increases expression ISO Tacrolimus results in increased expression of LIMK1 mRNA CTD PMID:29380240 NCBI chr12:22,026,697...22,060,605
Ensembl chr12:27,663,018...27,697,209
JBrowse link
G Llgl1 LLGL scribble cell polarity complex component 1 increases expression ISO Tacrolimus results in increased expression of LLGL1 mRNA CTD PMID:29380240 NCBI chr10:45,379,423...45,394,096
Ensembl chr10:45,879,012...45,893,603
JBrowse link
G Lta lymphotoxin alpha multiple interactions ISO Tacrolimus inhibits the reaction [enterotoxin A, Staphylococcal results in increased expression of LTA protein] CTD PMID:1371491 NCBI chr20:3,618,853...3,621,324
Ensembl chr20:3,623,527...3,625,533
JBrowse link
G Ltf lactotransferrin increases expression ISO Tacrolimus results in increased expression of LTF mRNA CTD PMID:21621594 NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:119,878,344...119,901,189
JBrowse link
G Ly86 lymphocyte antigen 86 increases expression ISO Tacrolimus results in increased expression of LY86 mRNA CTD PMID:29362864 NCBI chr17:27,415,807...27,499,695
Ensembl chr17:27,621,313...27,692,743
JBrowse link
G Lyve1 lymphatic vessel endothelial hyaluronan receptor 1 decreases expression ISO Tacrolimus results in decreased expression of LYVE1 mRNA CTD PMID:25270620 NCBI chr 1:164,962,872...164,976,309 JBrowse link
G Maff MAF bZIP transcription factor F increases expression ISO Tacrolimus results in increased expression of MAFF mRNA CTD PMID:23958496 NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:112,791,416...112,804,147
JBrowse link
G Mafk MAF bZIP transcription factor K increases expression ISO Tacrolimus results in increased expression of MAFK mRNA CTD PMID:23958496 NCBI chr12:14,834,628...14,856,414
Ensembl chr12:19,948,476...19,959,192
JBrowse link
G Manf mesencephalic astrocyte-derived neurotrophic factor increases expression ISO Tacrolimus results in increased expression of MANF mRNA CTD PMID:25270620 NCBI chr 8:107,500,856...107,551,595
Ensembl chr 8:116,427,048...116,429,910
JBrowse link
G Map3k7 mitogen activated protein kinase kinase kinase 7 increases phosphorylation ISO Tacrolimus results in increased phosphorylation of MAP3K7 protein CTD PMID:23958496 NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:51,154,352...51,212,012
JBrowse link
G Mapk8 mitogen-activated protein kinase 8 decreases activity
multiple interactions
EXP Tacrolimus results in decreased activity of MAPK8 protein
Tacrolimus inhibits the reaction [Oxygen deficiency results in increased activity of MAPK8 protein]
CTD PMID:12892836 NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
JBrowse link
G Mbnl2 muscleblind-like splicing regulator 2 decreases expression ISO Tacrolimus results in decreased expression of MBNL2 mRNA CTD PMID:25270620 NCBI chr15:97,385,278...97,542,924
Ensembl chr15:103,792,152...103,949,827
JBrowse link
G Mcam melanoma cell adhesion molecule decreases expression ISO Tacrolimus results in decreased expression of MCAM mRNA CTD PMID:25270620 NCBI chr 8:53,376,225...53,384,407
Ensembl chr 8:53,376,197...53,384,406
JBrowse link
G Mcrs1 microspherule protein 1 decreases expression ISO Tacrolimus results in decreased expression of MCRS1 mRNA CTD PMID:25270620 NCBI chr 7:130,383,853...130,392,667
Ensembl chr 7:132,262,722...132,271,533
JBrowse link
G Mettl1 methyltransferase 1, tRNA methylguanosine increases expression ISO Tacrolimus results in increased expression of METTL1 mRNA CTD PMID:25270620 NCBI chr 7:62,864,860...62,869,202
Ensembl chr 7:64,750,198...64,754,639
JBrowse link
G Mfsd1 major facilitator superfamily domain containing 1 increases expression ISO Tacrolimus results in increased expression of MFSD1 mRNA CTD PMID:25270620 NCBI chr 2:151,846,130...151,866,168
Ensembl chr 2:154,156,166...154,177,086
JBrowse link
G Mgll monoglyceride lipase decreases expression ISO Tacrolimus results in decreased expression of MGLL mRNA CTD PMID:25270620 NCBI chr 4:121,192,186...121,294,187
Ensembl chr 4:122,749,436...122,851,440
JBrowse link
G Mir146a microRNA 146a increases expression ISO Tacrolimus results in increased expression of MIR146 mRNA CTD PMID:29362864 NCBI chr10:27,848,516...27,848,610 JBrowse link
G Mir146b microRNA 146b increases expression ISO Tacrolimus results in increased expression of MIR146B mRNA CTD PMID:29362864 NCBI chr 1:245,203,438...245,203,525
Ensembl chr 1:255,144,860...255,144,947
JBrowse link
G Mir193a microRNA 193a decreases expression ISO Tacrolimus results in decreased expression of MIR193A mRNA CTD PMID:29362864 NCBI chr10:64,672,343...64,672,454 JBrowse link
G Mir200b microRNA 200b decreases expression ISO Tacrolimus results in decreased expression of MIR200B mRNA CTD PMID:29362864 NCBI chr 5:166,649,272...166,649,366 JBrowse link
G Mir21 microRNA 21 increases expression ISO Tacrolimus results in increased expression of MIR21A mRNA CTD PMID:29362864 NCBI chr10:71,405,257...71,405,348 JBrowse link
G Mir214 microRNA 214 increases expression ISO Tacrolimus results in increased expression of MIR214 mRNA CTD PMID:29362864 NCBI chr13:74,588,374...74,588,481
Ensembl chr13:77,121,643...77,121,752
JBrowse link
G Mir34b microRNA 34b increases expression ISO Tacrolimus results in increased expression of MIR34B mRNA CTD PMID:29362864 NCBI chr 8:51,410,244...51,410,327 JBrowse link
G Mir551b microRNA 551b decreases expression ISO Tacrolimus results in decreased expression of MIR551B mRNA CTD PMID:29362864 NCBI chr 2:113,989,203...113,989,300 JBrowse link
G Mob4 MOB family member 4, phocein increases expression ISO Tacrolimus results in increased expression of MOB4 mRNA CTD PMID:25270620 NCBI chr 9:56,617,374...56,641,336
Ensembl chr 9:64,111,718...64,135,779
JBrowse link
G Mpo myeloperoxidase multiple interactions
decreases expression
EXP Tacrolimus inhibits the reaction [Indomethacin results in increased activity of MPO protein]
Tacrolimus results in decreased expression of MPO protein
CTD PMID:9655420 PMID:17202747 NCBI chr10:72,594,883...72,608,862
Ensembl chr10:73,092,400...73,102,056
JBrowse link
G Mrm3 mitochondrial rRNA methyltransferase 3 decreases expression ISO Tacrolimus results in decreased expression of MRM3 mRNA CTD PMID:25270620 NCBI chr10:61,095,920...61,125,421
Ensembl chr10:61,593,999...61,600,865
JBrowse link
G Ms4a6a membrane spanning 4-domains A6A increases expression ISO Tacrolimus results in increased expression of MS4A6C mRNA CTD PMID:29362864 NCBI chr 1:208,401,465...208,414,831
Ensembl chr 1:217,826,261...217,850,013
JBrowse link
G Msln mesothelin increases expression ISO Tacrolimus results in increased expression of MSLN mRNA CTD PMID:29362864 NCBI chr10:15,276,489...15,285,921
Ensembl chr10:15,275,659...15,282,153
JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor increases expression EXP
ISO
Tacrolimus results in increased expression of MYC mRNA CTD PMID:21865292 PMID:23958496 NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
JBrowse link
G Naaa N-acylethanolamine acid amidase increases expression ISO Tacrolimus results in increased expression of NAAA mRNA CTD PMID:29362864 NCBI chr14:15,777,306...15,796,411
Ensembl chr14:16,061,583...16,080,702
JBrowse link
G Nckap1l NCK associated protein 1 like increases expression ISO Tacrolimus results in increased expression of NCKAP1L mRNA CTD PMID:29362864 NCBI chr 7:134,577,470...134,622,928
Ensembl chr 7:136,455,897...136,501,384
JBrowse link
G Ncr3 natural cytotoxicity triggering receptor 3 increases expression ISO Tacrolimus results in increased expression of NCR3 CTD PMID:20736080 NCBI chr20:3,637,242...3,643,748
Ensembl chr20:3,642,912...3,644,188
JBrowse link
G Ndrg1 N-myc downstream regulated 1 increases expression ISO Tacrolimus results in increased expression of NDRG1 mRNA CTD PMID:25270620 NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:100,573,523...100,614,913
JBrowse link
G Nfatc3 nuclear factor of activated T-cells 3 multiple interactions ISO Tacrolimus inhibits the reaction [bisphenol A promotes the reaction [NFATC3 protein binds to IL4 promoter]]; Tacrolimus inhibits the reaction [nonylphenol promotes the reaction [NFATC3 protein binds to IL4 promoter]]; Tacrolimus inhibits the reaction [Thapsigargin affects the localization of and results in increased activity of NFATC3 protein] CTD PMID:10339586 PMID:12709020 NCBI chr19:33,960,643...34,035,150
Ensembl chr19:50,870,489...50,944,992
JBrowse link
G Nfatc4 nuclear factor of activated T-cells 4 multiple interactions ISO
EXP
Tacrolimus inhibits the reaction [20-hydroxy-5,8,11,14-eicosatetraenoic acid results in increased localization of NFATC4 protein]; Tacrolimus inhibits the reaction [Phenylephrine results in increased localization of NFATC4 protein] CTD PMID:16055480 NCBI chr15:29,286,998...29,314,610
Ensembl chr15:33,274,153...33,285,582
JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 increases expression ISO Tacrolimus results in increased expression of NFE2L2 protein CTD PMID:23958496 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
JBrowse link
G Nfkb1 nuclear factor kappa B subunit 1 multiple interactions
increases expression
ISO Tacrolimus inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of NFKB1 protein]
Tacrolimus results in increased expression of NFKB1 mRNA
CTD PMID:18172213 PMID:18172886 PMID:23958496 NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:226,689,745...226,783,088
JBrowse link
G Nfkb2 nuclear factor kappa B subunit 2 increases expression ISO Tacrolimus results in increased expression of NFKB2 mRNA CTD PMID:23958496 NCBI chr 1:245,164,586...245,173,225
Ensembl chr 1:255,107,374...255,114,637
JBrowse link
G Nfkbia NFKB inhibitor alpha decreases degradation
increases phosphorylation
multiple interactions
ISO Tacrolimus results in decreased degradation of NFKBIA protein
Tacrolimus results in increased phosphorylation of NFKBIA protein
ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Tacrolimus results in increased phosphorylation of NFKBIA protein]
CTD PMID:16181452 PMID:23958496 NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:78,593,847...78,597,072
JBrowse link
G Nfkbib NFKB inhibitor beta multiple interactions ISO Tacrolimus inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of NFKBIB protein] CTD PMID:18172213 PMID:18172886 NCBI chr 1:84,046,292...84,053,862
Ensembl chr 1:93,173,820...93,326,366
JBrowse link
G Nfkbie NFKB inhibitor epsilon increases expression ISO Tacrolimus results in increased expression of NFKBIE mRNA CTD PMID:23958496 NCBI chr 9:15,443,600...15,450,437
Ensembl chr 9:22,941,040...22,947,872
JBrowse link
G Ngf nerve growth factor multiple interactions EXP NGF protein inhibits the reaction [Tacrolimus results in increased activity of CASP3 protein]; Tacrolimus inhibits the reaction [NGF protein results in increased expression of SERPINE1 mRNA]; Tacrolimus inhibits the reaction [NGF protein results in increased expression of SERPINE1 protein] CTD PMID:17385075 PMID:23825664 NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:192,589,582...192,643,834
JBrowse link
G Nol8 nucleolar protein 8 increases expression ISO Tacrolimus results in increased expression of NOL8 mRNA CTD PMID:25270620 NCBI chr17:14,990,394...15,013,784
Ensembl chr17:15,196,881...15,220,202
JBrowse link
G Nos1 nitric oxide synthase 1 multiple interactions EXP Tacrolimus inhibits the reaction [[Lithium co-treated with Pilocarpine] results in increased expression of NOS1 protein] CTD PMID:20149694 NCBI chr12:38,615,111...38,795,492
Ensembl chr12:44,287,614...44,371,837
JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO
EXP
Tacrolimus inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]
Tacrolimus inhibits the reaction [[Lithium co-treated with Pilocarpine] results in increased expression of NOS2 protein]; Tacrolimus inhibits the reaction [Indomethacin results in increased expression of NOS2 mRNA]
Tacrolimus inhibits the reaction [[Lipopolysaccharides results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]; Tacrolimus inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]
CTD PMID:12144947 PMID:17202747 PMID:20149694 PMID:27246103 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
JBrowse link
G Nos3 nitric oxide synthase 3 increases expression
decreases expression
decreases activity
ISO
EXP
Tacrolimus results in increased expression of NOS3 mRNA
Tacrolimus results in decreased expression of NOS3 mRNA
Tacrolimus results in decreased activity of NOS3 protein
CTD PMID:9931093 PMID:12352326 NCBI chr 4:11,686,088...11,706,604
Ensembl chr 4:11,686,268...11,706,664
JBrowse link
G Nox1 NADPH oxidase 1 increases expression EXP Tacrolimus results in increased expression of NOX1 mRNA CTD PMID:17085464 NCBI chr  X:97,279,058...97,332,291
Ensembl chr  X:101,572,340...101,595,520
JBrowse link
G Nppa natriuretic peptide A multiple interactions ISO Tacrolimus inhibits the reaction [NPR1 protein affects the expression of NPPA mRNA] CTD PMID:15939815 NCBI chr 5:158,429,042...158,430,351
Ensembl chr 5:163,712,184...163,713,493
JBrowse link
G Nppb natriuretic peptide B multiple interactions ISO Tacrolimus inhibits the reaction [NPR1 protein affects the expression of NPPB mRNA] CTD PMID:15939815 NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:163,699,839...163,701,310
JBrowse link
G Npr1 natriuretic peptide receptor 1 multiple interactions ISO Tacrolimus inhibits the reaction [NPR1 protein affects the expression of FN1 mRNA]; Tacrolimus inhibits the reaction [NPR1 protein affects the expression of NPPA mRNA]; Tacrolimus inhibits the reaction [NPR1 protein affects the expression of NPPB mRNA] CTD PMID:15939815 NCBI chr 2:175,934,181...175,950,118
Ensembl chr 2:178,231,766...178,247,088
JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions
increases activity
ISO Tacrolimus inhibits the reaction [NR3C1 protein binds to FKBP5 protein]; Tacrolimus promotes the reaction [Dexamethasone binds to NR3C1 protein]; Tacrolimus promotes the reaction [NR3C1 protein binds to PPP5C protein]
Tacrolimus results in increased activity of NR3C1 protein
CTD PMID:15697228 NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,522,783...31,643,843
JBrowse link
G Ogn osteoglycin increases expression EXP
ISO
Tacrolimus results in increased expression of OGN mRNA CTD PMID:21865292 PMID:29362864 NCBI chr17:15,032,069...15,052,626
Ensembl chr17:15,238,500...15,259,252
JBrowse link
G Olfml3 olfactomedin-like 3 increases expression ISO Tacrolimus results in increased expression of OLFML3 mRNA CTD PMID:29362864 NCBI chr 2:191,244,221...191,247,050
Ensembl chr 2:193,932,665...193,935,494
JBrowse link
G Panx1 Pannexin 1 increases expression ISO Tacrolimus results in increased expression of PANX1 mRNA CTD PMID:29362864 NCBI chr 8:11,851,176...11,889,774
Ensembl chr 8:20,132,165...20,171,200
JBrowse link
G Pbk PDZ binding kinase increases expression ISO Tacrolimus results in increased expression of PBK mRNA CTD PMID:29362864 NCBI chr15:40,022,873...40,034,014
Ensembl chr15:44,198,544...44,209,570
JBrowse link
G Pcbp4 poly(rC) binding protein 4 decreases expression ISO Tacrolimus results in decreased expression of PCBP4 mRNA CTD PMID:25270620 NCBI chr 8:107,092,688...107,103,276
Ensembl chr 8:115,971,326...115,981,982
JBrowse link
G Pcna proliferating cell nuclear antigen multiple interactions ISO Tacrolimus affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCNA protein]; Tacrolimus affects the reaction [Tacrolimus affects the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Tetradecanoylphorbol Acetate] affects the expression of PCNA protein]] CTD PMID:25770929 NCBI chr 3:139,951,948...139,955,820
Ensembl chr 3:139,951,941...139,955,901
JBrowse link
G Pcolce procollagen C-endopeptidase enhancer decreases expression ISO Tacrolimus results in decreased expression of PCOLCE mRNA CTD PMID:25270620 NCBI chr12:19,084,191...19,090,508
Ensembl chr12:24,720,936...24,727,287
JBrowse link
G Pdcd2 programmed cell death 2 increases expression ISO Tacrolimus results in increased expression of PDCD2 mRNA CTD PMID:25270620 NCBI chr 1:56,484,947...56,490,437
Ensembl chr 1:65,158,034...65,163,524
JBrowse link
G Pdgfra platelet derived growth factor receptor alpha increases expression ISO Tacrolimus results in increased expression of PDGFRA mRNA CTD PMID:29362864 NCBI chr14:33,360,027...33,408,604
Ensembl chr14:33,360,028...33,408,516
JBrowse link
G Pdia4 protein disulfide isomerase family A, member 4 increases expression ISO Tacrolimus results in increased expression of PDIA4 mRNA CTD PMID:25270620 NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:78,134,144...78,153,191
JBrowse link
G Pdia6 protein disulfide isomerase family A, member 6 increases expression ISO Tacrolimus results in increased expression of PDIA6 mRNA CTD PMID:25270620 NCBI chr 6:40,062,980...40,080,223
Ensembl chr 6:45,791,678...45,810,091
JBrowse link
G Phlda1 pleckstrin homology-like domain, family A, member 1 increases expression ISO Tacrolimus results in increased expression of PHLDA1 mRNA CTD PMID:23958496 NCBI chr 7:46,967,433...46,969,637
Ensembl chr 7:48,853,260...48,857,542
JBrowse link
G Pid1 phosphotyrosine interaction domain containing 1 increases expression ISO Tacrolimus results in increased expression of PID1 mRNA CTD PMID:29362864 NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:92,734,214...92,750,070
JBrowse link
G Pink1 PTEN induced kinase 1 multiple interactions ISO PINK1 protein affects the reaction [Tacrolimus results in increased phosphorylation of DNM1L protein] CTD PMID:19492085 NCBI chr 5:150,530,523...150,542,635
Ensembl chr 5:155,813,838...155,825,950
JBrowse link
G Pkmyt1 protein kinase, membrane associated tyrosine/threonine 1 increases expression ISO Tacrolimus results in increased expression of PKMYT1 mRNA CTD PMID:29362864 NCBI chr10:13,252,805...13,263,584
Ensembl chr10:13,252,816...13,264,263
JBrowse link
G Pkp4 plakophilin 4 decreases expression EXP Tacrolimus results in decreased expression of PKP4 mRNA CTD PMID:21865292 NCBI chr 3:43,632,364...43,835,834
Ensembl chr 3:64,141,771...64,244,586
JBrowse link
G Pla2g12a phospholipase A2, group XIIA increases expression ISO Tacrolimus results in increased expression of PLA2G12A mRNA CTD PMID:25270620 NCBI chr 2:218,436,497...218,452,742
Ensembl chr 2:221,110,685...221,126,964
JBrowse link
G Plat plasminogen activator, tissue type decreases expression ISO Tacrolimus results in decreased expression of PLAT mRNA CTD PMID:25270620 NCBI chr16:75,943,061...76,022,037
Ensembl chr16:75,943,064...75,967,696
JBrowse link
G Plbd2 phospholipase B domain containing 2 decreases expression ISO Tacrolimus results in decreased expression of PLBD2 mRNA CTD PMID:25270620 NCBI chr12:36,062,802...36,081,984
Ensembl chr12:41,723,360...41,744,454
JBrowse link
G Por cytochrome p450 oxidoreductase affects response to substance ISO POR polymorphism affects the susceptibility to Tacrolimus CTD PMID:24113216 NCBI chr12:20,951,058...20,999,198
Ensembl chr12:26,587,674...26,635,809
JBrowse link
G Ppara peroxisome proliferator activated receptor alpha affects response to substance ISO PPARA polymorphism affects the susceptibility to Tacrolimus CTD PMID:24113216 NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:118,712,412...118,780,714
JBrowse link
G Pparg peroxisome proliferator-activated receptor gamma multiple interactions ISO [Sirolimus co-treated with Tacrolimus] results in increased expression of PPARG protein CTD PMID:17016853 NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:150,095,787...150,221,104
JBrowse link
G Ppl periplakin increases expression EXP Tacrolimus results in increased expression of PPL mRNA CTD PMID:21865292 NCBI chr10:10,450,919...10,496,575
Ensembl chr10:10,957,341...11,003,658
JBrowse link
G Ppp1r15a protein phosphatase 1, regulatory subunit 15A increases expression ISO Tacrolimus results in increased expression of PPP1R15A mRNA CTD PMID:23958496 NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:105,136,525...105,139,774
JBrowse link
G Ppp3ca protein phosphatase 3 catalytic subunit alpha multiple interactions
decreases activity
ISO [Tacrolimus results in decreased activity of PPP3CA protein] which results in decreased susceptibility to Thapsigargin CTD PMID:10898953 PMID:19553475 NCBI chr 2:225,165,981...225,440,978
Ensembl chr 2:227,839,062...228,113,554
JBrowse link
G Ppp5c protein phosphatase 5, catalytic subunit multiple interactions ISO Tacrolimus promotes the reaction [NR3C1 protein binds to PPP5C protein] CTD PMID:15697228 NCBI chr 1:77,690,203...77,714,507
Ensembl chr 1:86,818,297...86,842,950
JBrowse link
G Prcp prolylcarboxypeptidase increases expression EXP Tacrolimus results in increased expression of PRCP mRNA CTD PMID:21865292 NCBI chr 1:146,931,487...146,983,891
Ensembl chr 1:156,343,896...156,396,939
JBrowse link
G Prlr prolactin receptor decreases expression EXP Tacrolimus results in decreased expression of PRLR mRNA CTD PMID:21865292 NCBI chr 2:59,134,147...59,324,719
Ensembl chr 2:60,861,658...61,051,882
JBrowse link
G Psmb10 proteasome 20S subunit beta 10 increases expression ISO Tacrolimus results in increased expression of PSMB10 mRNA CTD PMID:29362864 NCBI chr19:33,830,958...33,833,442
Ensembl chr19:50,740,811...50,743,210
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression
ISO Tacrolimus inhibits the reaction [bisperoxovanadium results in increased expression of PTGS2 mRNA]
Tacrolimus results in increased expression of PTGS2 mRNA
CTD PMID:12493747 PMID:23958496 NCBI chr13:64,714,063...64,722,320
Ensembl chr13:64,713,619...64,722,320
JBrowse link
G Ptpn5 protein tyrosine phosphatase, non-receptor type 5 decreases activity ISO Tacrolimus results in decreased activity of PTPN5 protein CTD PMID:17360923 NCBI chr 1:97,620,638...97,681,186
Ensembl chr 1:106,756,896...106,816,828
JBrowse link
G Ptprz1 protein tyrosine phosphatase, receptor type Z1 increases expression EXP Tacrolimus results in increased expression of PTPRZ1 mRNA CTD PMID:21865292 NCBI chr 4:51,397,316...51,595,220
Ensembl chr 4:52,363,295...52,560,903
JBrowse link
G Rab4a RAB4A, member RAS oncogene family increases expression ISO Tacrolimus results in increased expression of RAB4A mRNA CTD PMID:29380240 NCBI chr19:51,795,613...51,822,706
Ensembl chr19:68,692,890...68,720,166
JBrowse link
G Rac1 Rac family small GTPase 1 increases expression EXP Tacrolimus results in increased expression of RAC1 mRNA CTD PMID:17085464 NCBI chr12:11,037,028...11,057,251
Ensembl chr12:16,128,649...16,172,109
JBrowse link
G Ramp1 receptor activity modifying protein 1 increases expression ISO Tacrolimus results in increased expression of RAMP1 mRNA CTD PMID:29362864 NCBI chr 9:91,765,481...91,816,152 JBrowse link
G Rcc1 regulator of chromosome condensation 1 decreases expression ISO Tacrolimus results in decreased expression of RCC1 mRNA CTD PMID:25270620 NCBI chr 5:144,526,025...144,544,445
Ensembl chr 5:149,810,689...149,828,523
JBrowse link
G Rcor2 REST corepressor 2 decreases expression ISO Tacrolimus results in decreased expression of RCOR2 mRNA CTD PMID:25270620 NCBI chr 1:204,453,403...204,461,403
Ensembl chr 1:213,878,519...213,890,022
JBrowse link
G Rel REL proto-oncogene, NF-kB subunit multiple interactions ISO Tacrolimus inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of REL protein] CTD PMID:18172213 NCBI chr14:97,690,105...97,721,194
Ensembl chr14:101,891,243...101,921,938
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions ISO [Tacrolimus co-treated with Thapsigargin] affects the localization of and results in increased activity of RELA protein; Tacrolimus affects the localization of and results in increased activity of RELA protein; Tacrolimus inhibits the reaction [Tetrachlorodibenzodioxin affects the localization of RELA protein]; Tacrolimus results in increased phosphorylation of and affects the localization of RELA protein CTD PMID:10339586 PMID:18172886 PMID:23958496 NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
JBrowse link
G Relb RELB proto-oncogene, NF-kB subunit increases expression ISO Tacrolimus results in increased expression of RELB mRNA CTD PMID:23958496 NCBI chr 1:79,257,738...79,285,490
Ensembl chr 1:88,385,717...88,413,420
JBrowse link
G Ren renin multiple interactions
increases expression
decreases activity
EXP nilvadipine inhibits the reaction [Tacrolimus results in increased expression of REN protein]
Tacrolimus results in increased expression of REN mRNA; Tacrolimus results in increased expression of REN protein
Tacrolimus results in decreased activity of REN protein
CTD PMID:7509514 PMID:7532090 PMID:7533848 PMID:12469222 PMID:21865292 NCBI chr13:44,796,260...44,807,491
Ensembl chr13:47,348,143...47,359,543
JBrowse link
G Renbp renin binding protein increases expression ISO Tacrolimus results in increased expression of RENBP mRNA CTD PMID:25270620 NCBI chr  X:151,661,463...151,670,538
Ensembl chr  X:156,812,411...156,821,838
JBrowse link
G Rgn regucalcin decreases expression EXP Tacrolimus results in decreased expression of RGN mRNA CTD PMID:21865292 NCBI chr  X:1,619,030...1,634,456
Ensembl chr  X:4,172,537...4,190,251
JBrowse link
G Rgs16 regulator of G-protein signaling 16 increases expression ISO Tacrolimus results in increased expression of RGS16 mRNA CTD PMID:29362864 NCBI chr13:65,887,668...65,892,862
Ensembl chr13:68,438,120...68,443,313
JBrowse link
G Rhebl1 RHEB like 1 increases expression ISO Tacrolimus results in increased expression of RHEBL1 mRNA CTD PMID:23958496 NCBI chr 7:130,026,255...130,031,127
Ensembl chr 7:131,905,207...131,909,199
JBrowse link
G Rhou ras homolog family member U increases expression ISO Tacrolimus results in increased expression of RHOU mRNA CTD PMID:29362864 NCBI chr19:51,641,476...51,651,249
Ensembl chr19:68,538,960...68,548,733
JBrowse link
G Rnase2 ribonuclease A family member 2 increases expression ISO Tacrolimus results in increased expression of RNASE2A mRNA CTD PMID:29362864 NCBI chr15:24,449,618...24,450,427
Ensembl chr15:26,923,134...26,923,955
JBrowse link
G Rnase3 ribonuclease A family member 3 increases expression ISO Tacrolimus results in increased expression of EAR1 mRNA CTD PMID:29362864 NCBI chr15:24,511,894...24,512,764
Ensembl chr15:26,985,271...26,986,400
JBrowse link
G Rpn1 ribophorin I increases expression ISO Tacrolimus results in increased expression of RPN1 mRNA CTD PMID:25270620 NCBI chr 4:120,543,667...120,565,069
Ensembl chr 4:122,100,813...122,122,382
JBrowse link
G Rps6 ribosomal protein S6 multiple interactions ISO Tacrolimus inhibits the reaction [Sirolimus inhibits the reaction [IL2 protein results in increased phosphorylation of RPS6 protein]] CTD PMID:1614535 NCBI chr 5:101,371,716...101,374,576
Ensembl chr 5:106,417,680...106,420,566
JBrowse link
G Rrp9 ribosomal RNA processing 9, U3 small nucleolar RNA binding protein decreases expression ISO Tacrolimus results in decreased expression of RRP9 mRNA CTD PMID:25270620 NCBI chr 8:107,116,411...107,126,123
Ensembl chr 8:115,996,169...116,004,824
JBrowse link
G Runx2 RUNX family transcription factor 2 decreases expression EXP Tacrolimus results in decreased expression of RUNX2 mRNA CTD PMID:15780950 NCBI chr 9:16,167,504...16,492,826
Ensembl chr 9:23,664,952...23,990,027
JBrowse link
G Ryr1 ryanodine receptor 1 multiple interactions ISO Tacrolimus inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of RYR1 protein] CTD PMID:18172213 PMID:18172886 NCBI chr 1:84,292,578...84,423,824
Ensembl chr 1:93,420,078...93,551,305
JBrowse link
G S100a6 S100 calcium binding protein A6 increases expression ISO Tacrolimus results in increased expression of S100A6 mRNA CTD PMID:29362864 NCBI chr 2:176,100,619...176,102,181
Ensembl chr 2:178,398,481...178,399,762
JBrowse link
G Sct secretin increases expression ISO Tacrolimus results in increased expression of SCT mRNA CTD PMID:29362864 NCBI chr 1:196,382,857...196,383,668
Ensembl chr 1:205,812,435...205,813,246
JBrowse link
G Sdf2l1 stromal cell-derived factor 2-like 1 increases expression ISO Tacrolimus results in increased expression of SDF2L1 mRNA CTD PMID:25270620 NCBI chr11:83,872,659...83,874,902
Ensembl chr11:97,376,878...97,379,120
JBrowse link
G Seh1l SEH1-like nucleoporin increases expression ISO Tacrolimus results in increased expression of SEH1L mRNA CTD PMID:25270620 NCBI chr18:61,346,986...61,369,987
Ensembl chr18:63,616,768...63,639,840
JBrowse link
G Sele selectin E increases expression EXP Tacrolimus results in increased expression of SELE mRNA CTD PMID:21865292 NCBI chr13:76,402,841...76,412,741
Ensembl chr13:78,936,036...78,945,903
JBrowse link
G Selenos selenoprotein S increases expression ISO Tacrolimus results in increased expression of SELENOS mRNA CTD PMID:25270620 NCBI chr 1:119,659,779...119,669,546
Ensembl chr 1:129,070,230...129,077,991
JBrowse link
G Serinc3 serine incorporator 3 decreases expression ISO Tacrolimus results in decreased expression of SERINC3 mRNA CTD PMID:21621594 NCBI chr 3:152,301,882...152,321,327
Ensembl chr 3:172,721,321...172,740,765
JBrowse link
G Serp1 stress-associated endoplasmic reticulum protein 1 increases expression ISO Tacrolimus results in increased expression of SERP1 mRNA CTD PMID:25270620 NCBI chr 2:142,757,254...142,761,243
Ensembl chr 2:144,907,205...144,911,187
JBrowse link
G Serpina3n serpin family A member 3N increases expression EXP Tacrolimus results in increased expression of SERPINA3N mRNA CTD PMID:21865292 NCBI chr 6:123,323,623...123,331,181
Ensembl chr 6:129,088,398...129,097,415
JBrowse link
G Serpinb9 serpin family B member 9 increases expression ISO Tacrolimus results in increased expression of SERPINB9 mRNA CTD PMID:23958496 NCBI chr17:31,420,118...31,443,237
Ensembl chr17:31,629,392...31,651,974
JBrowse link
G Serpine1 serpin family E member 1 increases expression
multiple interactions
EXP Tacrolimus results in increased expression of SERPINE1 mRNA
Tacrolimus inhibits the reaction [Mercuric Chloride results in increased expression of SERPINE1 protein]; Tacrolimus inhibits the reaction [NGF protein results in increased expression of SERPINE1 mRNA]; Tacrolimus inhibits the reaction [NGF protein results in increased expression of SERPINE1 protein]
CTD PMID:9422427 PMID:14620542 PMID:21865292 PMID:23825664 NCBI chr12:25,237,977...25,248,356
Ensembl chr12:25,237,952...25,248,357
JBrowse link
G Sgo1 shugoshin 1 increases expression ISO Tacrolimus results in increased expression of SGO1 mRNA CTD PMID:29362864 NCBI chr 9:6,672,109...6,687,908
Ensembl chr 9:6,908,661...6,924,415
JBrowse link
G Shf Src homology 2 domain containing F decreases expression ISO Tacrolimus results in decreased expression of SHF mRNA CTD PMID:25270620 NCBI chr 3:109,296,517...109,316,315
Ensembl chr 3:129,749,584...129,769,929
JBrowse link
G Sla src-like adaptor increases expression ISO Tacrolimus results in increased expression of SLA mRNA CTD PMID:29362864 NCBI chr 7:98,534,431...98,584,810
Ensembl chr 7:100,424,169...100,473,684
JBrowse link
G Slc12a3 solute carrier family 12 member 3 affects response to substance
decreases expression
increases phosphorylation
ISO
EXP
SLC12A3 protein affects the susceptibility to Tacrolimus
Tacrolimus results in decreased expression of SLC12A3 mRNA; Tacrolimus results in decreased expression of SLC12A3 protein
Tacrolimus results in increased phosphorylation of SLC12A3 protein
CTD PMID:21865292 PMID:21963515 NCBI chr19:10,630,651...10,679,250
Ensembl chr19:10,636,596...10,675,050
JBrowse link
G Slc16a1 solute carrier family 16 member 1 decreases expression EXP Tacrolimus results in decreased expression of SLC16A1 mRNA CTD PMID:21865292 NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:194,812,502...194,832,977
JBrowse link
G Slc22a13 solute carrier family 22 member 13 decreases expression EXP Tacrolimus results in decreased expression of SLC22A13 mRNA CTD PMID:21865292 NCBI chr 8:118,922,367...118,934,020
Ensembl chr 8:127,800,097...127,811,724
JBrowse link
G Slc25a25 solute carrier family 25 member 25 decreases expression EXP Tacrolimus results in decreased expression of SLC25A25 mRNA CTD PMID:21865292 NCBI chr 3:15,708,702...15,742,195
Ensembl chr 3:36,106,449...36,140,011
JBrowse link
G Slc34a2 solute carrier family 34 member 2 increases expression EXP Tacrolimus results in increased expression of SLC34A2 mRNA CTD PMID:21865292 NCBI chr14:57,910,931...57,930,236
Ensembl chr14:62,123,316...62,143,360
JBrowse link
G Slco1a1 solute carrier organic anion transporter family, member 1a1 decreases expression EXP Tacrolimus results in decreased expression of SLCO1A1 mRNA CTD PMID:21865292 NCBI chr 4:174,877,045...174,950,900
Ensembl chr 4:176,607,687...176,681,992
JBrowse link
G Smad3 SMAD family member 3 multiple interactions EXP Tacrolimus inhibits the reaction [Paraquat results in increased expression of and results in increased secretion of SMAD3 protein]; Tacrolimus inhibits the reaction [Paraquat results in increased expression of SMAD3 mRNA] CTD PMID:33000210 NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:73,024,760...73,132,324
JBrowse link
G Smad7 SMAD family member 7 multiple interactions ISO
EXP
Tacrolimus inhibits the reaction [FKBP1A protein promotes the reaction [SMURF1 protein binds to SMAD7 protein binds to ACVR1B protein]]; Tacrolimus inhibits the reaction [SMAD7 protein binds to SMURF1 protein]
Tacrolimus promotes the reaction [Paraquat results in increased expression of and results in increased secretion of SMAD7 protein]; Tacrolimus promotes the reaction [Paraquat results in increased expression of SMAD7 mRNA]
CTD PMID:16720724 PMID:33000210 NCBI chr18:68,988,429...69,016,774
Ensembl chr18:71,263,508...71,291,849
JBrowse link
G Smim14 small integral membrane protein 14 increases expression ISO Tacrolimus results in increased expression of SMIM14 mRNA CTD PMID:25270620 NCBI chr14:42,783,361...42,829,762
Ensembl chr14:43,136,867...43,183,416
JBrowse link
G Smurf1 SMAD specific E3 ubiquitin protein ligase 1 multiple interactions ISO Tacrolimus inhibits the reaction [FKBP1A protein promotes the reaction [SMURF1 protein binds to SMAD7 protein binds to ACVR1B protein]]; Tacrolimus inhibits the reaction [SMAD7 protein binds to SMURF1 protein] CTD PMID:16720724 NCBI chr12:9,635,009...9,726,520
Ensembl chr12:14,749,043...14,840,273
JBrowse link
G Snai1 snail family transcriptional repressor 1 increases expression
multiple interactions
ISO Tacrolimus results in increased expression of SNAI1 protein
[GSK3A protein co-treated with GSK3B protein] affects the reaction [Tacrolimus results in increased expression of SNAI1 protein]
CTD PMID:22416070 NCBI chr 3:156,248,479...156,252,969 JBrowse link
G Snai2 snail family transcriptional repressor 2 increases expression ISO Tacrolimus results in increased expression of SNAI2 mRNA CTD PMID:22416070 NCBI chr11:99,686,934...99,690,349
Ensembl chr11:99,686,934...99,690,349
JBrowse link
G Sod2 superoxide dismutase 2 increases response to substance
decreases expression
multiple interactions
ISO
EXP
SOD2 protein results in increased susceptibility to Tacrolimus
Tacrolimus results in decreased expression of SOD2 protein
MK0626 inhibits the reaction [Tacrolimus results in decreased expression of SOD2 protein]
CTD PMID:14675044 PMID:24959755 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
JBrowse link
G Sox9 SRY-box transcription factor 9 increases expression ISO Tacrolimus results in increased expression of SOX9 mRNA CTD PMID:29362864 NCBI chr10:98,305,744...98,311,250
Ensembl chr10:98,305,744...98,311,250
JBrowse link
G Sp7 Sp7 transcription factor decreases expression EXP Tacrolimus results in decreased expression of SP7 mRNA CTD PMID:15780950 NCBI chr 7:133,484,609...133,494,788
Ensembl chr 7:135,363,199...135,373,559
JBrowse link
G Spaca7 sperm acrosome associated 7 increases expression ISO Tacrolimus results in increased expression of SPACA7 mRNA CTD PMID:29362864 NCBI chr16:76,928,611...76,955,547
Ensembl chr16:83,630,705...83,657,665
JBrowse link
G Spcs2 signal peptidase complex subunit 2 increases expression ISO Tacrolimus results in increased expression of SPCS2 mRNA CTD PMID:25270620 NCBI chr 1:154,163,724...154,183,152
Ensembl chr 1:163,575,842...163,595,271
JBrowse link
G Sphk2 sphingosine kinase 2 decreases expression ISO Tacrolimus results in decreased expression of SPHK2 mRNA CTD PMID:25270620 NCBI chr 1:96,180,872...96,188,592
Ensembl chr 1:105,317,333...105,321,637
JBrowse link
G Spic Spi-C transcription factor increases expression ISO Tacrolimus results in increased expression of SPIC mRNA CTD PMID:29362864 NCBI chr 7:23,069,815...23,077,517
Ensembl chr 7:24,957,219...24,964,900
JBrowse link
G Spp1 secreted phosphoprotein 1 increases expression EXP Tacrolimus results in increased expression of SPP1 mRNA CTD PMID:12472797 PMID:21865292 NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,613,576...5,619,820
JBrowse link
G Sqor sulfide quinone oxidoreductase decreases expression ISO Tacrolimus results in decreased expression of SQOR mRNA CTD PMID:25270620 NCBI chr 3:109,841,225...109,886,724
Ensembl chr 3:130,292,814...130,340,799
JBrowse link
G Ssr3 signal sequence receptor subunit 3 increases expression ISO Tacrolimus results in increased expression of SSR3 mRNA CTD PMID:25270620 NCBI chr 2:149,605,005...149,625,069
Ensembl chr 2:151,906,149...151,935,170
JBrowse link
G Stard4 StAR-related lipid transfer domain containing 4 decreases expression ISO Tacrolimus results in decreased expression of STARD4 mRNA CTD PMID:25270620 NCBI chr18:24,814,683...24,830,024
Ensembl chr18:25,091,255...25,104,172
JBrowse link
G Stat3 signal transducer and activator of transcription 3 increases phosphorylation ISO Tacrolimus results in increased phosphorylation of STAT3 protein CTD PMID:23958496 NCBI chr10:86,311,528...86,363,513
Ensembl chr10:86,311,535...86,363,359
JBrowse link
G Tada3 transcriptional adaptor 3 decreases expression ISO Tacrolimus results in decreased expression of TADA3 mRNA CTD PMID:25270620 NCBI chr 4:146,510,213...146,521,975
Ensembl chr 4:148,065,877...148,077,320
JBrowse link
G Tamalin trafficking regulator and scaffold protein tamalin increases expression ISO Tacrolimus results in increased expression of TAMALIN mRNA CTD PMID:25270620 NCBI chr 7:132,338,900...132,359,519
Ensembl chr 7:134,217,065...134,225,378
JBrowse link
G Tatdn1 TatD DNase domain containing 1 increases expression ISO Tacrolimus results in increased expression of TATDN1 mRNA CTD PMID:25270620 NCBI chr 7:90,449,979...90,481,000
Ensembl chr 7:92,330,554...92,370,400
JBrowse link
G Tbc1d7 TBC1 domain family, member 7 decreases expression ISO Tacrolimus results in decreased expression of TBC1D7 mRNA CTD PMID:25270620 NCBI chr17:21,530,709...21,548,556
Ensembl chr17:21,736,913...21,755,108
JBrowse link
G Tekt1 tektin 1 increases expression EXP Tacrolimus results in increased expression of TEKT1 mRNA CTD PMID:21865292 NCBI chr10:56,952,164...56,980,572
Ensembl chr10:57,450,715...57,479,121
JBrowse link
G Tfeb transcription factor EB multiple interactions ISO [Cyclosporine co-treated with Tacrolimus] inhibits the reaction [4-(4-fluorophenyl)sulfonyl-5-methylthio-2-phenyloxazole affects the localization of TFEB protein] CTD PMID:29650965 NCBI chr 9:20,696,440...20,752,265
Ensembl chr 9:20,696,441...20,727,863
JBrowse link
G Tfrc transferrin receptor decreases expression ISO Tacrolimus results in decreased expression of TFRC protein CTD PMID:1701765 NCBI chr11:68,163,413...68,185,257
Ensembl chr11:81,668,478...81,690,318
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions
increases expression
decreases expression
ISO
EXP
Ramipril inhibits the reaction [Tacrolimus results in increased expression of TGFB1 mRNA]
Tacrolimus results in increased expression of TGFB1 mRNA; Tacrolimus results in increased expression of TGFB1 protein
Tacrolimus results in decreased expression of TGFB1 mRNA
[Tacrolimus co-treated with Quinapril] results in increased expression of TGFB1 protein; [Tacrolimus co-treated with Valsartan] results in increased expression of TGFB1 protein; pyrrolidine dithiocarbamic acid inhibits the reaction [Tacrolimus results in increased expression of TGFB1 mRNA]; Ramipril inhibits the reaction [Tacrolimus results in increased expression of TGFB1 protein]; Tacrolimus inhibits the reaction [Mercuric Chloride results in increased expression of TGFB1 protein]; Tacrolimus inhibits the reaction [Paraquat results in increased expression of and results in increased secretion of TGFB1 protein]; Tacrolimus inhibits the reaction [Paraquat results in increased expression of TGFB1 mRNA]; Valsartan inhibits the reaction [Tacrolimus results in increased expression of TGFB1 protein]
CTD PMID:9422427 PMID:11091246 PMID:12352326 PMID:12472797 PMID:14620542 More... NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:90,324,046...90,340,899
JBrowse link
G Tgfbi transforming growth factor, beta induced increases expression ISO Tacrolimus results in increased expression of TGFBI mRNA CTD PMID:29362864 NCBI chr17:7,960,885...7,990,234
Ensembl chr17:7,960,516...7,990,471
JBrowse link
G Tgfbr1 transforming growth factor, beta receptor 1 increases expression EXP Tacrolimus results in increased expression of TGFBR1 mRNA; Tacrolimus results in increased expression of TGFBR1 protein CTD PMID:16980036 NCBI chr 5:66,449,348...66,506,371
Ensembl chr 5:66,449,293...66,527,260
JBrowse link
G Tgfbr2 transforming growth factor, beta receptor 2 increases expression EXP Tacrolimus results in increased expression of TGFBR2 mRNA; Tacrolimus results in increased expression of TGFBR2 protein CTD PMID:16980036 NCBI chr 8:115,794,537...115,883,615
Ensembl chr 8:124,674,986...124,761,469
JBrowse link
G Tgm1 transglutaminase 1 increases expression EXP Tacrolimus results in increased expression of TGM1 mRNA CTD PMID:21865292 NCBI chr15:29,191,039...29,206,000
Ensembl chr15:33,160,987...33,174,463
JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 multiple interactions
decreases expression
increases expression
EXP pirfenidone promotes the reaction [Tacrolimus results in decreased expression of TIMP1 mRNA]; pyrrolidine dithiocarbamic acid inhibits the reaction [Tacrolimus results in increased expression of TIMP1 mRNA] CTD PMID:11091246 PMID:12472797 PMID:15854665 PMID:21865292 NCBI chr  X:1,212,969...1,217,714
Ensembl chr  X:3,766,510...3,771,135
JBrowse link
G Tlr2 toll-like receptor 2 increases expression ISO Tacrolimus results in increased expression of TLR2 mRNA CTD PMID:29362864 NCBI chr 2:169,200,620...169,206,819
Ensembl chr 2:171,497,060...171,520,194
JBrowse link
G Tmem202 transmembrane protein 202 decreases expression ISO Tacrolimus results in decreased expression of TMEM202 mRNA CTD PMID:25270620 NCBI chr 8:59,910,824...59,919,342
Ensembl chr 8:68,806,632...68,812,417
JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression
decreases expression
decreases secretion
ISO
EXP
Tacrolimus inhibits the reaction [[N-Formylmethionine Leucyl-Phenylalanine co-treated with TNF protein] results in increased abundance of Superoxides]; Tacrolimus inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Calcimycin] results in increased expression of TNF protein]; Tacrolimus inhibits the reaction [Dieldrin results in increased expression of TNF mRNA]; Tacrolimus inhibits the reaction [enterotoxin A, Staphylococcal results in increased expression of TNF protein]; Tacrolimus inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein]; Tacrolimus inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]
Tacrolimus results in increased expression of TNF mRNA
Tacrolimus inhibits the reaction [Indomethacin results in increased expression of TNF mRNA]
[Tacrolimus co-treated with Thapsigargin] results in increased expression of TNF protein
Tacrolimus results in decreased expression of TNF mRNA; Tacrolimus results in decreased expression of TNF protein
Tacrolimus results in decreased secretion of TNF protein
CTD PMID:1371491 PMID:10339586 PMID:10385251 PMID:10685002 PMID:11121130 More... NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link
G Tnfaip8l2 TNF alpha induced protein 8 like 2 increases expression ISO Tacrolimus results in increased expression of TNFAIP8L2 mRNA CTD PMID:29362864 NCBI chr 2:182,710,433...182,726,724
Ensembl chr 2:185,397,029...185,418,455
JBrowse link
G Tnfrsf11b TNF receptor superfamily member 11B decreases expression EXP Tacrolimus results in decreased expression of TNFRSF11B mRNA CTD PMID:21865292 NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:87,456,319...87,485,075
JBrowse link
G Tnfsf11 TNF superfamily member 11 multiple interactions ISO Tacrolimus inhibits the reaction [TNFSF11 protein results in increased expression of ACP5 protein]; Tacrolimus inhibits the reaction [TNFSF11 protein results in increased expression of CALCR mRNA] CTD PMID:15207740 PMID:21869564 NCBI chr15:53,673,850...53,705,325
Ensembl chr15:60,083,008...60,114,479
JBrowse link
G Tnnt2 troponin T2, cardiac type increases expression ISO Tacrolimus results in increased expression of TNNT2 protein CTD PMID:12975596 NCBI chr13:47,267,325...47,285,390
Ensembl chr13:49,822,304...49,837,125
JBrowse link
G Tp53 tumor protein p53 multiple interactions EXP
ISO
Tacrolimus inhibits the reaction [Hydrogen Peroxide results in increased expression of TP53 protein]
Tacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in increased expression of TRP53 protein]
CTD PMID:10205001 PMID:12642403 NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,798,851...54,810,299
JBrowse link
G Trib3 tribbles pseudokinase 3 increases expression ISO Tacrolimus results in increased expression of TRIB3 mRNA CTD PMID:23958496 NCBI chr 3:161,269,939...161,275,533
Ensembl chr 3:161,269,955...161,274,802
JBrowse link
G Trim2 tripartite motif-containing 2 decreases expression ISO Tacrolimus results in decreased expression of TRIM2 mRNA CTD PMID:25270620 NCBI chr 2:169,500,628...169,652,855
Ensembl chr 2:171,798,660...171,913,468
JBrowse link
G Trip13 thyroid hormone receptor interactor 13 increases expression ISO Tacrolimus results in increased expression of TRIP13 mRNA CTD PMID:29362864 NCBI chr 1:31,185,700...31,230,638
Ensembl chr 1:31,185,594...31,230,634
JBrowse link
G Trpm6 transient receptor potential cation channel, subfamily M, member 6 decreases expression EXP Tacrolimus results in decreased expression of TRPM6 mRNA CTD PMID:14978156 NCBI chr 1:225,559,528...225,747,106
Ensembl chr 1:225,576,872...225,747,108
JBrowse link
G Trpv1 transient receptor potential cation channel, subfamily V, member 1 multiple interactions ISO
EXP
Tacrolimus results in increased phosphorylation of and affects the activity of TRPV1 protein
Tacrolimus affects the reaction [resiniferatoxin affects the reaction [[Sodium Chloride co-treated with benzamil] results in increased activity of TRPV1 protein]]
CTD PMID:19553475 NCBI chr10:57,851,428...57,876,513
Ensembl chr10:58,340,223...58,375,021
JBrowse link
G Trpv5 transient receptor potential cation channel, subfamily V, member 5 decreases expression EXP Tacrolimus results in decreased expression of TRPV5 mRNA; Tacrolimus results in decreased expression of TRPV5 protein CTD PMID:14978156 NCBI chr 4:70,536,432...70,562,743
Ensembl chr 4:71,503,093...71,529,384
JBrowse link
G Txn1 thioredoxin 1 decreases expression EXP Tacrolimus results in decreased expression of TXN mRNA CTD PMID:17085464 NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307
JBrowse link
G Ubd ubiquitin D increases expression ISO Tacrolimus results in increased expression of UBD mRNA CTD PMID:29362864 NCBI chr20:1,390,734...1,392,685
Ensembl chr20:1,390,600...1,413,965
JBrowse link
G Utf1 undifferentiated embryonic cell transcription factor 1 decreases expression ISO Tacrolimus results in decreased expression of UTF1 mRNA CTD PMID:25270620 NCBI chr 1:194,740,339...194,741,465
Ensembl chr 1:204,169,954...204,171,080
JBrowse link
G Vasn vasorin decreases expression EXP Tacrolimus results in decreased expression of VASN mRNA CTD PMID:17028423 NCBI chr10:11,424,174...11,434,681
Ensembl chr10:11,417,327...11,450,704
JBrowse link
G Vasp vasodilator-stimulated phosphoprotein decreases expression ISO Tacrolimus results in decreased expression of VASP mRNA CTD PMID:29380240 NCBI chr 1:88,038,026...88,053,783
Ensembl chr 1:88,038,037...88,058,650
JBrowse link
G Vcam1 vascular cell adhesion molecule 1 increases expression ISO Tacrolimus results in increased expression of VCAM1 mRNA CTD PMID:23958496 PMID:29362864 NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:206,723,044...206,742,801
JBrowse link
G Vcan versican increases expression EXP Tacrolimus results in increased expression of VCAN mRNA CTD PMID:21865292 NCBI chr 2:20,761,718...20,860,637
Ensembl chr 2:22,497,035...22,595,955
JBrowse link
G Vegfa vascular endothelial growth factor A increases expression EXP Tacrolimus results in increased expression of VEGFA protein CTD PMID:17703430 NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
JBrowse link
G Vim vimentin increases expression ISO Tacrolimus results in increased expression of VIM protein CTD PMID:22416070 PMID:29362864 NCBI chr17:76,668,701...76,677,186
Ensembl chr17:81,568,272...81,585,746
JBrowse link
G Wdfy4 WDFY family member 4 increases expression ISO Tacrolimus results in increased expression of WDFY4 mRNA CTD PMID:29362864 NCBI chr16:8,221,853...8,450,494
Ensembl chr16:8,228,147...8,456,761
JBrowse link
G Wdr31 WD repeat domain 31 decreases expression ISO Tacrolimus results in decreased expression of WDR31 mRNA CTD PMID:25270620 NCBI chr 5:80,914,338...80,933,022
Ensembl chr 5:80,908,726...80,933,046
JBrowse link
G Wdr54 WD repeat domain 54 decreases expression ISO Tacrolimus results in decreased expression of WDR54 mRNA CTD PMID:25270620 NCBI chr 4:115,654,968...115,677,979
Ensembl chr 4:117,212,677...117,219,270
JBrowse link
G Wdr73 WD repeat domain 73 decreases expression ISO Tacrolimus results in decreased expression of WDR73 mRNA CTD PMID:25270620 NCBI chr 1:134,860,329...134,868,475
Ensembl chr 1:144,269,562...144,277,840
JBrowse link
G Wfdc17 WAP four-disulfide core domain 17 increases expression ISO Tacrolimus results in increased expression of WFDC17 mRNA CTD PMID:29362864 NCBI chr10:68,561,954...68,562,801 JBrowse link
G Wfdc18 WAP four-disulfide core domain 18 increases expression ISO Tacrolimus results in increased expression of WFDC18 mRNA CTD PMID:29362864 NCBI chr10:68,588,818...68,590,972
Ensembl chr10:69,086,319...69,087,172
JBrowse link
G Wnk3 WNK lysine deficient protein kinase 3 increases phosphorylation ISO Tacrolimus results in increased phosphorylation of WNK3 protein CTD PMID:21963515 NCBI chr  X:20,156,260...20,299,252
Ensembl chr  X:23,599,305...23,742,290
JBrowse link
G Wnk4 WNK lysine deficient protein kinase 4 increases phosphorylation ISO Tacrolimus results in increased phosphorylation of WNK4 protein CTD PMID:21963515 NCBI chr10:86,202,552...86,219,655
Ensembl chr10:86,702,865...86,720,198
JBrowse link
G Xbp1 X-box binding protein 1 multiple interactions
increases expression
ISO Tacrolimus results in increased expression of and affects the localization of XBP1 protein modified form
Tacrolimus results in increased expression of XBP1 mRNA
CTD PMID:23958496 PMID:25270620 NCBI chr14:80,390,629...80,395,713
Ensembl chr14:84,604,107...84,609,706
JBrowse link
G Xcl1 X-C motif chemokine ligand 1 increases expression ISO Tacrolimus results in increased expression of XCL1 mRNA CTD PMID:29362864 NCBI chr13:77,248,687...77,252,343
Ensembl chr13:79,781,784...79,785,440
JBrowse link
G Zfyve16 zinc finger FYVE-type containing 16 increases expression ISO Tacrolimus results in increased expression of ZFYVE16 mRNA CTD PMID:25270620 NCBI chr 2:23,713,018...23,757,576
Ensembl chr 2:25,448,829...25,483,295
JBrowse link
water term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Agrp agouti related neuropeptide multiple interactions EXP [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of AGRP mRNA; AM 251 promotes the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of AGRP mRNA] CTD PMID:26468265 NCBI chr19:33,447,992...33,481,602
Ensembl chr19:50,357,905...50,358,698
JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of AKT1 mRNA CTD PMID:29335169 NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
JBrowse link
G Aqp1 aquaporin 1 increases transport
multiple interactions
ISO
EXP
AQP1 protein results in increased transport of Water
Mercuric Chloride inhibits the reaction [AQP1 protein results in increased transport of Water]; Mercury inhibits the reaction [AQP1 protein results in increased transport of Water]
CTD PMID:7528928 PMID:8457558 PMID:10559675 PMID:11035042 PMID:11078688 More... NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:85,812,784...85,830,504
JBrowse link
G Aqp11 aquaporin 11 multiple interactions
increases transport
ISO Mercaptoethanol inhibits the reaction [Mercuric Chloride inhibits the reaction [AQP11 protein results in increased transport of Water]]; Mercuric Chloride inhibits the reaction [AQP11 protein results in increased transport of Water] CTD PMID:21251984 NCBI chr 1:152,046,515...152,056,675
Ensembl chr 1:161,457,754...161,467,945
JBrowse link
G Aqp2 aquaporin 2 increases expression EXP Water deficiency results in increased expression of AQP2 mRNA CTD PMID:15462210 NCBI chr 7:130,711,433...130,716,468
Ensembl chr 7:132,590,225...132,595,319
JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) multiple interactions
increases expression
increases transport
ISO
EXP
Dexamethasone promotes the reaction [AQP3 protein results in increased transport of Water]; Mercaptoethanol inhibits the reaction [Mercuric Chloride inhibits the reaction [AQP3 protein results in increased transport of Water]]; Mercuric Chloride inhibits the reaction [AQP3 protein results in increased transport of Water]; Mercuric Chloride inhibits the reaction [Dexamethasone promotes the reaction [AQP3 protein results in increased transport of Water]]
Water deficiency results in increased expression of AQP3 mRNA; Water deficiency results in increased expression of AQP3 protein
Copper Sulfate inhibits the reaction [AQP3 protein results in increased transport of Water]; Mercuric Chloride inhibits the reaction [AQP3 protein results in increased transport of Water]
CTD PMID:9124401 PMID:9374739 PMID:15462210 PMID:22687538 NCBI chr 5:56,239,200...56,244,718
Ensembl chr 5:61,035,166...61,040,685
JBrowse link
G Aqp4 aquaporin 4 increases transport
increases response to substance
increases expression
affects transport
EXP
ISO
AQP4 protein results in increased transport of Water
AQP4 protein results in increased susceptibility to Water
Water deficiency results in increased expression of AQP4 mRNA
AQP4 protein affects the transport of Water
CTD PMID:7528931 PMID:15462210 PMID:20815926 PMID:21251984 NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,782,389...6,799,098
JBrowse link
G Aqp7 aquaporin 7 affects transport
increases transport
EXP AQP7 protein affects the transport of Water
AQP7 protein results in increased transport of Water
CTD PMID:9252401 PMID:18059526 NCBI chr 5:56,171,649...56,186,642
Ensembl chr 5:60,967,558...60,982,618
JBrowse link
G Aqp8 aquaporin 8 multiple interactions
increases transport
affects transport
EXP
ISO
Copper affects the reaction [AQP8 protein affects the transport of Water]; Mercury affects the reaction [AQP8 protein affects the transport of Water]
AQP8 protein results in increased transport of Water
Mercuric Chloride inhibits the reaction [AQP8 protein results in increased transport of Water]
CTD PMID:18059526 PMID:19840149 NCBI chr 1:177,993,313...177,999,158
Ensembl chr 1:187,424,417...187,430,242
JBrowse link
G Aqp9 aquaporin 9 multiple interactions
increases transport
affects transport
EXP
ISO
CFTR protein promotes the reaction [AQP9 protein affects the transport of Water]; lonidamine inhibits the reaction [CFTR protein promotes the reaction [AQP9 protein affects the transport of Water]]; Mercuric Chloride inhibits the reaction [AQP9 protein results in increased transport of Water]; Mercury inhibits the reaction [AQP9 protein results in increased transport of Water]; Phloretin inhibits the reaction [AQP9 protein results in increased transport of Water]; Phloretin inhibits the reaction [CFTR protein promotes the reaction [AQP9 protein affects the transport of Water]] CTD PMID:9514918 PMID:9733774 PMID:10205677 PMID:12606488 PMID:21259319 More... NCBI chr 8:80,678,027...80,718,273
Ensembl chr 8:80,678,030...80,717,240
JBrowse link
G Avp arginine vasopressin multiple interactions EXP [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of AVP mRNA; [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased secretion of AVP protein; AM 251 promotes the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of AVP mRNA]; arachidonyl-2-chloroethylamide inhibits the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of AVP mRNA] CTD PMID:26468265 NCBI chr 3:117,793,447...117,805,091
Ensembl chr 3:138,246,554...138,248,522
JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of BCL2 mRNA CTD PMID:29335169 NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
JBrowse link
G Becn1 beclin 1 multiple interactions ISO [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of BECN1 protein; Berberine promotes the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of BECN1 protein] CTD PMID:38705399 NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,731,650...86,747,002
JBrowse link
G Bnip3 BCL2 interacting protein 3 multiple interactions ISO [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of BNIP3 protein; Berberine promotes the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of BNIP3 protein] CTD PMID:38705399 NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:203,137,778...203,154,962
JBrowse link
G Cartpt CART prepropeptide multiple interactions EXP [AM 251 co-treated with Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of CARTPT mRNA; [arachidonyl-2-chloroethylamide co-treated with Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of CARTPT mRNA CTD PMID:26468265 NCBI chr 2:31,255,098...31,257,452
Ensembl chr 2:32,989,215...32,999,712
JBrowse link
G Casp1 caspase 1 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which affects the expression of CASP1 mRNA; [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of and results in increased cleavage of CASP1 protein; [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CASP1 mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of and results in increased cleavage of CASP1 protein]; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CASP1 mRNA] CTD PMID:29335169 PMID:38705399 NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:10,746,333...10,882,275
JBrowse link
G Casp3 caspase 3 multiple interactions EXP [Water deficiency co-treated with Diclofenac] results in increased expression of CASP3 protein; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in increased expression of CASP3 protein] CTD PMID:31042592 NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
JBrowse link
G Cat catalase multiple interactions EXP
ISO
[Water deficiency co-treated with Diclofenac] results in decreased activity of CAT protein; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in decreased activity of CAT protein]
[[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of CAT mRNA
CTD PMID:29335169 PMID:31042592 NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions EXP
ISO
[Water deficiency co-treated with Diclofenac] results in increased expression of CCL2 protein; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in increased expression of CCL2 protein]
[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CCL2 mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CCL2 mRNA]
CTD PMID:31042592 PMID:38705399 NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,503,077...67,504,875
JBrowse link
G Cftr CF transmembrane conductance regulator multiple interactions EXP 1-Methyl-3-isobutylxanthine promotes the reaction [CFTR protein affects the transport of Water]; CFTR protein promotes the reaction [AQP9 protein affects the transport of Water]; lonidamine inhibits the reaction [CFTR protein promotes the reaction [AQP9 protein affects the transport of Water]]; N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [CFTR protein affects the transport of Water]; Phloretin inhibits the reaction [CFTR protein promotes the reaction [AQP9 protein affects the transport of Water]] CTD PMID:12606488 NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:47,526,735...47,694,643
JBrowse link
G Cnr1 cannabinoid receptor 1 multiple interactions EXP [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of CNR1 mRNA; [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of CNR1 protein CTD PMID:26468265 NCBI chr 5:48,408,543...48,436,099
Ensembl chr 5:53,204,260...53,239,252
JBrowse link
G Col3a1 collagen type III alpha 1 chain multiple interactions EXP [Water deficiency co-treated with Diclofenac] results in increased expression of COL3A1 protein; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in increased expression of COL3A1 protein] CTD PMID:31042592 NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:54,866,632...54,903,232
JBrowse link
G Cr1l complement C3b/C4b receptor 1 like multiple interactions EXP [Water deficiency co-treated with Diclofenac] results in decreased expression of CR1L protein; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in decreased expression of CR1L protein] CTD PMID:31042592 NCBI chr13:106,606,952...106,660,442
Ensembl chr13:109,103,235...109,188,869
JBrowse link
G Crh corticotropin releasing hormone multiple interactions EXP [AM 251 co-treated with Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of CRH mRNA CTD PMID:26468265 NCBI chr 2:102,143,055...102,144,919
Ensembl chr 2:104,058,770...104,061,386
JBrowse link
G Cst3 cystatin C multiple interactions ISO [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CST3 protein; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of CST3 protein] CTD PMID:38705399 NCBI chr 3:156,790,061...156,794,116
Ensembl chr 3:156,790,079...156,793,937
JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in decreased expression of CYP1A1 mRNA CTD PMID:29335169 NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:66,991,970...66,998,012
JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in decreased expression of CYP2E1 mRNA CTD PMID:29335169 NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:205,267,505...205,293,495
JBrowse link
G Edn1 endothelin 1 affects export ISO EDN1 protein affects the export of Water CTD PMID:16340664 NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,660,799...22,666,687
JBrowse link
G Fgf2 fibroblast growth factor 2 increases expression ISO Water results in increased expression of FGF2 mRNA CTD PMID:26800359 NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:122,164,454...122,224,493
JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of GCLC mRNA CTD PMID:29335169 NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:87,510,463...87,548,893
JBrowse link
G Gpx1 glutathione peroxidase 1 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of GPX1 mRNA CTD PMID:29335169 NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:117,905,280...117,906,581
JBrowse link
G Gsr glutathione-disulfide reductase multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of GSR mRNA CTD PMID:29335169 NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
JBrowse link
G Hbegf heparin-binding EGF-like growth factor decreases expression ISO Water results in decreased expression of HBEGF mRNA CTD PMID:26800359 NCBI chr18:28,106,284...28,116,167
Ensembl chr18:28,380,337...28,390,220
JBrowse link
G Hcrt hypocretin neuropeptide precursor multiple interactions EXP [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of HCRT mRNA; AM 251 inhibits the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of HCRT mRNA] CTD PMID:26468265 NCBI chr10:85,689,979...85,691,214
Ensembl chr10:86,189,775...86,191,524
JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions ISO [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of HMGB1 protein; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of HMGB1 protein] CTD PMID:38705399 NCBI chr12:5,972,950...5,979,658
Ensembl chr16:39,039,050...39,041,327
Ensembl chr12:39,039,050...39,041,327
JBrowse link
G Hmox1 heme oxygenase 1 increases expression
multiple interactions
EXP
ISO
Water deficiency results in increased expression of HMOX1 protein
[[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of HMOX1 mRNA
CTD PMID:22060896 PMID:29335169 NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
JBrowse link
G Hpgds hematopoietic prostaglandin D synthase multiple interactions ISO Water affects the reaction [Isoquinolines analog binds to and results in decreased activity of HPGDS protein] CTD PMID:22546671 NCBI chr 4:94,368,426...94,397,931
Ensembl chr 4:95,702,392...95,938,501
JBrowse link
G Il10 interleukin 10 multiple interactions EXP [Gum Arabic co-treated with Water deficiency co-treated with Diclofenac] results in increased expression of IL10 protein CTD PMID:31042592 NCBI chr13:45,024,921...45,029,586
Ensembl chr13:45,025,087...45,029,580
JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP
ISO
[Water deficiency co-treated with Diclofenac] results in increased expression of IL1B protein; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in increased expression of IL1B protein]
[[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of IL1B mRNA; [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL1B mRNA; [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL1B protein; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL1B mRNA]; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL1B protein]
CTD PMID:29335169 PMID:31042592 PMID:38705399 NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:137,030,205...137,036,601
JBrowse link
G Il6 interleukin 6 multiple interactions ISO [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL6 mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of IL6 mRNA] CTD PMID:38705399 NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,889,999...5,894,610
JBrowse link
G Mt2 metallothionein 2 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which affects the expression of MT2 mRNA CTD PMID:29335169 NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,837,927...10,838,709
JBrowse link
G Nfe2l2 NFE2 like bZIP transcription factor 2 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of NFE2L2 mRNA CTD PMID:29335169 NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:81,001,529...81,029,090
JBrowse link
G Nlrp3 NLR family, pyrin domain containing 3 multiple interactions ISO [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of NLRP3 mRNA; [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of NLRP3 protein; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of NLRP3 mRNA]; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of NLRP3 protein] CTD PMID:38705399 NCBI chr10:44,826,299...44,853,373
Ensembl chr10:44,828,014...44,853,394
JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of NOS2 mRNA CTD PMID:29335169 NCBI chr10:64,313,335...64,349,221
Ensembl chr10:64,313,335...64,401,880
JBrowse link
G Npy neuropeptide Y multiple interactions EXP [AM 251 co-treated with Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of NPY mRNA CTD PMID:26468265 NCBI chr 4:78,881,294...78,888,495
Ensembl chr 4:80,212,111...80,219,310
JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of NQO1 mRNA CTD PMID:29335169 NCBI chr19:52,205,374...52,220,267
Ensembl chr19:52,205,314...52,220,260
JBrowse link
G Oxt oxytocin/neurophysin I prepropeptide multiple interactions EXP [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of OXT mRNA; [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased secretion of OXT protein; AM 251 promotes the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of OXT mRNA]; arachidonyl-2-chloroethylamide inhibits the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of OXT mRNA]; arachidonyl-2-chloroethylamide inhibits the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased secretion of OXT protein] CTD PMID:26468265 NCBI chr 3:117,782,650...117,783,490
Ensembl chr 3:138,235,754...138,236,594
JBrowse link
G Pmch pro-melanin-concentrating hormone multiple interactions EXP [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of PMCH mRNA; arachidonyl-2-chloroethylamide promotes the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of PMCH mRNA] CTD PMID:26468265 NCBI chr 7:22,511,934...22,513,250
Ensembl chr 7:24,399,404...24,400,720
JBrowse link
G Pomc proopiomelanocortin multiple interactions EXP [Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of POMC mRNA; AM 251 promotes the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of POMC mRNA]; arachidonyl-2-chloroethylamide inhibits the reaction [[Water deficiency co-treated with Sodium Chloride, Dietary deficiency] results in increased expression of POMC mRNA] CTD PMID:26468265 NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:32,659,346...32,665,173
JBrowse link
G Pycard PYD and CARD domain containing multiple interactions ISO [Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of PYCARD mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of PYCARD mRNA] CTD PMID:38705399 NCBI chr 1:182,601,657...182,603,013
Ensembl chr 1:192,032,124...192,033,419
JBrowse link
G Slc12a1 solute carrier family 12 member 1 multiple interactions
increases import
EXP [Glucose results in increased activity of SLC12A1 protein] which results in increased import of Water; [Mannitol results in increased activity of SLC12A1 protein] which results in increased import of Water
SLC12A1 protein results in increased import of Water
CTD PMID:12433675 NCBI chr 3:112,406,140...112,482,913
Ensembl chr 3:132,859,590...132,936,340
JBrowse link
G Slc5a3 solute carrier family 5 member 3 increases expression ISO Water deficiency results in increased expression of SLC5A3 mRNA CTD PMID:21219332 NCBI chr11:44,799,787...44,802,233
Ensembl chr11:44,790,297...44,818,157
JBrowse link
G Sod1 superoxide dismutase 1 multiple interactions ISO [[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of SOD1 mRNA CTD PMID:29335169 NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
JBrowse link
G Sod2 superoxide dismutase 2 increases expression
multiple interactions
ISO Water deficiency results in increased expression of SOD2 protein
[[Particulate Matter co-treated with Water] results in increased abundance of Metals] which results in increased expression of SOD2 mRNA
CTD PMID:22718889 PMID:29335169 NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:50,043,325...50,050,168
JBrowse link
G Sqstm1 sequestosome 1 multiple interactions ISO [Berberine co-treated with Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of SQSTM1 protein CTD PMID:38705399 NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
JBrowse link
G Tac1 tachykinin, precursor 1 multiple interactions EXP TAC1 protein alternative form inhibits the reaction [Cholera Toxin results in increased secretion of Water]; TAC1 protein inhibits the reaction [Cholera Toxin results in increased secretion of Water] CTD PMID:11040190 NCBI chr 4:35,679,183...35,687,180
Ensembl chr 4:36,645,571...36,653,546
JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP
ISO
[Water deficiency co-treated with Diclofenac] results in increased expression of TNF protein; Gum Arabic inhibits the reaction [[Water deficiency co-treated with Diclofenac] results in increased expression of TNF protein]
[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of TNF mRNA; Berberine inhibits the reaction [[Water deficiency co-treated with NG-Nitroarginine Methyl Ester co-treated with Indomethacin co-treated with Iohexol] results in increased expression of TNF mRNA]
CTD PMID:31042592 PMID:38705399 NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 20862
    chemical entity 20860
      molecular entity 20859
        inorganic molecular entity 20593
          inorganic hydroxy compound 773
            ammonium hydroxide 2
            metallic base + 38
            trioxidane + 0
            water + 754
Path 2
Term Annotations click to browse term
  CHEBI ontology 20862
    subatomic particle 20860
      composite particle 20860
        hadron 20860
          baryon 20860
            nucleon 20860
              atomic nucleus 20860
                atom 20860
                  main group element atom 20781
                    p-block element atom 20781
                      p-block molecular entity 20781
                        chalcogen molecular entity 20491
                          oxygen molecular entity 20457
                            hydroxides 20230
                              inorganic hydroxy compound 773
                                ammonium hydroxide 2
                                metallic base + 38
                                trioxidane + 0
                                water + 754
paths to the root